קוד ATC code - ATC
מפתח קודי ATC
Anatomical Therapeutic Chemical (ATC) Classification System
מפתח זה לא כולל מוצרים וטרינריים המסווגים תחת סיווג ATCvet (Anatomical Therapeutic Chemical Classification System for veterinary medicinal products)
גישה מהירה A / B / C / D / G / H / J / L / M / N / P / R / S / V
- הטבלא ניתנת למיון לפי כל אחת מהעמודות
| 1st level | 2nd level | 3rd level | 4th level | 5th level | Contents |
|---|---|---|---|---|---|
| A | Alimentary tract and metabolism | ||||
| A01 | Stomatological preparations | ||||
| A01A | Stomatological preparations | ||||
| A01AA | Caries prophylactic agents | ||||
| A01AA01 | Sodium fluoride | ||||
| A01AA02 | Sodium monofluorophosphate | ||||
| A01AA03 | Olaflur | ||||
| A01AA04 | Stannous fluoride | ||||
| A01AA30 | Combinations | ||||
| A01AA51 | Sodium fluoride, combinations | ||||
| A01AB | Anti-infectives and antiseptics for local oral treatment | ||||
| A01AB02 | Hydrogen peroxide | ||||
| A01AB03 | Chlorhexidine | ||||
| A01AB04 | Amphotericin B | ||||
| A01AB05 | Polynoxylin | ||||
| A01AB06 | Domiphen | ||||
| A01AB07 | Oxyquinoline | ||||
| A01AB08 | Neomycin | ||||
| A01AB09 | Miconazole | ||||
| A01AB10 | Natamycin | ||||
| A01AB11 | Various | ||||
| A01AB12 | Hexetidine | ||||
| A01AB13 | Tetracycline | ||||
| A01AB14 | Benzoxonium chloride | ||||
| A01AB15 | Tibezonium iodide | ||||
| A01AB16 | Mepartricin | ||||
| A01AB17 | Metronidazole | ||||
| A01AB18 | Clotrimazole | ||||
| A01AB19 | Sodium perborate | ||||
| A01AB21 | Chlortetracycline | ||||
| A01AB22 | Doxycycline | ||||
| A01AB23 | Minocycline | ||||
| A01AC | Corticosteroids for local oral treatment | ||||
| A01AC01 | Triamcinolone | ||||
| A01AC02 | Dexamethasone | ||||
| A01AC03 | Hydrocortisone | ||||
| A01AC54 | Prednisolone, combinations | ||||
| A01AD | Other agents for local oral treatment | ||||
| A01AD01 | Epinephrine | ||||
| A01AD02 | Benzydamine | ||||
| A01AD05 | Acetylsalicylic acid | ||||
| A01AD06 | Adrenalone | ||||
| A01AD07 | Amlexanox | ||||
| A01AD08 | Becaplermin | ||||
| A01AD11 | Various | ||||
| A02 | Drugs for acid related disorders | ||||
| A02A | Antacids | ||||
| A02AA | Magnesium compounds | ||||
| A02AA01 | Magnesium carbonate | ||||
| A02AA02 | Magnesium oxide | ||||
| A02AA03 | Magnesium peroxide | ||||
| A02AA04 | Magnesium hydroxide | ||||
| A02AA05 | Magnesium silicate | ||||
| A02AA10 | Combinations | ||||
| A02AB | Aluminium compounds | ||||
| A02AB01 | Aluminium hydroxide | ||||
| A02AB02 | Algeldrate | ||||
| A02AB03 | Aluminium phosphate | ||||
| A02AB04 | Dihydroxialumini sodium carbonate | ||||
| A02AB05 | Aluminium acetoacetate | ||||
| A02AB06 | Aloglutamol | ||||
| A02AB07 | Aluminium glycinate | ||||
| A02AB10 | Combinations | ||||
| A02AC | Calcium compounds | ||||
| A02AC01 | Calcium carbonate | ||||
| A02AC02 | Calcium silicate | ||||
| A02AC10 | Combinations | ||||
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | ||||
| A02AD01 | Ordinary salt combinations | ||||
| A02AD02 | Magaldrate | ||||
| A02AD03 | Almagate | ||||
| A02AD04 | Hydrotalcite | ||||
| A02AD05 | Almasilate | ||||
| A02AF | Antacids with antiflatulents | ||||
| A02AF01 | Magaldrate and antiflatulents | ||||
| A02AF02 | Ordinary salt combinations and antiflatulents | ||||
| A02AG | Antacids with antispasmodics | ||||
| Empty | |||||
| A02AH | Antacids with sodium bicarbonate | ||||
| Empty | |||||
| A02AX | Antacids, other combinations | ||||
| Empty | |||||
| A02B | Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | ||||
| A02BA | H2-receptor antagonists | ||||
| A02BA01 | Cimetidine | ||||
| A02BA02 | Ranitidine | ||||
| A02BA03 | Famotidine | ||||
| A02BA04 | Nizatidine | ||||
| A02BA05 | Niperotidine | ||||
| A02BA06 | Roxatidine | ||||
| A02BA07 | Ranitidine bismuth citrate | ||||
| A02BA08 | Lafutidine | ||||
| A02BA51 | Cimetidine, combinations | ||||
| A02BA53 | Famotidine, combinations | ||||
| A02BB | Prostaglandins | ||||
| A02BB01 | Misoprostol | ||||
| A02BB02 | Enprostil | ||||
| A02BC | Proton pump inhibitors | ||||
| A02BC01 | Omeprazole | ||||
| A02BC02 | Pantoprazole | ||||
| A02BC03 | Lansoprazole | ||||
| A02BC04 | Rabeprazole | ||||
| A02BC05 | Esomeprazole | ||||
| A02BC06 | Dexlansoprazole | ||||
| A02BC07 | dexrabeprazole | ||||
| A02BC08 | vonoprazan | ||||
| A02BC09 | tegoprazan | ||||
| A02BC10 | fexuprazan | ||||
| A02BC11 | ilaprazole | ||||
| A02BC51 | omeprazole, combinations | ||||
| A02BC53 | lansoprazole, combinations | ||||
| A02BC54 | rabeprazole, combinations | ||||
| A02BD | Combinations for eradication of Helicobacter pylori | ||||
| A02BD01 | Omeprazole, amoxicillin and metronidazole | ||||
| A02BD02 | Lansoprazole, tetracycline and metronidazole | ||||
| A02BD03 | Lansoprazole, amoxicillin and metronidazole | ||||
| A02BD04 | Pantoprazole, amoxicillin and clarithromycin | ||||
| A02BD05 | Omeprazole, amoxicillin and clarithromycin | ||||
| A02BD06 | Esomeprazole, amoxicillin and clarithromycin | ||||
| A02BD07 | Lansoprazole, amoxicillin and clarithromycin | ||||
| A02BD08 | Bismuth subcitrate, tetracycline and metronidazole | ||||
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | ||||
| A02BX01 | Carbenoxolone | ||||
| A02BX02 | Sucralfate | ||||
| A02BX03 | Pirenzepine | ||||
| A02BX04 | Methiosulfonium chloride | ||||
| A02BX05 | Bismuth subcitrate | ||||
| A02BX06 | Proglumide | ||||
| A02BX07 | Gefarnate | ||||
| A02BX08 | Sulglicotide | ||||
| A02BX09 | Acetoxolone | ||||
| A02BX10 | Zolimidine | ||||
| A02BX11 | Troxipide | ||||
| A02BX12 | Bismuth subnitrate | ||||
| A02BX13 | Alginic acid | ||||
| A02BX51 | Carbenoxolone, combinations excluding psycholeptics | ||||
| A02BX71 | Carbenoxolone, combinations with psycholeptics | ||||
| A02BX77 | Gefarnate, combinations with psycholeptics | ||||
| A02X | Other drugs for acid related disorders | ||||
| Empty | |||||
| A03 | Drugs for functional gastrointestinal disorders | ||||
| A03A | Drugs for functional gastrointestinal disorders | ||||
| A03AA | Synthetic anticholinergics, esters with tertiary amino group | ||||
| A03AA01 | Oxyphencyclimine | ||||
| A03AA03 | Camylofin | ||||
| A03AA04 | Mebeverine | ||||
| A03AA05 | Trimebutine | ||||
| A03AA06 | Rociverine | ||||
| A03AA07 | Dicycloverine | ||||
| A03AA08 | Dihexyverine | ||||
| A03AA09 | Difemerine | ||||
| A03AA30 | Piperidolate | ||||
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds | ||||
| A03AB01 | Benzilone | ||||
| A03AB02 | Glycopyrronium | ||||
| A03AB03 | Oxyphenonium | ||||
| A03AB04 | Penthienate | ||||
| A03AB05 | Propantheline | ||||
| A03AB06 | Otilonium bromide | ||||
| A03AB07 | Methantheline | ||||
| A03AB08 | Tridihexethyl | ||||
| A03AB09 | Isopropamide | ||||
| A03AB10 | Hexocyclium | ||||
| A03AB11 | Poldine | ||||
| A03AB12 | Mepenzolate | ||||
| A03AB13 | Bevonium | ||||
| A03AB14 | Pipenzolate | ||||
| A03AB15 | Diphemanil | ||||
| A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide | ||||
| A03AB17 | Tiemonium iodide | ||||
| A03AB18 | Prifinium bromide | ||||
| A03AB19 | Timepidium bromide | ||||
| A03AB21 | Fenpiverinium | ||||
| A03AB53 | Oxyphenonium, combinations | ||||
| A03AC | Synthetic antispasmodics, amides with tertiary amines | ||||
| A03AC02 | Dimethylaminopropionylphenothiazine | ||||
| A03AC04 | Nicofetamide | ||||
| A03AC05 | Tiropramide | ||||
| A03AD | Papaverine and derivatives | ||||
| A03AD01 | Papaverine | ||||
| A03AD02 | Drotaverine | ||||
| A03AD30 | Moxaverine | ||||
| A03AE | Serotonin receptor antagonists | ||||
| A03AE01 | Alosetron | ||||
| A03AE02 | tegaserod (New ATC code A06AX06) | ||||
| A03AE03 | Cilansetron | ||||
| A03AE04 | prucalopride (New ATC code A06AX05) | ||||
| A03AX | Other drugs for functional gastrointestinal disorders | ||||
| A03AX01 | Fenpiprane | ||||
| A03AX02 | Diisopromine | ||||
| A03AX03 | Chlorbenzoxamine | ||||
| A03AX04 | Pinaverium | ||||
| A03AX05 | Fenoverine | ||||
| A03AX06 | Idanpramine | ||||
| A03AX07 | Proxazole | ||||
| A03AX08 | Alverine | ||||
| A03AX09 | Trepibutone | ||||
| A03AX10 | Isometheptene | ||||
| A03AX11 | Caroverine | ||||
| A03AX12 | Phloroglucinol | ||||
| A03AX13 | Silicones | ||||
| A03AX30 | Trimethyldiphenylpropylamine | ||||
| A03AX58 | Alverine, combinations | ||||
| A03B | Belladonna and derivatives, plain | ||||
| A03BA | Belladonna alkaloids, tertiary amines | ||||
| A03BA01 | Atropine | ||||
| A03BA03 | Hyoscyamine | ||||
| A03BA04 | Belladonna total alkaloids | ||||
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | ||||
| A03BB01 | Butylscopolamine | ||||
| A03BB02 | Methylatropine | ||||
| A03BB03 | Methylscopolamine | ||||
| A03BB04 | Fentonium | ||||
| A03BB05 | Cimetropium bromide | ||||
| A03C | Antispasmodics in combination with psycholeptics | ||||
| A03CA | Synthetic anticholinergic agents in combination with psycholeptics | ||||
| A03CA01 | Isopropamide and psycholeptics | ||||
| A03CA02 | Clidinium and psycholeptics | ||||
| A03CA03 | Oxyphencyclimine and psycholeptics | ||||
| A03CA04 | Otilonium bromide and psycholeptics | ||||
| A03CA05 | Glycopyrronium and psycholeptics | ||||
| A03CA06 | Bevonium and psycholeptics | ||||
| A03CA07 | Ambutonium and psycholeptics | ||||
| A03CA08 | Diphemanil and psycholeptics | ||||
| A03CA30 | Emepronium and psycholeptics | ||||
| A03CA34 | Propantheline and psycholeptics | ||||
| A03CB | Belladonna and derivatives in combination with psycholeptics | ||||
| A03CB01 | Methylscopolamine and psycholeptics | ||||
| A03CB02 | Belladonna total alkaloids and psycholeptics | ||||
| A03CB03 | Atropine and psycholeptics | ||||
| A03CB04 | Methylhomatropine and psycholeptics | ||||
| A03CB31 | Hyoscyamine and psycholeptics | ||||
| A03CC | Other antispasmodics in combination with psycholeptics | ||||
| empty | |||||
| A03D | Antispasmodics in combination with analgesics | ||||
| A03DA | Synthetic anticholinergic agents in combination with analgesics | ||||
| A03DA01 | Tropenzilone and analgesics | ||||
| A03DA02 | Pitofenone and analgesics | ||||
| A03DA03 | Bevonium and analgesics | ||||
| A03DA04 | Ciclonium and analgesics | ||||
| A03DA05 | Camylofin and analgesics | ||||
| A03DA06 | Trospium and analgesics | ||||
| A03DA07 | Tiemonium iodide and analgesics | ||||
| A03DB | Belladonna and derivatives in combination with analgesics | ||||
| A03DB04 | Butylscopolamine and analgesics | ||||
| A03DC | Other antispasmodics in combination with analgesics | ||||
| empty | |||||
| A03E | Antispasmodics and anticholinergics in combination with other drugs | ||||
| A03EA | Antispasmodics, psycholeptics and analgesics in combination | ||||
| empty | |||||
| A03ED | Antispasmodics in combination with other drugs | ||||
| empty | |||||
| A03F | Propulsives | ||||
| A03FA | Propulsives | ||||
| A03FA01 | Metoclopramide | ||||
| A03FA02 | Cisapride | ||||
| A03FA03 | Domperidone | ||||
| A03FA04 | Bromopride | ||||
| A03FA05 | Alizapride | ||||
| A03FA06 | Clebopride | ||||
| A04 | Antiemetics and antinauseants | ||||
| A04A | Antiemetics and antinauseants | ||||
| A04AA | Serotonin (5-HT3) antagonists | ||||
| A04AA01 | Ondansetron | ||||
| A04AA02 | Granisetron | ||||
| A04AA03 | Tropisetron | ||||
| A04AA04 | Dolasetron | ||||
| A04AA05 | Palonosetron | ||||
| A04AA55 | palonosetron, combinations | ||||
| A04AD | Other antiemetics | ||||
| A04AD01 | Scopolamine | ||||
| A04AD02 | Cerium oxalate | ||||
| A04AD04 | Chlorobutanol | ||||
| A04AD05 | Metopimazine | ||||
| A04AD10 | Dronabinol | ||||
| A04AD11 | Nabilone | ||||
| A04AD12 | Aprepitant | ||||
| A04AD13 | Casopitant | ||||
| A04AD51 | Scopolamine, combinations | ||||
| A04AD54 | Chlorobutanol, combinations | ||||
| A05 | Bile and liver therapy | ||||
| A05A | Bile therapy | ||||
| A05AA | Bile acids and derivatives | ||||
| A05AA01 | Chenodeoxycholic acid | ||||
| A05AA02 | Ursodeoxycholic acid | ||||
| A05AA03 | Cholic acid | ||||
| A05AA04 | obeticholic acid | ||||
| A05AA05 | ursodoxicoltaurine | ||||
| A05AB | Preparations for biliary tract therapy | ||||
| A05AB01 | Nicotinyl methylamide | ||||
| A05AX | Other drugs for bile therapy | ||||
| A05AX01 | Piprozolin | ||||
| A05AX02 | Hymecromone | ||||
| A05AX03 | Cyclobutyrol | ||||
| A05AX04 | maralixibat chloride | ||||
| A05AX05 | odevixibat | ||||
| A05AX06 | elafibranor | ||||
| A05B | Liver therapy, lipotropics | ||||
| A05BA | Liver therapy | ||||
| A05BA01 | Arginine glutamate | ||||
| A05BA03 | Silymarin | ||||
| A05BA04 | Citiolone | ||||
| A05BA05 | Epomediol | ||||
| A05BA06 | Ornithine oxoglutarate | ||||
| A05BA07 | Tidiacic arginine | ||||
| A05BA08 | Glycyrrhizic acid (glycyrrhizin) | ||||
| A05C | Drugs for bile therapy and lipotropics in combination | ||||
| Empty | |||||
| A06 | Drugs for constipation | ||||
| A06A | Drugs for constipation | ||||
| A06AA | Softeners, emollients | ||||
| A06AA01 | Liquid paraffin | ||||
| A06AA02 | Docusate sodium | ||||
| A06AA51 | Liquid paraffin, combinations | ||||
| A06AB | Contact laxatives | ||||
| A06AB01 | Oxyphenisatine | ||||
| A06AB02 | Bisacodyl | ||||
| A06AB03 | Dantron | ||||
| A06AB04 | Phenolphthalein | ||||
| A06AB05 | Castor oil | ||||
| A06AB06 | Senna glycosides | ||||
| A06AB07 | Cascara | ||||
| A06AB08 | Sodium picosulfate | ||||
| A06AB09 | Bisoxatin | ||||
| A06AB20 | Contact laxatives in combination | ||||
| A06AB30 | Contact laxatives in combination with belladonna alkaloids | ||||
| A06AB52 | Bisacodyl, combinations | ||||
| A06AB53 | Dantron, combinations | ||||
| A06AB56 | Senna glycosides, combinations | ||||
| A06AB57 | Cascara, combinations | ||||
| A06AB58 | Sodium picosulfate, combinations | ||||
| A06AC | Bulk-forming laxatives | ||||
| A06AC01 | Ispaghula (psylla seeds) | ||||
| A06AC02 | Ethulose | ||||
| A06AC03 | Sterculia | ||||
| A06AC05 | Linseed | ||||
| A06AC06 | Methylcellulose | ||||
| A06AC07 | Triticum (wheat fibre) | ||||
| A06AC08 | Polycarbophil calcium | ||||
| A06AC51 | Ispaghula, combinations | ||||
| A06AC53 | Sterculia, combinations | ||||
| A06AC55 | Linseed, combinations | ||||
| A06AD | Osmotically acting laxatives | ||||
| A06AD01 | Magnesium carbonate | ||||
| A06AD02 | Magnesium oxide | ||||
| A06AD03 | Magnesium peroxide | ||||
| A06AD04 | Magnesium sulfate | ||||
| A06AD10 | Mineral salts in combination | ||||
| A06AD11 | Lactulose | ||||
| A06AD12 | Lactitol | ||||
| A06AD13 | Sodium sulfate | ||||
| A06AD14 | Pentaerithrityl | ||||
| A06AD15 | Macrogol | ||||
| A06AD16 | Mannitol | ||||
| A06AD17 | Sodium phosphate | ||||
| A06AD18 | Sorbitol | ||||
| A06AD19 | Magnesium citrate | ||||
| A06AD21 | Sodium tartrate | ||||
| A06AD61 | Lactulose, combinations | ||||
| A06AD65 | Macrogol, combinations | ||||
| A06AG | Enemas | ||||
| A06AG01 | Sodium phosphate | ||||
| A06AG02 | Bisacodyl | ||||
| A06AG03 | Dantron, including combinations | ||||
| A06AG04 | Glycerol | ||||
| A06AG06 | Oil | ||||
| A06AG07 | Sorbitol | ||||
| A06AG10 | Docusate sodium, including combinations | ||||
| A06AG11 | Laurilsulfate, including combinations | ||||
| A06AG20 | Combinations | ||||
| A06AH | Peripheral opioid receptor antagonists | ||||
| A06AH01 | Methylnaltrexone bromide | ||||
| A06AH02 | Alvimopan | ||||
| A06AH03 | naloxegol | ||||
| A06AH04 | naloxone | ||||
| A06AH05 | naldemedine | ||||
| A06AX | Other drugs for constipation | ||||
| A06AX01 | Glycerol | ||||
| A06AX02 | Carbon dioxide producing drugs | ||||
| A06AX03 | Lubiprostone | ||||
| A06AX04 | Linaclotide | ||||
| A06AX05 | Prucalopride | ||||
| A06AX06 | Tegaserod | ||||
| A06AX07 | plecanatide | ||||
| A06AX08 | tenapanor | ||||
| A06AX09 | elobixibat | ||||
| A07 | Antidiarrheals, intestinal anti-inflammatory/anti-infective agents | ||||
| A07A | Intestinal anti-infectives | ||||
| A07AA | Antibiotics | ||||
| A07AA01 | Neomycin | ||||
| A07AA02 | Nystatin | ||||
| A07AA03 | Natamycin | ||||
| A07AA04 | Streptomycin | ||||
| A07AA05 | Polymyxin B | ||||
| A07AA06 | Paromomycin | ||||
| A07AA07 | Amphotericin B | ||||
| A07AA08 | Kanamycin | ||||
| A07AA09 | Vancomycin | ||||
| A07AA10 | Colistin | ||||
| A07AA11 | Rifaximin | ||||
| A07AA12 | Fidaxomicin | ||||
| A07AA51 | Neomycin, combinations | ||||
| A07AA54 | Streptomycin, combinations | ||||
| A07AB | Sulfonamides | ||||
| A07AB02 | Phthalylsulfathiazole | ||||
| A07AB03 | Sulfaguanidine | ||||
| A07AB04 | Succinylsulfathiazole | ||||
| A07AC | Imidazole derivatives | ||||
| A07AC01 | Miconazole | ||||
| A07AX | Other intestinal anti-infectives | ||||
| A07AX01 | Broxyquinoline | ||||
| A07AX02 | Acetarsol | ||||
| A07AX03 | Nifuroxazide | ||||
| A07AX04 | Nifurzide | ||||
| A07B | Intestinal adsorbents | ||||
| A07BA | Charcoal preparations | ||||
| A07BA01 | Medicinal charcoal | ||||
| A07BA51 | Medicinal charcoal, combinations | ||||
| A07BB | Bismuth preparations | ||||
| empty | |||||
| A07BC | Other intestinal adsorbents | ||||
| A07BC01 | Pectin | ||||
| A07BC02 | Kaolin | ||||
| A07BC03 | Crospovidone | ||||
| A07BC04 | Attapulgite | ||||
| A07BC05 | Diosmectite | ||||
| A07BC30 | Combinations | ||||
| A07BC54 | Attapulgite, combinations | ||||
| A07C | Electrolytes with carbohydrates | ||||
| A07CA | Oral rehydration salt formulations | ||||
| human ATC classification. | |||||
| A07D | Antipropulsives | ||||
| A07DA | Antipropulsives | ||||
| A07DA01 | Diphenoxylate | ||||
| A07DA02 | Opium | ||||
| A07DA03 | Loperamide | ||||
| A07DA04 | Difenoxin | ||||
| A07DA05 | Loperamide oxide | ||||
| A07DA06 | eluxadoline | ||||
| A07DA52 | Morphine, combinations | ||||
| A07DA53 | Loperamide, combinations | ||||
| A07E | Intestinal anti-inflammatory agents | ||||
| A07EA | Corticosteroids acting locally | ||||
| A07EA01 | Prednisolone | ||||
| A07EA02 | Hydrocortisone | ||||
| A07EA03 | Prednisone | ||||
| A07EA04 | Betamethasone | ||||
| A07EA05 | Tixocortol | ||||
| A07EA06 | Budesonide | ||||
| A07EA07 | Beclometasone | ||||
| A07EB | Antiallergic agents, excluding corticosteroids | ||||
| A07EB01 | Cromoglicic acid | ||||
| A07EC | Aminosalicylic acid and similar agents | ||||
| A07EC01 | Sulfasalazine | ||||
| A07EC02 | Mesalazine | ||||
| A07EC03 | Olsalazine | ||||
| A07EC04 | Balsalazide | ||||
| A07F | Antidiarrheal micro-organisms | ||||
| A07FA | Antidiarrheal micro-organisms | ||||
| A07FA01 | Lactic acid producing organisms | ||||
| A07FA02 | Saccharomyces boulardii | ||||
| A07FA51 | Lactic acid producing organisms, combinations | ||||
| A07X | Other antidiarrheals | ||||
| A07XA | Other antidiarrheals | ||||
| A07XA01 | Albumin tannate | ||||
| A07XA02 | Ceratonia | ||||
| A07XA03 | Calcium compounds | ||||
| A07XA04 | Racecadotril | ||||
| A07XA51 | Albumin tannate, combinations | ||||
| A08 | Antiobesity preparations, excluding diet products | ||||
| A08A | Antiobesity preparations, excluding diet products | ||||
| A08AA | Centrally acting antiobesity products | ||||
| A08AA01 | Phentermine | ||||
| A08AA02 | Fenfluramine | ||||
| A08AA03 | Amfepramone | ||||
| A08AA04 | Dexfenfluramine | ||||
| A08AA05 | Mazindol | ||||
| A08AA06 | Etilamfetamine | ||||
| A08AA07 | Cathine | ||||
| A08AA08 | Clobenzorex | ||||
| A08AA09 | Mefenorex | ||||
| A08AA10 | Sibutramine | ||||
| A08AA11 | lorcaserin | ||||
| A08AA12 | setmelanotide | ||||
| A08AA51 | phentermine and topiramate | ||||
| A08AA56 | Ephedrine, combinations | ||||
| A08AA62 | bupropion and naltrexone | ||||
| A08AB | Peripherally acting antiobesity products | ||||
| A08AB01 | Orlistat | ||||
| A08AX | Other antiobesity drugs | ||||
| A08AX01 | Rimonabant | ||||
| A09 | Digestives,including enzymes | ||||
| A09A | Digestives, including enzymes | ||||
| A09AA | Enzyme preparations | ||||
| A09AA01 | Diastase | ||||
| A09AA02 | Multienzymes (lipase, protease, etc.) | ||||
| A09AA03 | Pepsin | ||||
| A09AA04 | Tilactase | ||||
| A09AB | Acid preparations | ||||
| A09AB01 | Glutamic acid hydrochloride | ||||
| A09AB02 | Betaine hydrochloride | ||||
| A09AB03 | Hydrochloric acid | ||||
| A09AB04 | Citric acid | ||||
| A09AC | Enzyme and acid preparations, combinations | ||||
| A09AC01 | Pepsin and acid preparations | ||||
| A09AC02 | Multienzymes and acid preparations | ||||
| A10 | Drugs used in diabetes | ||||
| A10A | Insulins and analogues | ||||
| A10AB | Insulins and analogues for injection, fast-acting | ||||
| A10AB01 | Insulin (human) | ||||
| A10AB02 | Insulin (beef) | ||||
| A10AB03 | Insulin (pork) | ||||
| A10AB04 | Insulin lispro | ||||
| A10AB05 | Insulin aspart | ||||
| A10AB06 | Insulin glulisine | ||||
| A10AB30 | Combinations | ||||
| A10AC | Insulins and analogues for injection, intermediate-acting | ||||
| A10AC01 | Insulin (human) | ||||
| A10AC02 | Insulin (beef) | ||||
| A10AC03 | Insulin (pork) | ||||
| A10AC04 | Insulin lispro | ||||
| A10AC30 | Combinations | ||||
| A10AD | Insulins and analogues for injection, intermediate-acting combined with fast-acting | ||||
| A10AD01 | Insulin (human) | ||||
| A10AD02 | Insulin (beef) | ||||
| A10AD03 | Insulin (pork) | ||||
| A10AD04 | Insulin lispro | ||||
| A10AD05 | Insulin aspart | ||||
| A10AD30 | Combinations | ||||
| A10AE | Insulins and analogues for injection, long-acting | ||||
| A10AE01 | Insulin (human) | ||||
| A10AE02 | Insulin (beef) | ||||
| A10AE03 | Insulin (pork) | ||||
| A10AE04 | Insulin glargine | ||||
| A10AE05 | Insulin detemir | ||||
| A10AE06 | insulin degludec | ||||
| A10AE07 | insulin icodec | ||||
| A10AE30 | Combinations | ||||
| A10AE54 | insulin glargine and lixisenatide | ||||
| A10AE56 | insulin degludec and liraglutide | ||||
| A10AF | Insulins and analogues for inhalation | ||||
| A10AF01 | Insulin (human) | ||||
| A10B | Blood glucose lowering drugs, excluding insulins | ||||
| A10BA | Biguanides | ||||
| A10BA01 | Phenformin | ||||
| A10BA02 | Metformin | ||||
| A10BA03 | Buformin | ||||
| A10BB | Sulfonamides, urea derivatives | ||||
| A10BB01 | Glibenclamide | ||||
| A10BB02 | Chlorpropamide | ||||
| A10BB03 | Tolbutamide | ||||
| A10BB04 | Glibornuride | ||||
| A10BB05 | Tolazamide | ||||
| A10BB06 | Carbutamide | ||||
| A10BB07 | Glipizide | ||||
| A10BB08 | Gliquidone | ||||
| A10BB09 | Gliclazide | ||||
| A10BB10 | Metahexamide | ||||
| A10BB11 | Glisoxepide | ||||
| A10BB12 | Glimepiride | ||||
| A10BB31 | Acetohexamide | ||||
| A10BC | Sulfonamides (heterocyclic) | ||||
| A10BC01 | Glymidine | ||||
| A10BD | Combinations of oral blood glucose lowering drugs | ||||
| A10BD01 | Phenformin and sulfonamides | ||||
| A10BD02 | Metformin and sulfonamides | ||||
| A10BD03 | Metformin and rosiglitazone | ||||
| A10BD04 | Glimepiride and rosiglitazone | ||||
| A10BD05 | Metformin and pioglitazone | ||||
| A10BD06 | Glimepiride and pioglitazone | ||||
| A10BD07 | Metformin and sitagliptin | ||||
| A10BD08 | Metformin and vildagliptin | ||||
| A10BD09 | Pioglitazone and alogliptin | ||||
| A10BD10 | Metformin and saxagliptin | ||||
| A10BD11 | Metformin and linagliptin | ||||
| A10BD12 | Pioglitazone and sitagliptin | ||||
| A10BD13 | Metformin and alogliptin | ||||
| A10BD14 | metformin and repaglinide | ||||
| A10BD15 | metformin and dapagliflozin | ||||
| A10BD16 | metformin and canagliflozin | ||||
| A10BD17 | metformin and acarbose | ||||
| A10BD18 | metformin and gemigliptin | ||||
| A10BD19 | linagliptin and empagliflozin | ||||
| A10BD20 | metformin and empagliflozin | ||||
| A10BD21 | saxagliptin and dapagliflozin | ||||
| A10BD22 | metformin and evogliptin | ||||
| A10BD23 | metformin and ertugliflozin | ||||
| A10BD24 | sitagliptin and ertugliflozin | ||||
| A10BD25 | metformin, saxagliptin and dapagliflozin | ||||
| A10BD26 | metformin and lobeglitazone | ||||
| A10BD27 | metformin, linagliptin and empagliflozin | ||||
| A10BD28 | metformin and teneligliptin | ||||
| A10BD29 | sitagliptin and dapagliflozin | ||||
| A10BD30 | gemigliptin and dapagliflozin | ||||
| A10BF | Alpha glucosidase inhibitors | ||||
| A10BF01 | Acarbose | ||||
| A10BF02 | Miglitol | ||||
| A10BF03 | Voglibose | ||||
| A10BG | Thiazolidinediones | ||||
| A10BG01 | Troglitazone | ||||
| A10BG02 | Rosiglitazone | ||||
| A10BG03 | Pioglitazone | ||||
| A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors | ||||
| A10BH01 | Sitagliptin | ||||
| A10BH02 | Vildagliptin | ||||
| A10BH03 | Saxagliptin | ||||
| A10BH04 | Alogliptin | ||||
| A10BH05 | Linagliptin | ||||
| A10BH06 | gemigliptin | ||||
| A10BH07 | evogliptin | ||||
| A10BH08 | eneligliptin | ||||
| A10BH51 | Sitagliptin and simvastatin | ||||
| A10BH52 | gemigliptin and rosuvastatin | ||||
| A10BJ | Glucagon-like peptide-1 (GLP-1) analogues | ||||
| A10BJ01 | exenatide | ||||
| A10BJ02 | liraglutide | ||||
| A10BJ03 | lixisenatide | ||||
| A10BJ04 | albiglutide | ||||
| A10BJ05 | dulaglutide | ||||
| A10BJ06 | semaglutide | ||||
| A10BJ07 | beinaglutide | ||||
| A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors | ||||
| A10BK01 | Dapagliflozin | ||||
| A10BK02 | Canagliflozin | ||||
| A10BK03 | Empagliflozin | ||||
| A10BK04 | Ertugliflozin | ||||
| A10BK05 | Ipragliflozin | ||||
| A10BK06 | Sotagliflozin | ||||
| A10BK07 | Luseogliflozin | ||||
| A10BK08 | bexagliflozin | ||||
| A10BK09 | enavogliflozin | ||||
| A10BX | Other blood glucose lowering drugs, excluding insulins | ||||
| A10BX01 | Guar gum | ||||
| A10BX02 | Repaglinide | ||||
| A10BX03 | Nateglinide | ||||
| A10BX04 | Exenatide (New ATC code A10BJ01) | ||||
| A10BX05 | Pramlintide | ||||
| A10BX06 | Benfluorex | ||||
| A10BX07 | Liraglutide (New ATC code A10BJ02) | ||||
| A10BX08 | Mitiglinide | ||||
| A10BX09 | Dapagliflozin (New ATC code A10BK01) | ||||
| A10BX10 | lixisenatide (New ATC code A10BJ03) | ||||
| A10BX11 | canagliflozin (New ATC code A10BK02) | ||||
| A10BX12 | empagliflozin (New ATC code A10BK03) | ||||
| A10BX13 | albiglutide (New ATC code A10BJ04) | ||||
| A10BX14 | dulaglutide (New ATC code A10BJ05) | ||||
| A10BX15 | imeglimin | ||||
| A10BX16 | tirzepatide | ||||
| A10BX17 | carfloglitazar | ||||
| A10BX18 | dorzagliatin | ||||
| A10X | Other drugs used in diabetes | ||||
| A10XA | Aldose reductase inhibitors | ||||
| A10XA01 | Tolrestat | ||||
| A10XX | Other drugs used in diabetes | ||||
| A10XX01 | teplizumab | ||||
| A10XX02 | donislecel | ||||
| A11 | Vitamins | ||||
| A11A | Multivitamins, combinations | ||||
| A11AA | Multivitamins with minerals | ||||
| A11AA01 | Multivitamins and iron | ||||
| A11AA02 | Multivitamins and calcium | ||||
| A11AA03 | Multivitamins and other minerals, including combinations | ||||
| A11AA04 | Multivitamins and trace elements | ||||
| A11AB | Multivitamins, other combinations | ||||
| empty | |||||
| A11B | Multivitamins, plain | ||||
| A11BA | Multivitamins, plain | ||||
| empty | |||||
| A11C | Vitamin A and D, including combinations of the two | ||||
| A11CA | Vitamin A, plain | ||||
| A11CA01 | Retinol (vitamin A) | ||||
| A11CA02 | Betacarotene | ||||
| A11CB | Vitamin A and D in combination | ||||
| empty | |||||
| A11CC | Vitamin D and analogues | ||||
| A11CC01 | Ergocalciferol | ||||
| A11CC02 | Dihydrotachysterol | ||||
| A11CC03 | Alfacalcidol | ||||
| A11CC04 | Calcitriol | ||||
| A11CC05 | Colecalciferol | ||||
| A11CC06 | Calcifediol | ||||
| A11CC07 | paricalcitol (New ATC code H05BX02) | ||||
| A11CC20 | Combinations | ||||
| A11D | Vitamin B1, plain and in combination with vitamin B6 and B12 | ||||
| A11DA | Vitamin B1, plain | ||||
| A11DA01 | Thiamine (vitamin B1) | ||||
| A11DA02 | Sulbutiamine | ||||
| A11DA03 | Benfotiamine | ||||
| A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 | ||||
| empty | |||||
| A11E | Vitamin B-complex, including combinations | ||||
| A11EA | Vitamin B-complex, plain | ||||
| empty | |||||
| A11EB | Vitamin B-complex with vitamin C | ||||
| empty | |||||
| A11EC | Vitamin B-complex with minerals | ||||
| empty | |||||
| A11ED | Vitamin B-complex with anabolic steroids | ||||
| empty | |||||
| A11EX | Vitamin B-complex, other combinations | ||||
| empty | |||||
| A11G | Ascorbic acid (vitamin C), including combinations | ||||
| A11GA | Ascorbic acid (vitamin C), plain | ||||
| A11GA01 | Ascorbic acid (vitamin C) | ||||
| A11GB | Ascorbic acid (vitamin C), combinations | ||||
| A11GB01 | Ascorbic acid (vitamin C) and calcium | ||||
| A11H | Other plain vitamin preparations | ||||
| A11HA | Other plain vitamin preparations | ||||
| A11HA01 | Nicotinamide | ||||
| A11HA02 | Pyridoxine (vitamin B6) | ||||
| A11HA03 | Tocopherol (vitamin E) | ||||
| A11HA04 | Riboflavin (vitamin B2) | ||||
| A11HA05 | Biotin | ||||
| A11HA06 | Pyridoxal phosphate | ||||
| A11HA07 | Inositol | ||||
| A11HA08 | Tocofersolan | ||||
| A11HA30 | Dexpanthenol | ||||
| A11HA31 | Calcium pantothenate | ||||
| A11HA32 | Pantethine | ||||
| A11J | Other vitamin products, combinations | ||||
| A11JA | Combinations of vitamins | ||||
| empty | |||||
| A11JB | Vitamins with minerals | ||||
| empty | |||||
| A11JC | Vitamins, other combinations | ||||
| empty | |||||
| A12 | Mineral supplements | ||||
| A12A | Calcium | ||||
| A12AA | Calcium | ||||
| A12AA01 | Calcium phosphate | ||||
| A12AA02 | Calcium glubionate | ||||
| A12AA03 | Calcium gluconate | ||||
| A12AA04 | Calcium carbonate | ||||
| A12AA05 | Calcium lactate | ||||
| A12AA06 | Calcium lactate gluconate | ||||
| A12AA07 | Calcium chloride | ||||
| A12AA08 | Calcium glycerylphosphate | ||||
| A12AA09 | Calcium citrate lysine complex | ||||
| A12AA10 | Calcium glucoheptonate | ||||
| A12AA11 | Calcium pangamate | ||||
| A12AA12 | Calcium acetate anhydrous (New ATC code V03AE07) | ||||
| A12AA20 | Calcium (different salts in combination) | ||||
| A12AA30 | Calcium laevulate | ||||
| A12AX | Calcium, combinations with vitamin D and/or other drugs | ||||
| empty | |||||
| A12B | Potassium | ||||
| A12BA | Potassium | ||||
| A12BA01 | Potassium chloride | ||||
| A12BA02 | Potassium citrate | ||||
| A12BA03 | Potassium hydrogentartrate | ||||
| A12BA04 | Potassium hydrogencarbonate | ||||
| A12BA05 | Potassium gluconate | ||||
| A12BA30 | Combinations | ||||
| A12BA51 | Potassium chloride, combinations | ||||
| A12C | Other mineral supplements | ||||
| A12CA | Sodium | ||||
| A12CA01 | Sodium chloride | ||||
| A12CA02 | Sodium sulfate | ||||
| A12CB | Zinc | ||||
| A12CB01 | Zinc sulfate | ||||
| A12CB02 | Zinc gluconate | ||||
| A12CB03 | Zinc protein complex | ||||
| A12CC | Magnesium | ||||
| A12CC01 | Magnesium chloride | ||||
| A12CC02 | Magnesium sulfate | ||||
| A12CC03 | Magnesium gluconate | ||||
| A12CC04 | Magnesium citrate | ||||
| A12CC05 | Magnesium aspartate | ||||
| A12CC06 | Magnesium lactate | ||||
| A12CC07 | Magnesium levulinate | ||||
| A12CC08 | Magnesium pidolate | ||||
| A12CC09 | Magnesium orotate | ||||
| A12CC10 | Magnesium oxide | ||||
| A12CC30 | Magnesium (different salts in combination) | ||||
| A12CD | Fluoride | ||||
| A12CD01 | Sodium fluoride | ||||
| A12CD02 | Sodium monofluorophosphate | ||||
| A12CD51 | Fluoride, combinations | ||||
| A12CE | Selenium | ||||
| A12CE01 | Sodium selenate | ||||
| A12CE02 | Sodium selenite | ||||
| A12CX | Other mineral products | ||||
| empty | |||||
| A13 | Tonics | ||||
| A13A | Tonics | ||||
| empty | |||||
| A14 | Anabolic agents for systemic use | ||||
| A14A | Anabolic steroids | ||||
| A14AA | Androstan derivatives | ||||
| A14AA01 | Androstanolone | ||||
| A14AA02 | Stanozolol | ||||
| A14AA03 | Metandienone | ||||
| A14AA04 | Metenolone | ||||
| A14AA05 | Oxymetholone | ||||
| A14AA06 | Quinbolone | ||||
| A14AA07 | Prasterone | ||||
| A14AA08 | Oxandrolone | ||||
| A14AA09 | Norethandrolone | ||||
| A14AB | Estren derivatives | ||||
| A14AB01 | Nandrolone | ||||
| A14AB02 | Ethylestrenol | ||||
| A14AB03 | Oxabolone cipionate | ||||
| A14B | Other anabolic agents | ||||
| empty | |||||
| A15 | Appetite stimulants | ||||
| empty | |||||
| A16 | Other alimentary tract and metabolism products | ||||
| A16A | Other alimentary tract and metabolism products | ||||
| A16AA | Amino acids and derivatives | ||||
| A16AA01 | Levocarnitine | ||||
| A16AA02 | Ademetionine | ||||
| A16AA03 | Levoglutamide | ||||
| A16AA04 | Mercaptamine | ||||
| A16AA05 | Carglumic acid | ||||
| A16AA06 | Betaine | ||||
| A16AB | Enzymes | ||||
| A16AB01 | Alglucerase | ||||
| A16AB02 | Imiglucerase | ||||
| A16AB03 | Agalsidase alfa | ||||
| A16AB04 | Agalsidase beta | ||||
| A16AB05 | Laronidase | ||||
| A16AB06 | Sacrosidase | ||||
| A16AB07 | Alglucosidase alfa | ||||
| A16AB08 | Galsulfase | ||||
| A16AB09 | Idursulfase | ||||
| A16AB10 | Velaglucerase alfa | ||||
| A16AB11 | Taliglucerase alfa | ||||
| A16AB12 | elosulfase alfa | ||||
| A16AB13 | asfotase alfa | ||||
| A16AB14 | sebelipase alfa | ||||
| A16AB15 | velmanase alfa | ||||
| A16AB16 | idursulfase beta | ||||
| A16AB17 | cerliponase alfa | ||||
| A16AB18 | vestronidase alfa | ||||
| A16AB19 | pegvaliase | ||||
| A16AB20 | pegunigalsidase alfa | ||||
| A16AB21 | atidarsagene autotemcel | ||||
| A16AB22 | avalglucosidase alfa | ||||
| A16AB23 | cipaglucosidase alfa | ||||
| A16AB24 | pegzilarginase | ||||
| A16AB25 | olipudase alfa | ||||
| A16AB26 | eladocagene exuparvovec | ||||
| A16AB27 | pabinafusp alfa | ||||
| A16AX | Various alimentary tract and metabolism products | ||||
| A16AX01 | Thioctic acid | ||||
| A16AX02 | Anethole trithione | ||||
| A16AX03 | Sodium phenylbutyrate | ||||
| A16AX04 | Nitisinone | ||||
| A16AX05 | Zinc acetate | ||||
| A16AX06 | Miglustat | ||||
| A16AX07 | Sapropterin | ||||
| A16AX08 | Teduglutide | ||||
| A16AX09 | Glycerol phenylbutyrate | ||||
| A16AX10 | eliglustat | ||||
| A16AX11 | sodium benzoate | ||||
| A16AX12 | trientine | ||||
| A16AX13 | uridine triacetate | ||||
| A16AX14 | migalastat | ||||
| A16AX15 | telotristat | ||||
| A16AX16 | givosiran | ||||
| A16AX17 | triheptanoin | ||||
| A16AX18 | lumasiran | ||||
| A16AX19 | fosdenopterin | ||||
| A16AX20 | lonafarnib | ||||
| A16AX21 | elivaldogene autotemcel | ||||
| A16AX22 | tiomolibdic acid | ||||
| A16AX23 | leriglitazone | ||||
| A16AX24 | govorestat | ||||
| A16AX30 | sodium benzoate and sodium phenylacetate | ||||
| B | Blood and blood forming organs | ||||
| B01 | Antithrombotic agents | ||||
| B01A | Antithrombotic agents | ||||
| B01AA | Vitamin K antagonists | ||||
| B01AA01 | Dicoumarol | ||||
| B01AA02 | Phenindione | ||||
| B01AA03 | Warfarin | ||||
| B01AA04 | Phenprocoumon | ||||
| B01AA07 | Acenocoumarol | ||||
| B01AA08 | Ethyl biscoumacetate | ||||
| B01AA09 | Clorindione | ||||
| B01AA10 | Diphenadione | ||||
| B01AA11 | Tioclomarol | ||||
| B01AA12 | Fluindione | ||||
| B01AB | Heparin group | ||||
| B01AB01 | Heparin | ||||
| B01AB02 | Antithrombin III | ||||
| B01AB04 | Dalteparin | ||||
| B01AB05 | Enoxaparin | ||||
| B01AB06 | Nadroparin | ||||
| B01AB07 | Parnaparin | ||||
| B01AB08 | Reviparin | ||||
| B01AB09 | Danaparoid | ||||
| B01AB10 | Tinzaparin | ||||
| B01AB11 | Sulodexide | ||||
| B01AB12 | Bemiparin | ||||
| B01AB51 | Heparin, combinations | ||||
| B01AC | Platelet aggregation inhibitors excluding heparin | ||||
| B01AC01 | Ditazole | ||||
| B01AC02 | Cloricromen | ||||
| B01AC03 | Picotamide | ||||
| B01AC04 | Clopidogrel | ||||
| B01AC05 | Ticlopidine | ||||
| B01AC06 | Acetylsalicylic acid | ||||
| B01AC07 | Dipyridamole | ||||
| B01AC08 | Carbasalate calcium | ||||
| B01AC09 | Epoprostenol | ||||
| B01AC10 | Indobufen | ||||
| B01AC11 | Iloprost | ||||
| B01AC13 | Abciximab | ||||
| B01AC14 | anagrelide (New ATC code L01XX35) | ||||
| B01AC15 | Aloxiprin | ||||
| B01AC16 | Eptifibatide | ||||
| B01AC17 | Tirofiban | ||||
| B01AC18 | Triflusal | ||||
| B01AC19 | Beraprost | ||||
| B01AC21 | Treprostinil | ||||
| B01AC22 | Prasugrel | ||||
| B01AC23 | Cilostazol | ||||
| B01AC24 | Ticagrelor | ||||
| B01AC30 | Combinations | ||||
| B01AC56 | Acetylsalicylic acid and esomeprazole | ||||
| B01AD | Enzymes | ||||
| B01AD01 | Streptokinase | ||||
| B01AD02 | Alteplase | ||||
| B01AD03 | Anistreplase | ||||
| B01AD04 | Urokinase | ||||
| B01AD05 | Fibrinolysin | ||||
| B01AD06 | Brinase | ||||
| B01AD07 | Reteplase | ||||
| B01AD08 | Saruplase | ||||
| B01AD09 | Ancrod | ||||
| B01AD10 | Drotrecogin alfa (activated) | ||||
| B01AD11 | Tenecteplase | ||||
| B01AD12 | Protein C | ||||
| B01AE | Direct thrombin inhibitors | ||||
| B01AE01 | Desirudin | ||||
| B01AE02 | Lepirudin | ||||
| B01AE03 | Argatroban | ||||
| B01AE04 | Melagatran | ||||
| B01AE05 | Ximelagatran | ||||
| B01AE06 | Bivalirudin | ||||
| B01AE07 | Dabigatran etexilate | ||||
| B01AF | Direct factor Xa inhibitors | ||||
| B01AF01 | Rivaroxaban | ||||
| B01AF02 | Apixaban | ||||
| B01AF03 | edoxaban | ||||
| B01AF04 | betrixaban | ||||
| B01AX | Other antithrombotic agents | ||||
| B01AX01 | Defibrotide | ||||
| B01AX04 | Dermatan sulfate | ||||
| B01AX05 | Fondaparinux | ||||
| B01AX06 | rivaroxaban (New ATC code B01AF01) | ||||
| B01AX07 | caplacizumab | ||||
| B02 | Antihemorrhagics | ||||
| B02A | Antifibrinolytics | ||||
| B02AA | Amino acids | ||||
| B02AA01 | Aminocaproic acid | ||||
| B02AA02 | Tranexamic acid | ||||
| B02AA03 | Aminomethylbenzoic acid | ||||
| B02AB | Proteinase inhibitors | ||||
| B02AB01 | Aprotinin | ||||
| B02AB02 | Alfa1 antitrypsin | ||||
| B02AB03 | c1-inhibitor, plasma derived (New ATC code B06AC01) | ||||
| B02AB04 | Camostat | ||||
| B02B | Vitamin K and other hemostatics | ||||
| B02BA | Vitamin K | ||||
| B02BA01 | Phytomenadione | ||||
| B02BA02 | Menadione | ||||
| B02BB | Fibrinogen | ||||
| B02BB01 | Human fibrinogen | ||||
| B02BC | Local hemostatics | ||||
| B02BC01 | Absorbable gelatin sponge | ||||
| B02BC02 | Oxidized cellulose | ||||
| B02BC03 | Tetragalacturonic acid hydroxymethylester | ||||
| B02BC05 | Adrenalone | ||||
| B02BC06 | Thrombin | ||||
| B02BC07 | Collagen | ||||
| B02BC08 | Calcium alginate | ||||
| B02BC09 | Epinephrine | ||||
| B02BC10 | Fibrinogen, human (New ATC code B02BC30) | ||||
| B02BC30 | Combinations | ||||
| B02BD | Blood coagulation factors | ||||
| B02BD01 | Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate) | ||||
| B02BD02 | Coagulation factor VIII | ||||
| B02BD03 | Factor VIII inhibitor bypassing activity | ||||
| B02BD04 | Coagulation factor IX | ||||
| B02BD05 | Coagulation factor VII | ||||
| B02BD06 | Von Willebrand factor and coagulation factor VIII in combination | ||||
| B02BD07 | Coagulation factor XIII | ||||
| B02BD08 | Eptacog alfa (activated) | ||||
| B02BD09 | Nonacog alfa (New ATC code B02BD04) | ||||
| B02BD10 | von Willebrand factor | ||||
| B02BD11 | Catridecacog | ||||
| B02BD12 | Trenonacog alfa (New ATC code B02BD04) | ||||
| B02BD13 | coagulation factor X | ||||
| B02BD14 | susoctocog alfa | ||||
| B02BD15 | valoctocogene roxaparvovec | ||||
| B02BD16 | etranacogene dezaparvovec | ||||
| B02BD17 | fidanacogene elaparvovec | ||||
| B02BD30 | Thrombin | ||||
| B02BX | Other systemic hemostatics | ||||
| B02BX01 | Etamsylate | ||||
| B02BX02 | Carbazochrome | ||||
| B02BX03 | Batroxobin | ||||
| B02BX04 | Romiplostim | ||||
| B02BX05 | Eltrombopag | ||||
| B02BX06 | emicizumab | ||||
| B02BX07 | lusutrombopag | ||||
| B02BX08 | avatrombopag | ||||
| B02BX09 | fostamatinib | ||||
| B03 | Antianemic preparations | ||||
| B03A | Iron preparations | ||||
| B03AA | Iron bivalent, oral preparations | ||||
| B03AA01 | Ferrous glycine sulfate | ||||
| B03AA02 | Ferrous fumarate | ||||
| B03AA03 | Ferrous gluconate | ||||
| B03AA04 | Ferrous carbonate | ||||
| B03AA05 | Ferrous chloride | ||||
| B03AA06 | Ferrous succinate | ||||
| B03AA07 | Ferrous sulfate | ||||
| B03AA08 | Ferrous tartrate | ||||
| B03AA09 | Ferrous aspartate | ||||
| B03AA10 | Ferrous ascorbate | ||||
| B03AA11 | Ferrous iodine | ||||
| B03AB | Iron trivalent, oral preparations | ||||
| B03AB01 | Ferric sodium citrate | ||||
| B03AB02 | Saccharated iron oxide | ||||
| B03AB03 | Sodium feredetate | ||||
| B03AB04 | Ferric hydroxide | ||||
| B03AB05 | Ferric oxide polymaltose complexes | ||||
| B03AB06 | Ferric citrate (New ATC code V03AE08) | ||||
| B03AB07 | Chondroitin sulfate-iron complex | ||||
| B03AB08 | Ferric acetyl transferrin | ||||
| B03AB09 | Ferric proteinsuccinylate | ||||
| B03AC | Iron trivalent, parenteral preparations | ||||
| B03AC01 | Ferric oxide polymaltose complexes | ||||
| B03AC02 | Saccharated iron oxide | ||||
| B03AC03 | Iron-sorbitol-citric acid complex | ||||
| B03AC05 | Ferric sorbitol gluconic acid complex | ||||
| B03AC06 | Ferric oxide dextran complexes | ||||
| B03AC07 | Ferric sodium gluconate complex | ||||
| B03AD | Iron in combination with folic acid | ||||
| B03AD01 | Ferrous amino acid complex | ||||
| B03AD02 | Ferrous fumarate | ||||
| B03AD03 | Ferrous sulfate | ||||
| B03AD04 | Ferric oxide polymaltose complexes | ||||
| B03AE | Iron in other combinations | ||||
| B03AE01 | Iron, vitamin B12 and folic acid | ||||
| B03AE02 | Iron, multivitamins and folic acid | ||||
| B03AE03 | Iron and multivitamins | ||||
| B03AE04 | Iron, multivitamins and minerals | ||||
| B03AE10 | Various combinations | ||||
| B03B | Vitamin B12 and folic acid | ||||
| B03BA | Vitamin B12 (cyanocobalamin and analogues) | ||||
| B03BA01 | Cyanocobalamin | ||||
| B03BA02 | Cyanocobalamin tannin complex | ||||
| B03BA03 | Hydroxocobalamin | ||||
| B03BA04 | Cobamamide | ||||
| B03BA05 | Mecobalamin | ||||
| B03BA51 | Cyanocobalamin, combinations | ||||
| B03BA53 | Hydroxocobalamin, combinations | ||||
| B03BB | Folic acid and derivatives | ||||
| B03BB01 | Folic acid | ||||
| B03BB51 | Folic acid, combinations | ||||
| B03X | Other antianemic preparations | ||||
| B03XA | Other antianemic preparations | ||||
| B03XA01 | Erythropoietin | ||||
| B03XA02 | Darbepoetin alfa | ||||
| B03XA03 | Methoxy polyethylene glycol-epoetin beta | ||||
| B03XA04 | Peginesatide | ||||
| B03XA05 | roxadustat | ||||
| B03XA06 | luspatercept | ||||
| B03XA07 | daprodustat | ||||
| B03XA08 | vadadustat | ||||
| B05 | Blood substitutes and perfusion solutions | ||||
| B05A | Blood and related products | ||||
| B05AA | Blood substitutes and plasma protein fractions | ||||
| B05AA01 | Serum albumin | ||||
| B05AA02 | Other plasma protein fractions | ||||
| B05AA03 | Fluorocarbon blood substitutes | ||||
| B05AA05 | Dextran | ||||
| B05AA06 | Gelatin agents | ||||
| B05AA07 | Hydroxyethylstarch | ||||
| B05AA08 | Hemoglobin crosfumaril | ||||
| B05AA09 | Hemoglobin raffimer | ||||
| B05AA10 | Hemoglobin glutamer (bovine) | ||||
| B05AX | Other blood products | ||||
| B05AX01 | Erythrocytes | ||||
| B05AX02 | Thrombocytes | ||||
| B05AX03 | Blood plasma | ||||
| B05AX04 | Stem cells from umbilical cord blood | ||||
| B05B | I.v. solutions | ||||
| B05BA | Solutions for parenteral nutrition | ||||
| B05BA01 | Amino acids | ||||
| B05BA02 | Fat emulsions | ||||
| B05BA03 | Carbohydrates | ||||
| B05BA04 | Protein hydrolysates | ||||
| B05BA10 | Combinations | ||||
| B05BB | Solutions affecting the electrolyte balance | ||||
| B05BB01 | Electrolytes | ||||
| B05BB02 | Electrolytes with carbohydrates | ||||
| B05BB03 | Trometamol | ||||
| B05BB04 | Electrolytes in combination with other drugs | ||||
| B05BC | Solutions producing osmotic diuresis | ||||
| B05BC01 | Mannitol | ||||
| B05BC02 | Carbamide | ||||
| B05C | Irrigating solutions | ||||
| B05CA | Antiinfectives | ||||
| B05CA01 | Cetylpyridinium | ||||
| B05CA02 | Chlorhexidine | ||||
| B05CA03 | Nitrofural | ||||
| B05CA04 | Sulfamethizole | ||||
| B05CA05 | Taurolidine | ||||
| B05CA06 | Mandelic acid | ||||
| B05CA07 | Noxytiolin | ||||
| B05CA08 | Ethacridine lactate | ||||
| B05CA09 | Neomycin | ||||
| B05CA10 | Combinations | ||||
| B05CB | Salt solutions | ||||
| B05CB01 | Sodium chloride | ||||
| B05CB02 | Sodium citrate | ||||
| B05CB03 | Magnesium citrate | ||||
| B05CB04 | Sodium bicarbonate | ||||
| B05CB10 | Combinations | ||||
| B05CX | Other irrigating solutions | ||||
| B05CX01 | Glucose | ||||
| B05CX02 | Sorbitol | ||||
| B05CX03 | Glycine | ||||
| B05CX04 | Mannitol | ||||
| B05CX10 | Combinations | ||||
| B05D | Peritoneal dialytics | ||||
| B05DA | Isotonic solutions | ||||
| empty | |||||
| B05DB | Hypertonic solutions | ||||
| empty | |||||
| B05X | I.v. solution additives | ||||
| B05XA | Electrolyte solutions | ||||
| B05XA01 | Potassium chloride | ||||
| B05XA02 | Sodium bicarbonate | ||||
| B05XA03 | Sodium chloride | ||||
| B05XA04 | Ammonium chloride | ||||
| B05XA05 | Magnesium sulfate | ||||
| B05XA06 | Potassium phosphate, including combinations with other potassium salts | ||||
| B05XA07 | Calcium chloride | ||||
| B05XA08 | Sodium acetate | ||||
| B05XA09 | Sodium phosphate | ||||
| B05XA10 | Magnesium phosphate | ||||
| B05XA11 | Magnesium chloride | ||||
| B05XA12 | Zinc chloride | ||||
| B05XA13 | Hydrochloric acid | ||||
| B05XA14 | Sodium glycerophosphate | ||||
| B05XA15 | Potassium lactate | ||||
| B05XA16 | Cardioplegia solutions | ||||
| B05XA17 | Potassium acetate | ||||
| B05XA30 | Combinations of electrolytes | ||||
| B05XA31 | Electrolytes in combination with other drugs | ||||
| B05XB | Amino acids | ||||
| B05XB01 | Arginine hydrochloride | ||||
| B05XB02 | Alanyl glutamine | ||||
| B05XB03 | Lysine | ||||
| B05XC | Vitamins | ||||
| empty | |||||
| B05XX | Other i.v. solution additives | ||||
| B05XX02 | Trometamol | ||||
| B05Z | Hemodialytics and hemofiltrates | ||||
| B05ZA | Hemodialytics, concentrates | ||||
| empty | |||||
| B05ZB | Hemofiltrates | ||||
| empty | |||||
| B06 | Other hematological agents | ||||
| B06A | Other hematological agents | ||||
| B06AA | Enzymes | ||||
| B06AA02 | Fibrinolysin and desoxyribonuclease | ||||
| B06AA03 | Hyaluronidase | ||||
| B06AA04 | Chymotrypsin | ||||
| B06AA07 | Trypsin | ||||
| B06AA10 | Desoxyribonuclease | ||||
| B06AA11 | Bromelain (New ATC code D03BA03) | ||||
| B06AA55 | Streptokinase, combinations | ||||
| B06AB | Other hematological products | ||||
| B06AB01 | Hematin | ||||
| B06AC | Drugs used in hereditary angioedema | ||||
| B06AC01 | C1-inhibitor, plasma derived | ||||
| B06AC02 | Icatibant | ||||
| B06AC03 | Ecallantide | ||||
| B06AC04 | Conestat alfa | ||||
| C | Cardiovascular system | ||||
| C01 | Cardiac therapy | ||||
| C01A | Cardiac glycosides | ||||
| C01AA | Digitalis glycosides | ||||
| C01AA01 | Acetyldigitoxin | ||||
| C01AA02 | Acetyldigoxin | ||||
| C01AA03 | Digitalis leaves | ||||
| C01AA04 | Digitoxin | ||||
| C01AA05 | Digoxin | ||||
| C01AA06 | Lanatoside C | ||||
| C01AA07 | Deslanoside | ||||
| C01AA08 | Metildigoxin | ||||
| C01AA09 | Gitoformate | ||||
| C01AA52 | Acetyldigoxin, combinations | ||||
| C01AB | Scilla glycosides | ||||
| C01AB01 | Proscillaridin | ||||
| C01AB51 | Proscillaridin, combinations | ||||
| C01AC | Strophantus glycosides | ||||
| C01AC01 | G-strophanthin | ||||
| C01AC03 | Cymarin | ||||
| C01AX | Other cardiac glycosides | ||||
| C01AX02 | Peruvoside | ||||
| C01B | Antiarrhythmics, class I and III | ||||
| C01BA | Antiarrhythmics, class Ia | ||||
| C01BA01 | Quinidine | ||||
| C01BA02 | Procainamide | ||||
| C01BA03 | Disopyramide | ||||
| C01BA04 | Sparteine | ||||
| C01BA05 | Ajmaline | ||||
| C01BA08 | Prajmaline | ||||
| C01BA12 | Lorajmine | ||||
| C01BA51 | Quinidine, combinations excluding psycholeptics | ||||
| C01BA71 | Quinidine, combinations with psycholeptics | ||||
| C01BB | Antiarrhythmics, class Ib | ||||
| C01BB01 | Lidocaine | ||||
| C01BB02 | Mexiletine | ||||
| C01BB03 | Tocainide | ||||
| C01BB04 | Aprindine | ||||
| C01BC | Antiarrhythmics, class Ic | ||||
| C01BC03 | Propafenone | ||||
| C01BC04 | Flecainide | ||||
| C01BC07 | Lorcainide | ||||
| C01BC08 | Encainide | ||||
| C01BC09 | Ethacizine | ||||
| C01BD | Antiarrhythmics, class III | ||||
| C01BD01 | Amiodarone | ||||
| C01BD02 | Bretylium tosilate | ||||
| C01BD03 | Bunaftine | ||||
| C01BD04 | Dofetilide | ||||
| C01BD05 | Ibutilide | ||||
| C01BD06 | Tedisamil | ||||
| C01BD07 | Dronedarone | ||||
| C01BG | Other antiarrhythmics, class I and III | ||||
| C01BG01 | Moracizine | ||||
| C01BG07 | Cibenzoline | ||||
| C01BG11 | Vernakalant | ||||
| C01C | Cardiac stimulants excluding cardiac glycosides | ||||
| C01CA | Adrenergic and dopaminergic agents | ||||
| C01CA01 | Etilefrine | ||||
| C01CA02 | Isoprenaline | ||||
| C01CA03 | Norepinephrine | ||||
| C01CA04 | Dopamine | ||||
| C01CA05 | Norfenefrine | ||||
| C01CA06 | Phenylephrine | ||||
| C01CA07 | Dobutamine | ||||
| C01CA08 | Oxedrine | ||||
| C01CA09 | Metaraminol | ||||
| C01CA10 | Methoxamine | ||||
| C01CA11 | Mephentermine | ||||
| C01CA12 | Dimetofrine | ||||
| C01CA13 | Prenalterol | ||||
| C01CA14 | Dopexamine | ||||
| C01CA15 | Gepefrine | ||||
| C01CA16 | Ibopamine | ||||
| C01CA17 | Midodrine | ||||
| C01CA18 | Octopamine | ||||
| C01CA19 | Fenoldopam | ||||
| C01CA21 | Cafedrine | ||||
| C01CA22 | Arbutamine | ||||
| C01CA23 | Theodrenaline | ||||
| C01CA24 | Epinephrine | ||||
| C01CA25 | Amezinium metilsulfate | ||||
| C01CA26 | Ephedrine | ||||
| C01CA27 | droxidopa | ||||
| C01CA30 | Combinations | ||||
| C01CA51 | Etilefrine, combinations | ||||
| C01CE | Phosphodiesterase inhibitors | ||||
| C01CE01 | Amrinone | ||||
| C01CE02 | Milrinone | ||||
| C01CE03 | Enoximone | ||||
| C01CE04 | Bucladesine | ||||
| C01CX | Other cardiac stimulants | ||||
| C01CX06 | Angiotensinamide | ||||
| C01CX07 | Xamoterol | ||||
| C01CX08 | Levosimendan | ||||
| C01D | Vasodilators used in cardiac diseases | ||||
| C01DA | Organic nitrates | ||||
| C01DA02 | Glyceryl trinitrate | ||||
| C01DA04 | Methylpropylpropanediol dinitrate | ||||
| C01DA05 | Pentaerithrityl tetranitrate | ||||
| C01DA07 | Propatylnitrate | ||||
| C01DA08 | Isosorbide dinitrate | ||||
| C01DA09 | Trolnitrate | ||||
| C01DA13 | Eritrityl tetranitrate | ||||
| C01DA14 | Isosorbide mononitrate | ||||
| C01DA20 | Organic nitrates in combination | ||||
| C01DA38 | Tenitramine | ||||
| C01DA52 | Glyceryl trinitrate, combinations | ||||
| C01DA54 | Methylpropylpropanediol dinitrate, combinations | ||||
| C01DA55 | Pentaerithrityl tetranitrate, combinations | ||||
| C01DA57 | Propatylnitrate, combinations | ||||
| C01DA58 | Isosorbide dinitrate, combinations | ||||
| C01DA59 | Trolnitrate, combinations | ||||
| C01DA63 | Eritrityl tetranitrate, combinations | ||||
| C01DA70 | Organic nitrates in combination with psycholeptics | ||||
| C01DB | Quinolone vasodilators | ||||
| C01DB01 | Flosequinan | ||||
| C01DX | Other vasodilators used in cardiac diseases | ||||
| C01DX01 | Itramin tosilate | ||||
| C01DX02 | Prenylamine | ||||
| C01DX03 | Oxyfedrine | ||||
| C01DX04 | Benziodarone | ||||
| C01DX05 | Carbocromen | ||||
| C01DX06 | Hexobendine | ||||
| C01DX07 | Etafenone | ||||
| C01DX08 | Heptaminol | ||||
| C01DX09 | Imolamine | ||||
| C01DX10 | Dilazep | ||||
| C01DX11 | Trapidil | ||||
| C01DX12 | Molsidomine | ||||
| C01DX13 | Efloxate | ||||
| C01DX14 | Cinepazet | ||||
| C01DX15 | Cloridarol | ||||
| C01DX16 | Nicorandil | ||||
| C01DX18 | Linsidomine | ||||
| C01DX19 | Nesiritide | ||||
| C01DX51 | Itramin tosilate, combinations | ||||
| C01DX52 | Prenylamine, combinations | ||||
| C01DX53 | Oxyfedrine, combinations | ||||
| C01DX54 | Benziodarone, combinations | ||||
| C01E | Other cardiac preparations | ||||
| C01EA | Prostaglandins | ||||
| C01EA01 | Alprostadil | ||||
| C01EB | Other cardiac preparations | ||||
| C01EB02 | Camphora | ||||
| C01EB03 | Indometacin | ||||
| C01EB04 | Crataegus glycosides | ||||
| C01EB05 | Creatinolfosfate | ||||
| C01EB06 | Fosfocreatine | ||||
| C01EB07 | Fructose 1,6-diphosphate | ||||
| C01EB09 | Ubidecarenone | ||||
| C01EB10 | Adenosine | ||||
| C01EB11 | Tiracizine | ||||
| C01EB12 | tedisamil (New ATC code C01BD06) | ||||
| C01EB13 | Acadesine | ||||
| C01EB15 | Trimetazidine | ||||
| C01EB16 | Ibuprofen | ||||
| C01EB17 | Ivabradine | ||||
| C01EB18 | Ranolazine | ||||
| C01EB19 | icatibant (New ATC code B06AC02) | ||||
| C01EB21 | Regadenoson | ||||
| C01EB22 | meldonium | ||||
| C01EB23 | tiazotic acid | ||||
| C01EB24 | mavacamten | ||||
| C01EB25 | acoramidis | ||||
| C01EX | Other cardiac combination products | ||||
| empty | |||||
| C02 | Antihypertensives | ||||
| C02A | Antiadrenergic agents, centrally acting | ||||
| C02AA | Rauvolfia alkaloids | ||||
| C02AA01 | Rescinnamine | ||||
| C02AA02 | Reserpine | ||||
| C02AA03 | Combinations of rauwolfia alkaloids | ||||
| C02AA04 | Rauwolfia alkaloids, whole root | ||||
| C02AA05 | Deserpidine | ||||
| C02AA06 | Methoserpidine | ||||
| C02AA07 | Bietaserpine | ||||
| C02AA52 | Reserpine, combinations | ||||
| C02AA53 | Combinations of rauwolfia alkoloids, combinations | ||||
| C02AA57 | Bietaserpine, combinations | ||||
| C02AB | Methyldopa | ||||
| C02AB01 | Methyldopa (levorotatory) | ||||
| C02AB02 | Methyldopa (racemic) | ||||
| C02AC | Imidazoline receptor agonists | ||||
| C02AC01 | Clonidine | ||||
| C02AC02 | Guanfacine | ||||
| C02AC04 | Tolonidine | ||||
| C02AC05 | Moxonidine | ||||
| C02AC06 | Rilmenidine | ||||
| C02B | Antiadrenergic agents, ganglion-blocking | ||||
| C02BA | Sulfonium derivatives | ||||
| C02BA01 | Trimetaphan | ||||
| C02BB | Secondary and tertiary amines | ||||
| C02BB01 | Mecamylamine | ||||
| C02BC | Bisquaternary ammonium compounds | ||||
| empty | |||||
| C02C | Antiadrenergic agents, peripherally acting | ||||
| C02CA | Alpha-adrenoreceptor antagonists | ||||
| C02CA01 | Prazosin | ||||
| C02CA02 | Indoramin | ||||
| C02CA03 | Trimazosin | ||||
| C02CA04 | Doxazosin | ||||
| C02CA06 | Urapidil | ||||
| C02CC | Guanidine derivatives | ||||
| C02CC01 | Betanidine | ||||
| C02CC02 | Guanethidine | ||||
| C02CC03 | Guanoxan | ||||
| C02CC04 | Debrisoquine | ||||
| C02CC05 | Guanoclor | ||||
| C02CC06 | Guanazodine | ||||
| C02CC07 | Guanoxabenz | ||||
| C02D | Arteriolar smooth muscle, agents acting on | ||||
| C02DA | Thiazide derivatives | ||||
| C02DA01 | Diazoxide | ||||
| C02DB | Hydrazinophthalazine derivatives | ||||
| C02DB01 | Dihydralazine | ||||
| C02DB02 | Hydralazine | ||||
| C02DB03 | Endralazine | ||||
| C02DB04 | Cadralazine | ||||
| C02DC | Pyrimidine derivatives | ||||
| C02DC01 | Minoxidil | ||||
| C02DD | Nitroferricyanide derivatives | ||||
| C02DD01 | Nitroprusside | ||||
| C02DG | Guanidine derivatives | ||||
| C02DG01 | Pinacidil | ||||
| C02K | Other antihypertensives | ||||
| C02KA | Alkaloids, excluding rauwolfia | ||||
| C02KA01 | Veratrum | ||||
| C02KB | Tyrosine hydroxylase inhibitors | ||||
| C02KB01 | Metirosine | ||||
| C02KC | MAO inhibitors | ||||
| C02KC01 | Pargyline | ||||
| C02KD | Serotonin antagonists | ||||
| C02KD01 | Ketanserin | ||||
| C02KX | Other antihypertensives | ||||
| C02KX01 | Bosentan | ||||
| C02KX02 | Ambrisentan | ||||
| C02KX03 | Sitaxentan | ||||
| C02KX04 | macitentan | ||||
| C02KX05 | riociguat | ||||
| C02KX52 | ambrisentan and tadalafil | ||||
| C02L | Antihypertensives and diuretics in combination | ||||
| C02LA | Rauwolfia alkaloids and diuretics in combination | ||||
| C02LA01 | Reserpine and diuretics | ||||
| C02LA02 | Rescinnamine and diuretics | ||||
| C02LA03 | Deserpidine and diuretics | ||||
| C02LA04 | Methoserpidine and diuretics | ||||
| C02LA07 | Bietaserpine and diuretics | ||||
| C02LA08 | Rauwolfia alkaloids, whole root and diuretics | ||||
| C02LA09 | Syrosingopine and diuretics | ||||
| C02LA50 | Combinations of rauwolfia alkaloids and diuretics including other combinations | ||||
| C02LA51 | Reserpine and diuretics, combinations with other drugs | ||||
| C02LA52 | Rescinnamine and diuretics, combinations with other drugs | ||||
| C02LA71 | Reserpine and diuretics, combinations with psycholeptics | ||||
| C02LB | Methyldopa and diuretics in combination | ||||
| C02LB01 | Methyldopa (levorotatory) and diuretics | ||||
| C02LC | Imidazoline receptor agonists in combination with diuretics | ||||
| C02LC01 | Clonidine and diuretics | ||||
| C02LC05 | Moxonidine and diuretics | ||||
| C02LC51 | Clonidine and diuretics, combinations with other drugs | ||||
| C02LE | Alpha-adrenoreceptor antagonists and diuretics | ||||
| C02LE01 | Prazosin and diuretics | ||||
| C02LF | Guanidine derivatives and diuretics | ||||
| C02LF01 | Guanethidine and diuretics | ||||
| C02LG | Hydrazinophthalazine derivatives and diuretics | ||||
| C02LG01 | Dihydralazine and diuretics | ||||
| C02LG02 | Hydralazine and diuretics | ||||
| C02LG03 | Picodralazine and diuretics | ||||
| C02LG51 | Dihydralazine and diuretics, combinations with other drugs | ||||
| C02LG73 | Picodralazine and diuretics, combinations with psycholeptics | ||||
| C02LK | Alkaloids, excluding rauwolfia, in combination with diuretics | ||||
| C02LK01 | Veratrum and diuretics | ||||
| C02LL | MAO inhibitors and diuretics | ||||
| C02LL01 | Pargyline and diuretics | ||||
| C02LN | Serotonin antagonists and diuretics | ||||
| empty | |||||
| C02LX | Other antihypertensives and diuretics | ||||
| C02LX01 | Pinacidil and diuretics | ||||
| C02N | Combinations of antihypertensives in ATC-group C02 | ||||
| empty | |||||
| C03 | Diuretics | ||||
| C03A | Low-ceiling diuretics, thiazides | ||||
| C03AA | Thiazides, plain | ||||
| C03AA01 | Bendroflumethiazide | ||||
| C03AA02 | Hydroflumethiazide | ||||
| C03AA03 | Hydrochlorothiazide | ||||
| C03AA04 | Chlorothiazide | ||||
| C03AA05 | Polythiazide | ||||
| C03AA06 | Trichlormethiazide | ||||
| C03AA07 | Cyclopenthiazide | ||||
| C03AA08 | Methyclothiazide | ||||
| C03AA09 | Cyclothiazide | ||||
| C03AA13 | Mebutizide | ||||
| C03AB | Thiazides and potassium in combination | ||||
| C03AB01 | Bendroflumethiazide and potassium | ||||
| C03AB02 | Hydroflumethiazide and potassium | ||||
| C03AB03 | Hydrochlorothiazide and potassium | ||||
| C03AB04 | Chlorothiazide and potassium | ||||
| C03AB05 | Polythiazide and potassium | ||||
| C03AB06 | Trichlormethiazide and potassium | ||||
| C03AB07 | Cyclopenthiazide and potassium | ||||
| C03AB08 | Methyclothiazide and potassium | ||||
| C03AB09 | Cyclothiazide and potassium | ||||
| C03AH | Thiazides, combinations with psycholeptics and/or analgesics | ||||
| C03AH01 | Chlorothiazide, combinations | ||||
| C03AH02 | Hydroflumethiazide, combinations | ||||
| C03AX | Thiazides, combinations with other drugs | ||||
| C03AX01 | Hydrochlorothiazide, combinations | ||||
| C03B | Low-ceiling diuretics, excluding thiazides | ||||
| C03BA | Sulfonamides, plain | ||||
| C03BA02 | Quinethazone | ||||
| C03BA03 | Clopamide | ||||
| C03BA04 | Chlortalidone | ||||
| C03BA05 | Mefruside | ||||
| C03BA07 | Clofenamide | ||||
| C03BA08 | Metolazone | ||||
| C03BA09 | Meticrane | ||||
| C03BA10 | Xipamide | ||||
| C03BA11 | Indapamide | ||||
| C03BA12 | Clorexolone | ||||
| C03BA13 | Fenquizone | ||||
| C03BA82 | Clorexolone, combinations with psycholeptics | ||||
| C03BB | Sulfonamides and potassium in combination | ||||
| C03BB02 | Quinethazone and potassium | ||||
| C03BB03 | Clopamide and potassium | ||||
| C03BB04 | Chlortalidone and potassium | ||||
| C03BB05 | Mefruside and potassium | ||||
| C03BB07 | Clofenamide and potassium | ||||
| C03BC | Mercurial diuretics | ||||
| C03BC01 | Mersalyl | ||||
| C03BD | Xanthine derivatives | ||||
| C03BD01 | Theobromine | ||||
| C03BK | Sulfonamides, combinations with other drugs | ||||
| empty | |||||
| C03BX | Other low-ceiling diuretics | ||||
| C03BX03 | Cicletanine | ||||
| C03C | High-ceiling diuretics | ||||
| C03CA | Sulfonamides, plain | ||||
| C03CA01 | Furosemide | ||||
| C03CA02 | Bumetanide | ||||
| C03CA03 | Piretanide | ||||
| C03CA04 | Torasemide | ||||
| C03CB | Sulfonamides and potassium in combination | ||||
| C03CB01 | Furosemide and potassium | ||||
| C03CB02 | Bumetanide and potassium | ||||
| C03CC | Aryloxyacetic acid derivatives | ||||
| C03CC01 | Etacrynic acid | ||||
| C03CC02 | Tienilic acid | ||||
| C03CD | Pyrazolone derivatives | ||||
| C03CD01 | Muzolimine | ||||
| C03CX | Other high-ceiling diuretics | ||||
| C03CX01 | Etozolin | ||||
| C03D | Potassium-sparing agents | ||||
| C03DA | Aldosterone antagonists | ||||
| C03DA01 | Spironolactone | ||||
| C03DA02 | Potassium canrenoate | ||||
| C03DA03 | Canrenone | ||||
| C03DA04 | Eplerenone | ||||
| C03DA05 | finerenone | ||||
| C03DB | Other potassium-sparing agents | ||||
| C03DB01 | Amiloride | ||||
| C03DB02 | Triamterene | ||||
| C03E | Diuretics and potassium-sparing agents in combination | ||||
| C03EA | Low-ceiling diuretics and potassium-sparing agents | ||||
| C03EA01 | Hydrochlorothiazide and potassium-sparing agents | ||||
| C03EA02 | Trichlormethiazide and potassium-sparing agents | ||||
| C03EA03 | Epitizide and potassium-sparing agents | ||||
| C03EA04 | Altizide and potassium-sparing agents | ||||
| C03EA05 | Mebutizide and potassium-sparing agents | ||||
| C03EA06 | Chlortalidone and potassium-sparing agents | ||||
| C03EA07 | Cyclopenthiazide and potassium-sparing agents | ||||
| C03EA12 | Metolazone and potassium-sparing agents | ||||
| C03EA13 | Bendroflumethiazide and potassium-sparing agents | ||||
| C03EA14 | Butizide and potassium-sparing agents | ||||
| C03EB | High-ceiling diuretics and potassium-sparing agents | ||||
| C03EB01 | Furosemide and potassium-sparing agents | ||||
| C03EB02 | Bumetanide and potassium-sparing agents | ||||
| C03X | Other diuretics | ||||
| C03XA | Vasopressin antagonists | ||||
| C03XA01 | Tolvaptan | ||||
| C03XA02 | Conivaptan | ||||
| C04 | Peripheral vasodilators | ||||
| C04A | Peripheral vasodilators | ||||
| C04AA | 2-amino-1-phenylethanol derivatives | ||||
| C04AA01 | Isoxsuprine | ||||
| C04AA02 | Buphenine | ||||
| C04AA31 | Bamethan | ||||
| C04AB | Imidazoline derivatives | ||||
| C04AB01 | Phentolamine | ||||
| C04AB02 | Tolazoline | ||||
| C04AC | Nicotinic acid and derivatives | ||||
| C04AC01 | Nicotinic acid | ||||
| C04AC02 | Nicotinyl alcohol (pyridylcarbinol) | ||||
| C04AC03 | Inositol nicotinate | ||||
| C04AC07 | Ciclonicate | ||||
| C04AD | Purine derivatives | ||||
| C04AD01 | Pentifylline | ||||
| C04AD02 | Xantinol nicotinate | ||||
| C04AD03 | Pentoxifylline | ||||
| C04AD04 | Etofylline nicotinate | ||||
| C04AE | Ergot alkaloids | ||||
| C04AE01 | Ergoloid mesylates | ||||
| C04AE02 | Nicergoline | ||||
| C04AE04 | Dihydroergocristine | ||||
| C04AE51 | Ergoloid mesylates, combinations | ||||
| C04AE54 | Dihydroergocristine, combinations | ||||
| C04AF | Enzymes | ||||
| C04AF01 | Kallidinogenase | ||||
| C04AX | Other peripheral vasodilators | ||||
| C04AX01 | Cyclandelate | ||||
| C04AX02 | Phenoxybenzamine | ||||
| C04AX07 | Vincamine | ||||
| C04AX10 | Moxisylyte | ||||
| C04AX11 | Bencyclane | ||||
| C04AX13 | piribedil (New ATC code N04BC08) | ||||
| C04AX17 | Vinburnine | ||||
| C04AX19 | Sulcotidil | ||||
| C04AX20 | Buflomedil | ||||
| C04AX21 | Naftidrofuryl | ||||
| C04AX23 | Butalamine | ||||
| C04AX24 | Visnadine | ||||
| C04AX26 | Cetiedil | ||||
| C04AX27 | Cinepazide | ||||
| C04AX28 | Ifenprodil | ||||
| C04AX30 | Azapetine | ||||
| C04AX32 | Fasudil | ||||
| C05 | Vasoprotectives | ||||
| C05A | Agents for treatment of hemorrhoids and anal fissures for topical use | ||||
| C05AA | Corticosteroids | ||||
| C05AA01 | Hydrocortisone | ||||
| C05AA04 | Prednisolone | ||||
| C05AA05 | Betamethasone | ||||
| C05AA06 | Fluorometholone | ||||
| C05AA08 | Fluocortolone | ||||
| C05AA09 | Dexamethasone | ||||
| C05AA10 | Fluocinolone acetonide | ||||
| C05AA11 | Fluocinonide | ||||
| C05AA12 | Triamcinolone | ||||
| C05AB | Antibiotics | ||||
| empty | |||||
| C05AD | Local anesthetics | ||||
| C05AD01 | Lidocaine | ||||
| C05AD02 | Tetracaine | ||||
| C05AD03 | Benzocaine | ||||
| C05AD04 | Cinchocaine | ||||
| C05AD05 | Procaine | ||||
| C05AD06 | Oxetacaine | ||||
| C05AD07 | Pramocaine | ||||
| C05AE | Muscle relaxants | ||||
| C05AE01 | Glyceryl trinitrate | ||||
| C05AE02 | Isosorbide dinitrate | ||||
| C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | ||||
| C05AX01 | Aluminium preparations | ||||
| C05AX02 | Bismuth preparations, combinations | ||||
| C05AX03 | Other preparations, combinations | ||||
| C05AX04 | Zinc preparations | ||||
| C05AX05 | Tribenoside | ||||
| C05B | Antivaricose therapy | ||||
| C05BA | Heparins or heparinoids for topical use | ||||
| C05BA01 | Organo-heparinoid | ||||
| C05BA02 | Sodium apolate | ||||
| C05BA03 | Heparin | ||||
| C05BA04 | Pentosan polysulfate sodium | ||||
| C05BA51 | Heparinoid, combinations | ||||
| C05BA53 | Heparin, combinations | ||||
| C05BB | Sclerosing agents for local injection | ||||
| C05BB01 | Monoethanolamine oleate | ||||
| C05BB02 | Polidocanol | ||||
| C05BB03 | Invert sugar | ||||
| C05BB04 | Sodium tetradecyl sulfate | ||||
| C05BB05 | Phenol | ||||
| C05BB56 | Glucose, combinations | ||||
| C05BX | Other sclerosing agents | ||||
| C05BX01 | Calcium dobesilate | ||||
| C05BX51 | Calcium dobesilate, combinations | ||||
| C05C | Capillary stabilising agents | ||||
| C05CA | Bioflavonoids | ||||
| C05CA01 | Rutoside | ||||
| C05CA02 | Monoxerutin | ||||
| C05CA03 | Diosmin | ||||
| C05CA04 | Troxerutin | ||||
| C05CA05 | Hidrosmin | ||||
| C05CA51 | Rutoside, combinations | ||||
| C05CA53 | Diosmin, combinations | ||||
| C05CA54 | Troxerutin, combinations | ||||
| C05CX | Other capillary stabilising agents | ||||
| C05CX01 | Tribenoside | ||||
| C05CX02 | Naftazone | ||||
| C05CX03 | Hippocastani semen | ||||
| C07 | Beta blocking agents | ||||
| C07A | Beta blocking agents | ||||
| C07AA | Beta blocking agents, non-selective | ||||
| C07AA01 | Alprenolol | ||||
| C07AA02 | Oxprenolol | ||||
| C07AA03 | Pindolol | ||||
| C07AA05 | Propranolol | ||||
| C07AA06 | Timolol | ||||
| C07AA07 | Sotalol | ||||
| C07AA12 | Nadolol | ||||
| C07AA14 | Mepindolol | ||||
| C07AA15 | Carteolol | ||||
| C07AA16 | Tertatolol | ||||
| C07AA17 | Bopindolol | ||||
| C07AA19 | Bupranolol | ||||
| C07AA23 | Penbutolol | ||||
| C07AA27 | Cloranolol | ||||
| C07AA57 | Sotalol, combinations (New ATC code C07FX02) | ||||
| C07AB | Beta blocking agents, selective | ||||
| C07AB01 | Practolol | ||||
| C07AB02 | Metoprolol | ||||
| C07AB03 | Atenolol | ||||
| C07AB04 | Acebutolol | ||||
| C07AB05 | Betaxolol | ||||
| C07AB06 | Bevantolol | ||||
| C07AB07 | Bisoprolol | ||||
| C07AB08 | Celiprolol | ||||
| C07AB09 | Esmolol | ||||
| C07AB10 | Epanolol | ||||
| C07AB11 | S-atenolol | ||||
| C07AB12 | Nebivolol | ||||
| C07AB13 | Talinolol | ||||
| C07AB52 | Metoprolol, combinations (New ATC code C07FX03) | ||||
| C07AB57 | Bisoprolol, combinations (New ATC code C07FX04) | ||||
| C07AG | Alpha and beta blocking agents | ||||
| C07AG01 | Labetalol | ||||
| C07AG02 | Carvedilol | ||||
| C07B | Beta blocking agents and thiazides | ||||
| C07BA | Beta blocking agents, non-selective, and thiazides | ||||
| C07BA02 | Oxprenolol and thiazides | ||||
| C07BA05 | Propranolol and thiazides | ||||
| C07BA06 | Timolol and thiazides | ||||
| C07BA07 | Sotalol and thiazides | ||||
| C07BA12 | Nadolol and thiazides | ||||
| C07BA68 | Metipranolol and thiazides, combinations | ||||
| C07BB | Beta blocking agents, selective, and thiazides | ||||
| C07BB02 | Metoprolol and thiazides | ||||
| C07BB03 | Atenolol and thiazides | ||||
| C07BB04 | Acebutolol and thiazides | ||||
| C07BB06 | Bevantolol and thiazides | ||||
| C07BB07 | Bisoprolol and thiazides | ||||
| C07BB12 | Nebivolol and thiazides | ||||
| C07BB52 | Metoprolol and thiazides, combinations | ||||
| C07BG | Alpha and beta blocking agents and thiazides | ||||
| C07BG01 | Labetalol and thiazides | ||||
| C07C | Beta blocking agents and other diuretics | ||||
| C07CA | Beta blocking agents, non-selective, and other diuretics | ||||
| C07CA02 | Oxprenolol and other diuretics | ||||
| C07CA03 | Pindolol and other diuretics | ||||
| C07CA17 | Bopindolol and other diuretics | ||||
| C07CA23 | Penbutolol and other diuretics | ||||
| C07CB | Beta blocking agents, selective, and other diuretics | ||||
| C07CB02 | Metoprolol and other diuretics | ||||
| C07CB03 | Atenolol and other diuretics | ||||
| C07CB53 | Atenolol and other diuretics, combinations | ||||
| C07CG | Alpha and beta blocking agents and other diuretics | ||||
| C07CG01 | Labetalol and other diuretics | ||||
| C07D | Beta blocking agents, thiazides and other diuretics | ||||
| C07DA | Beta blocking agents, non-selective, thiazides and other diuretics | ||||
| C07DA06 | Timolol, thiazides and other diuretics | ||||
| C07DB | Beta blocking agents, selective, thiazides and other diuretics | ||||
| C07DB01 | Atenolol, thiazides and other diuretics | ||||
| C07E | Beta blocking agents and vasodilators | ||||
| C07EA | Beta blocking agents, non-selective, and vasodilators | ||||
| empty | |||||
| C07EB | Beta blocking agents, selective, and vasodilators | ||||
| empty | |||||
| C07F | Beta blocking agents and other antihypertensives | ||||
| C07FA | Beta blocking agents, non-selective, and other antihypertensives | ||||
| C07FA05 | Propranolol and other antihypertensives (New ATC code C07FX01) | ||||
| C07FB | Beta blocking agents and calcium channel blockers | ||||
| C07FB02 | metoprolol and felodipine (New ATC code C07FB13) | ||||
| C07FB03 | atenolol and nifedipine | ||||
| C07FB07 | bisoprolol and amlodipine | ||||
| C07FB12 | nebivolol and amlodipine | ||||
| C07FB13 | metoprolol and amlodipine | ||||
| C07FX | Beta blocking agents, other combinations | ||||
| C07FX01 | propranolol and other combinations | ||||
| C07FX02 | sotalol and acetylsalicylic acid | ||||
| C07FX03 | metoprolol and acetylsalicylic acid | ||||
| C07FX04 | bisoprolol and acetylsalicylic acid | ||||
| C07FX05 | metoprolol and ivabradine | ||||
| C07FX06 | carvedilol and ivabradine | ||||
| C08 | Calcium channel blockers | ||||
| C08C | Selective calcium channel blockers with mainly vascular effects | ||||
| C08CA | Dihydropyridine derivatives | ||||
| C08CA01 | Amlodipine | ||||
| C08CA02 | Felodipine | ||||
| C08CA03 | Isradipine | ||||
| C08CA04 | Nicardipine | ||||
| C08CA05 | Nifedipine | ||||
| C08CA06 | Nimodipine | ||||
| C08CA07 | Nisoldipine | ||||
| C08CA08 | Nitrendipine | ||||
| C08CA09 | Lacidipine | ||||
| C08CA10 | Nilvadipine | ||||
| C08CA11 | Manidipine | ||||
| C08CA12 | Barnidipine | ||||
| C08CA13 | Lercanidipine | ||||
| C08CA14 | Cilnidipine | ||||
| C08CA15 | Benidipine | ||||
| C08CA16 | Clevidipine | ||||
| C08CA17 | levamlodipine | ||||
| C08CA51 | amlodipine and celecoxib | ||||
| C08CA55 | Nifedipine, combinations | ||||
| C08CX | Other selective calcium channel blockers with mainly vascular effects | ||||
| C08CX01 | Mibefradil | ||||
| C08D | Selective calcium channel blockers with direct cardiac effects | ||||
| C08DA | Phenylalkylamine derivatives | ||||
| C08DA01 | Verapamil | ||||
| C08DA02 | Gallopamil | ||||
| C08DA51 | Verapamil, combinations | ||||
| C08DB | Benzothiazepine derivatives | ||||
| C08DB01 | Diltiazem | ||||
| C08E | Non-selective calcium channel blockers | ||||
| C08EA | Phenylalkylamine derivatives | ||||
| C08EA01 | Fendiline | ||||
| C08EA02 | Bepridil | ||||
| C08EX | Other non-selective calcium channel blockers | ||||
| C08EX01 | Lidoflazine | ||||
| C08EX02 | Perhexiline | ||||
| C08G | Calcium channel blockers and diuretics | ||||
| C08GA | Calcium channel blockers and diuretics | ||||
| C08GA01 | Nifedipine and diuretics | ||||
| C09 | Agents acting on the renin-angiotensin system | ||||
| C09A | ACE inhibitors, plain | ||||
| C09AA | ACE inhibitors, plain | ||||
| C09AA01 | Captopril | ||||
| C09AA02 | Enalapril | ||||
| C09AA03 | Lisinopril | ||||
| C09AA04 | Perindopril | ||||
| C09AA05 | Ramipril | ||||
| C09AA06 | Quinaprl | ||||
| C09AA07 | Benazepril | ||||
| C09AA08 | Cilazapril | ||||
| C09AA09 | Fosinopril | ||||
| C09AA10 | Trandolapril | ||||
| C09AA11 | Spirapril | ||||
| C09AA12 | Delapril | ||||
| C09AA13 | Moexipril | ||||
| C09AA14 | Temocapril | ||||
| C09AA15 | Zofenopril | ||||
| C09AA16 | Imidapril | ||||
| C09B | ACE inhibitors, combinations | ||||
| C09BA | ACE inhibitors and diuretics | ||||
| C09BA01 | Captopril and diuretics | ||||
| C09BA02 | Enalapril and diuretics | ||||
| C09BA03 | Lisinopril and diuretics | ||||
| C09BA04 | Perindopril and diuretics | ||||
| C09BA05 | Ramipril and diuretics | ||||
| C09BA06 | Quinapril and diuretics | ||||
| C09BA07 | Benazepril and diuretics | ||||
| C09BA08 | Cilazapril and diuretics | ||||
| C09BA09 | Fosinopril and diuretics | ||||
| C09BA12 | Delapril and diuretics | ||||
| C09BA13 | Moexipril and diuretics | ||||
| C09BA15 | Zofenopril and diuretics | ||||
| C09BB | ACE inhibitors and calcium channel blockers | ||||
| C09BB02 | Enalapril and lercanidipine | ||||
| C09BB03 | Lisinopril and amlodipine | ||||
| C09BB04 | Perindopril and amlodipine | ||||
| C09BB05 | Ramipril and felodipine | ||||
| C09BB06 | Enalapril and nitrendipine | ||||
| C09BB07 | Ramipril and amlodipine | ||||
| C09BB10 | Trandolapril and verapamil | ||||
| C09BB12 | Delapril and manidipine | ||||
| C09C | Angiotensin II antagonists, plain | ||||
| C09CA | Angiotensin II antagonists, plain | ||||
| C09CA01 | Losartan | ||||
| C09CA02 | Eprosartan | ||||
| C09CA03 | Valsartan | ||||
| C09CA04 | Irbesartan | ||||
| C09CA05 | Tasosartan | ||||
| C09CA06 | Candesartan | ||||
| C09CA07 | Telmisartan | ||||
| C09CA08 | Olmesartan medoxomil | ||||
| C09CA09 | Azilsartan medoxomil | ||||
| C09D | Angiotensin II antagonists, combinations | ||||
| C09DA | Angiotensin II antagonists and diuretics | ||||
| C09DA01 | Losartan and diuretics | ||||
| C09DA02 | Eprosartan and diuretics | ||||
| C09DA03 | Valsartan and diuretics | ||||
| C09DA04 | Irbesartan and diuretics | ||||
| C09DA06 | Candesartan and diuretics | ||||
| C09DA07 | Telmisartan and diuretics | ||||
| C09DA08 | Olmesartan medoxomil and diuretics | ||||
| C09DB | Angiotensin II antagonists and calcium channel blockers | ||||
| C09DB01 | Valsartan and amlodipine | ||||
| C09DB02 | Olmesartan medoxomil and amlodipine | ||||
| C09DB04 | Telmisartan and amlodipine | ||||
| C09DB05 | Irbesartan and amlodipine | ||||
| C09DB06 | Losartan and amlodipine | ||||
| C09DX | Angiotensin II antagonists, other combinations | ||||
| C09X | Other agents acting on the renin-angiotensin system | ||||
| C09DX01 | Valsartan, amlodipine and hydrochlorothiazide | ||||
| C09DX02 | Valsartan and aliskiren | ||||
| C09DX03 | Olmesartan medoxomil, amlodipine and hydrochlorothiazide | ||||
| C09XA | Renin-inhibitors | ||||
| C09XA01 | Remikiren | ||||
| C09XA02 | Aliskiren | ||||
| C09XA52 | Aliskiren and hydrochlorothiazide | ||||
| C09XA53 | Aliskiren and amlodipine | ||||
| C09XA54 | Aliskiren, amlodipine and hydrochlorothiazide | ||||
| C10 | Lipid modifying agents | ||||
| C10A | Lipid modifying agents, plain | ||||
| C10AA | HMG CoA reductase inhibitors | ||||
| C10AA01 | Simvastatin | ||||
| C10AA02 | Lovastatin | ||||
| C10AA03 | Pravastatin | ||||
| C10AA04 | Fluvastatin | ||||
| C10AA05 | Atorvastatin | ||||
| C10AA06 | Cerivastatin | ||||
| C10AA07 | Rosuvastatin | ||||
| C10AA08 | Pitavastatin | ||||
| C10AA51 | simvastatin, combinations (New ATC code C10BX01) | ||||
| C10AA52 | lovastatin, combinations (New ATC code C10BA01) | ||||
| C10AA53 | pravastatin, combinations (New ATC code C10BX02) | ||||
| C10AA55 | atorvastatin, combinations (New ATC code C10BX03) | ||||
| C10AB | Fibrates | ||||
| C10AB01 | Clofibrate | ||||
| C10AB02 | Bezafibrate | ||||
| C10AB03 | Aluminium clofibrate | ||||
| C10AB04 | Gemfibrozil | ||||
| C10AB05 | Fenofibrate | ||||
| C10AB06 | Simfibrate | ||||
| C10AB07 | Ronifibrate | ||||
| C10AB08 | Ciprofibrate | ||||
| C10AB09 | Etofibrate | ||||
| C10AB10 | Clofibride | ||||
| C10AB11 | Choline fenofibrate | ||||
| C10AC | Bile acid sequestrants | ||||
| C10AC01 | Colestyramine | ||||
| C10AC02 | Colestipol | ||||
| C10AC03 | Colextran | ||||
| C10AC04 | Colesevelam | ||||
| C10AD | Nicotinic acid and derivatives | ||||
| C10AD01 | Niceritrol | ||||
| C10AD02 | Nicotinic acid | ||||
| C10AD03 | Nicofuranose | ||||
| C10AD04 | Aluminium nicotinate | ||||
| C10AD05 | Nicotinyl alcohol (pyridylcarbinol) | ||||
| C10AD06 | Acipimox | ||||
| C10AD52 | Nicotinic acid, combinations | ||||
| C10AX | Other lipid modifying agents | ||||
| C10AX01 | Dextrothyroxine | ||||
| C10AX02 | Probucol | ||||
| C10AX03 | Tiadenol | ||||
| C10AX04 | benfluorex (New ATC code A10BX06) | ||||
| C10AX05 | Meglutol | ||||
| C10AX06 | Omega-3-triglycerides | ||||
| C10AX07 | Magnesium pyridoxal 5-phosphate glutamate | ||||
| C10AX08 | Policosanol | ||||
| C10AX09 | Ezetimibe | ||||
| C10AX10 | Alipogene tiparvovec | ||||
| C10AX11 | Mipomersen | ||||
| C10AX12 | Lomitapide | ||||
| C10AX13 | evolocumab | ||||
| C10AX14 | alirocumab | ||||
| C10AX15 | bempedoic acid | ||||
| C10AX16 | inclisiran | ||||
| C10AX17 | evinacumab | ||||
| C10AX18 | volanesorsen | ||||
| C10B | Lipid modifying agents, combinations | ||||
| C10BA | Combinations of various lipid modifying agents | ||||
| C10BA01 | Lovastatin and nicotinic acid | ||||
| C10BA02 | Simvastatin and ezetimibe | ||||
| C10BA03 | Pravastatin and fenofibrate | ||||
| C10BA04 | Simvastatin and fenofibrate | ||||
| C10BA05 | Atorvastatin and ezetimibe | ||||
| C10BA06 | rosuvastatin and ezetimibe | ||||
| C10BA07 | rosuvastatin and omega-3 fatty acids | ||||
| C10BA08 | atorvastatin and omega-3 fatty acids | ||||
| C10BA09 | rosuvastatin and fenofibrate | ||||
| C10BA10 | bempedoic acid and ezetimibe | ||||
| C10BA11 | pravastatin and ezetimibe | ||||
| C10BA12 | pravastatin, ezetimibe and fenofibrate | ||||
| C10BX | HMG CoA reductase inhibitors, other combinations | ||||
| C10BX01 | Simvastatin and acetylsalicylic acid | ||||
| C10BX02 | Pravastatin and acetylsalicylic acid | ||||
| C10BX03 | Atorvastatin and amlodipine | ||||
| C10BX04 | Simvastatin, acetylsalicylic acid and ramipril | ||||
| D | Dermatologicals | ||||
| D01 | Antifungals for dermatological use | ||||
| D01A | Antifungals for topical use | ||||
| D01AA | Antibiotics | ||||
| D01AA01 | Nystatin | ||||
| D01AA02 | Natamycin | ||||
| D01AA03 | Hachimycin | ||||
| D01AA04 | Pecilocin | ||||
| D01AA06 | Mepartricin | ||||
| D01AA07 | Pyrrolnitrin | ||||
| D01AA08 | Griseofulvin | ||||
| D01AA20 | Combinations | ||||
| D01AC | Imidazole and triazole derivatives | ||||
| D01AC01 | Clotrimazole | ||||
| D01AC02 | Miconazole | ||||
| D01AC03 | Econazole | ||||
| D01AC04 | Clomidazole | ||||
| D01AC05 | Isoconazole | ||||
| D01AC06 | Tiabendazole | ||||
| D01AC07 | Tioconazole | ||||
| D01AC08 | Ketoconazole | ||||
| D01AC09 | Sulconazole | ||||
| D01AC10 | Bifonazole | ||||
| D01AC11 | Oxiconazole | ||||
| D01AC12 | Fenticonazole | ||||
| D01AC13 | Omoconazole | ||||
| D01AC14 | Sertaconazole | ||||
| D01AC15 | Fluconazole | ||||
| D01AC16 | Flutrimazole | ||||
| D01AC17 | Eberconazole | ||||
| D01AC20 | Combinations | ||||
| D01AC52 | Miconazole, combinations | ||||
| D01AC60 | Bifonazole, combinations | ||||
| D01AE | Other antifungals for topical use | ||||
| D01AE01 | Bromochlorosalicylanilide | ||||
| D01AE02 | Methylrosaniline | ||||
| D01AE03 | Tribromometacresol | ||||
| D01AE04 | Undecylenic acid | ||||
| D01AE05 | Polynoxylin | ||||
| D01AE06 | 2-(4-chlorphenoxy)-ethanol | ||||
| D01AE07 | Chlorphenesin | ||||
| D01AE08 | Ticlatone | ||||
| D01AE09 | Sulbentine | ||||
| D01AE10 | Ethyl hydroxybenzoate | ||||
| D01AE11 | Haloprogin | ||||
| D01AE12 | Salicylic acid | ||||
| D01AE13 | Selenium sulfide | ||||
| D01AE14 | Ciclopirox | ||||
| D01AE15 | Terbinafine | ||||
| D01AE16 | Amorolfine | ||||
| D01AE17 | Dimazole | ||||
| D01AE18 | Tolnaftate | ||||
| D01AE19 | Tolciclate | ||||
| D01AE20 | Combinations | ||||
| D01AE21 | Flucytosine | ||||
| D01AE22 | Naftifine | ||||
| D01AE23 | Butenafine | ||||
| D01AE54 | Undecylenic acid, combinations | ||||
| D01B | Antifungals for systemic use | ||||
| D01BA | Antifungals for systemic use | ||||
| D01BA01 | Griseofulvin | ||||
| D01BA02 | Terbinafine | ||||
| D02 | Emollients and protectives | ||||
| D02A | Emollients and protectives | ||||
| D02AA | Silicone products | ||||
| empty | |||||
| D02AB | Zinc products | ||||
| empty | |||||
| D02AC | Soft paraffin and fat products | ||||
| empty | |||||
| D02AD | Liquid plasters | ||||
| empty | |||||
| D02AE | Carbamide products | ||||
| D02AE01 | Carbamide | ||||
| D02AE51 | Carbamide, combinations | ||||
| D02AF | Salicylic acid preparations | ||||
| empty | |||||
| D02AX | Other emollients and protectives | ||||
| empty | |||||
| D02B | Protectives against UV-radiation | ||||
| D02BA | Protectives against UV-radiation for topical use | ||||
| D02BA01 | Aminobenzoic acid | ||||
| D02BA02 | Octinoxate | ||||
| D02BB | Protectives against UV-radiation for systemic use | ||||
| D02BB01 | Betacarotene | ||||
| D03 | Preparations for treatment of wounds and ulcers | ||||
| D03A | Cicatrizants | ||||
| D03AA | Cod-liver oil ointments | ||||
| empty | |||||
| D03AX | Other cicatrizants | ||||
| D03AX01 | Cadexomer iodine | ||||
| D03AX02 | Dextranomer | ||||
| D03AX03 | Dexpanthenol | ||||
| D03AX04 | Calcium pantothenate | ||||
| D03AX05 | Hyaluronic acid | ||||
| D03AX06 | Becaplermin | ||||
| D03AX07 | glyceryl trinitrate (בוטל, קוד חדש C05AE01) | ||||
| D03AX08 | isosorbide dinitrate (בוטל, קוד חדש C05AE02) | ||||
| D03AX09 | Crilanomer | ||||
| D03AX10 | Enoxolone | ||||
| D03AX11 | Sodium chlorite (tetrachlorodecaoxide) | ||||
| D03AX12 | trolamine | ||||
| D03AX13 | Betulae cortex | ||||
| D03AX14 | Centella asiatica herba | ||||
| D03AX15 | trafermin | ||||
| D03B | Enzymes | ||||
| D03BA | Proteolytic enzymes | ||||
| D03BA01 | Trypsin | ||||
| D03BA02 | Clostridiopeptidase | ||||
| D03BA03 | bromelains | ||||
| D03BA52 | Clostridiopeptidase, combinations | ||||
| D04 | Antipruritics, including antihistamines, anesthetics, etc | ||||
| D04A | Antipruritics, including antihistamines, anesthetics, etc. | ||||
| D04AA | Antihistamines for topical use | ||||
| D04AA01 | Thonzylamine | ||||
| D04AA02 | Mepyramine | ||||
| D04AA03 | Thenalidine | ||||
| D04AA04 | Tripelennamine | ||||
| D04AA09 | Chloropyramine | ||||
| D04AA10 | Promethazine | ||||
| D04AA12 | Tolpropamine | ||||
| D04AA13 | Dimetindene | ||||
| D04AA14 | Clemastine | ||||
| D04AA15 | Bamipine | ||||
| D04AA22 | Isothipendyl | ||||
| D04AA32 | Diphenhydramine | ||||
| D04AA33 | Diphenhydramine methylbromide | ||||
| D04AA34 | Chlorphenoxamine | ||||
| D04AB | Anesthetics for topical use | ||||
| D04AB01 | Lidocaine | ||||
| D04AB02 | Cinchocaine | ||||
| D04AB03 | Oxybuprocaine | ||||
| D04AB04 | Benzocaine | ||||
| D04AB05 | Quinisocaine | ||||
| D04AB06 | Tetracaine | ||||
| D04AB07 | Pramocaine | ||||
| D04AX | Other antipruritics | ||||
| empty | |||||
| D05 | Antipsoriatics | ||||
| D05A | Antipsoriatics for topical use | ||||
| D05AA | Tars | ||||
| empty | |||||
| D05AC | Antracen derivatives | ||||
| D05AC01 | Dithranol | ||||
| D05AC51 | Dithranol, combinations | ||||
| D05AD | Psoralens for topical use | ||||
| D05AD01 | Trioxysalen | ||||
| D05AD02 | Methoxsalen | ||||
| D05AX | Other antipsoriatics for topical use | ||||
| D05AX01 | Fumaric acid | ||||
| D05AX02 | Calcipotriol | ||||
| D05AX03 | Calcitriol | ||||
| D05AX04 | Tacalcitol | ||||
| D05AX05 | Tazarotene | ||||
| D05AX52 | Calcipotriol, combinations | ||||
| D05B | Antipsoriatics for systemic use | ||||
| D05BA | Psoralens for systemic use | ||||
| D05BA01 | Trioxysalen | ||||
| D05BA02 | Methoxsalen | ||||
| D05BA03 | Bergapten | ||||
| D05BB | Retinoids for treatment of psoriasis | ||||
| D05BB01 | Etretinate | ||||
| D05BB02 | Acitretin | ||||
| D05BX | Other antipsoriatics for systemic use | ||||
| D05BX51 | Fumaric acid derivatives, combinations | ||||
| D06 | Antibiotics and chemotherapeutics for dermatological use | ||||
| D06A | Antibiotics for topical use | ||||
| D06AA | Tetracycline and derivatives | ||||
| D06AA01 | Demeclocycline | ||||
| D06AA02 | Chlortetracycline | ||||
| D06AA03 | Oxytetracycline | ||||
| D06AA04 | Tetracycline | ||||
| D06AX | Other antibiotics for topical use | ||||
| D06AX01 | Fusidic acid | ||||
| D06AX02 | Chloramphenicol | ||||
| D06AX04 | Neomycin | ||||
| D06AX05 | Bacitracin | ||||
| D06AX07 | Gentamicin | ||||
| D06AX08 | Tyrothricin | ||||
| D06AX09 | Mupirocin | ||||
| D06AX10 | Virginiamycin | ||||
| D06AX11 | Rifaximin | ||||
| D06AX12 | Amikacin | ||||
| D06AX13 | Retapamulin | ||||
| D06B | Chemotherapeutics for topical use | ||||
| D06BA | Sulfonamides | ||||
| D06BA01 | Silver sulfadiazine | ||||
| D06BA02 | Sulfathiazole | ||||
| D06BA03 | Mafenide | ||||
| D06BA04 | Sulfamethizole | ||||
| D06BA05 | Sulfanilamide | ||||
| D06BA06 | Sulfamerazine | ||||
| D06BB | Antivirals | ||||
| D06BB01 | Idoxuridine | ||||
| D06BB02 | Tromantadine | ||||
| D06BB03 | Aciclovir | ||||
| D06BB04 | Podophyllotoxin | ||||
| D06BB05 | Inosine | ||||
| D06BB06 | Penciclovir | ||||
| D06BB07 | Lysozyme | ||||
| D06BB08 | Ibacitabine | ||||
| D06BB09 | Edoxudine | ||||
| D06BB10 | Imiquimod | ||||
| D06BB11 | Docosanol | ||||
| D06BB12 | Sinecatechins | ||||
| D06BB53 | Aciclovir, combinations | ||||
| D06BX | Other chemotherapeutics | ||||
| D06BX01 | Metronidazole | ||||
| D06BX02 | Ingenol mebutate | ||||
| D06BX03 | tirbanibulin | ||||
| D06C | Antibiotics and chemotherapeutics, combinations | ||||
| empty | |||||
| D07 | Corticosteroids, dermatological preparations | ||||
| D07A | Corticosteroids, plain | ||||
| D07AA | Corticosteroids, weak (group I) | ||||
| D07AA01 | Methylprednisolone | ||||
| D07AA02 | Hydrocortisone | ||||
| D07AA03 | Prednisolone | ||||
| D07AB | Corticosteroids, moderately potent (group II) | ||||
| D07AB01 | Clobetasone | ||||
| D07AB02 | Hydrocortisone butyrate | ||||
| D07AB03 | Flumetasone | ||||
| D07AB04 | Fluocortin | ||||
| D07AB05 | Fluperolone | ||||
| D07AB06 | Fluorometholone | ||||
| D07AB07 | Fluprednidene | ||||
| D07AB08 | Desonide | ||||
| D07AB09 | Triamcinolone | ||||
| D07AB10 | Alclometasone | ||||
| D07AB11 | Hydrocortisone buteprate | ||||
| D07AB19 | Dexamethasone | ||||
| D07AB21 | Clocortolone | ||||
| D07AB30 | Combinations of corticosteroids | ||||
| D07AC | Corticosteroids, potent (group III) | ||||
| D07AC01 | Betamethasone | ||||
| D07AC02 | Fluclorolone | ||||
| D07AC03 | Desoximetasone | ||||
| D07AC04 | Fluocinolone acetonide | ||||
| D07AC05 | Fluocortolone | ||||
| D07AC06 | Diflucortolone | ||||
| D07AC07 | Fludroxycortide | ||||
| D07AC08 | Fluocinonide | ||||
| D07AC09 | Budesonide | ||||
| D07AC10 | Diflorasone | ||||
| D07AC11 | Amcinonide | ||||
| D07AC12 | Halometasone | ||||
| D07AC13 | Mometasone | ||||
| D07AC14 | Methylprednisolone aceponate | ||||
| D07AC15 | Beclometasone | ||||
| D07AC16 | Hydrocortisone aceponate | ||||
| D07AC17 | Fluticasone | ||||
| D07AC18 | Prednicarbate | ||||
| D07AC19 | Difluprednate | ||||
| D07AC21 | Ulobetasol | ||||
| D07AD | Corticosteroids, very potent (group IV) | ||||
| D07AD01 | Clobetasol | ||||
| D07AD02 | Halcinonide | ||||
| D07B | Corticosteroids, combinations with antiseptics | ||||
| D07BA | Corticosteroids, weak, combinations with antiseptics | ||||
| D07BA01 | Prednisolone and antiseptics | ||||
| D07BA04 | Hydrocortisone and antiseptics | ||||
| D07BB | Corticosteroids, moderately potent, combinations with antiseptics | ||||
| D07BB01 | Flumetasone and antiseptics | ||||
| D07BB02 | Desonide and antiseptics | ||||
| D07BB03 | Triamcinolone and antiseptics | ||||
| D07BB04 | Hydrocortisone butyrate and antiseptics | ||||
| D07BC | Corticosteroids, potent, combinations with antiseptics | ||||
| D07BC01 | Betamethasone and antiseptics | ||||
| D07BC02 | Fluocinolone acetonide and antiseptics | ||||
| D07BC03 | Fluocortolone and antiseptics | ||||
| D07BC04 | Diflucortolone and antiseptics | ||||
| D07BD | Corticosteroids, very potent, combinations with antiseptics | ||||
| empty | |||||
| D07C | Corticosteroids, combinations with antibiotics | ||||
| D07CA | Corticosteroids, weak, combinations with antibiotics | ||||
| D07CA01 | Hydrocortisone and antibiotics | ||||
| D07CA02 | Methylprednisolone and antibiotics | ||||
| D07CA03 | Prednisolone and antibiotics | ||||
| D07CB | Corticosteroids, moderately potent, combinations with antibiotics | ||||
| D07CB01 | Triamcinolone and antibiotics | ||||
| D07CB02 | Fluprednidene and antibiotics | ||||
| D07CB03 | Fluorometholone and antibiotics | ||||
| D07CB04 | Dexamethasone and antibiotics | ||||
| D07CB05 | Flumetasone and antibiotics | ||||
| D07CC | Corticosteroids, potent, combinations with antibiotics | ||||
| D07CC01 | Betamethasone and antibiotics | ||||
| D07CC02 | Fluocinolone acetonide and antibiotics | ||||
| D07CC03 | Fludroxycortide and antibiotics | ||||
| D07CC04 | Beclometasone and antibiotics | ||||
| D07CC05 | Fluocinonide and antibiotics | ||||
| D07CC06 | Fluocortolone and antibiotics | ||||
| D07CD | Corticosteroids, very potent, combinations with antibiotics | ||||
| D07CD01 | Clobetasol and antibiotics | ||||
| D07X | Corticosteroids, other combinations | ||||
| D07XA | Corticosteroids, weak, other combinations | ||||
| D07XA01 | Hydrocortisone | ||||
| D07XA02 | Prednisolone | ||||
| D07XB | Corticosteroids, moderately potent, other combinations | ||||
| D07XB01 | Flumetasone | ||||
| D07XB02 | Triamcinolone | ||||
| D07XB03 | Fluprednidene | ||||
| D07XB04 | Fluorometholone | ||||
| D07XB05 | Dexamethasone | ||||
| D07XB30 | Combinations of corticosteroids | ||||
| D07XC | Corticosteroids, potent, other combinations | ||||
| D07XC01 | Betamethasone | ||||
| D07XC02 | Desoximetasone | ||||
| D07XC03 | Mometasone | ||||
| D07XC04 | Diflucortolone | ||||
| D07XD | Corticosteroids, very potent, other combinations | ||||
| empty | |||||
| D08 | Antiseptics and disinfectants | ||||
| D08A | Antiseptics and disinfectants | ||||
| D08AA | Acridine derivatives | ||||
| D08AA01 | Ethacridine lactate | ||||
| D08AA02 | Aminoacridine | ||||
| D08AA03 | Euflavine | ||||
| D08AB | Aluminium agents | ||||
| empty | |||||
| D08AC | Biguanides and amidines | ||||
| D08AC01 | Dibrompropamidine | ||||
| D08AC02 | Chlorhexidine | ||||
| D08AC03 | Propamidine | ||||
| D08AC04 | Hexamidine | ||||
| D08AC05 | Polihexanide | ||||
| D08AC52 | Chlorhexidine, combinations | ||||
| D08AD | Boric acid products | ||||
| empty | |||||
| D08AE | Phenol and derivatives | ||||
| D08AE01 | Hexachlorophene | ||||
| D08AE02 | Policresulen | ||||
| D08AE03 | Phenol | ||||
| D08AE04 | Triclosan | ||||
| D08AE05 | Chloroxylenol | ||||
| D08AE06 | Biphenylol | ||||
| D08AF | Nitrofuran derivatives | ||||
| D08AF01 | Nitrofural | ||||
| D08AG | Iodine products | ||||
| D08AG01 | Iodine/octylphenoxypolyglycolether | ||||
| D08AG02 | Povidone-iodine | ||||
| D08AG03 | Iodine | ||||
| D08AG04 | Diiodohydroxypropane | ||||
| D08AH | Quinoline derivatives | ||||
| D08AH01 | Dequalinium | ||||
| D08AH02 | Chlorquinaldol | ||||
| D08AH03 | Oxyquinoline | ||||
| D08AH30 | Clioquinol | ||||
| D08AJ | Quaternary ammonium compounds | ||||
| D08AJ01 | Benzalkonium | ||||
| D08AJ02 | Cetrimonium | ||||
| D08AJ03 | Cetylpyridinium | ||||
| D08AJ04 | Cetrimide | ||||
| D08AJ05 | Benzoxonium chloride | ||||
| D08AJ06 | Didecyldimethylammonium chloride | ||||
| D08AJ08 | Benzethonium chloride | ||||
| D08AJ57 | Octenidine, combinations | ||||
| D08AJ58 | Benzethonium chloride, combinations | ||||
| D08AJ59 | Dodeclonium bromide, combinations | ||||
| D08AK | Mercurial products | ||||
| D08AK01 | Mercuric amidochloride | ||||
| D08AK02 | Phenylmercuric borate | ||||
| D08AK03 | Mercuric chloride | ||||
| D08AK04 | Mercurochrome | ||||
| D08AK05 | Mercury, metallic | ||||
| D08AK06 | Thiomersal | ||||
| D08AK30 | Mercuric iodide | ||||
| D08AL | Silver compounds | ||||
| D08AL01 | Silver nitrate | ||||
| D08AL30 | Silver | ||||
| D08AX | Other antiseptics and disinfectants | ||||
| D08AX01 | Hydrogen peroxide | ||||
| D08AX02 | Eosin | ||||
| D08AX03 | Propanol | ||||
| D08AX04 | Tosylchloramide sodium | ||||
| D08AX05 | Isopropanol | ||||
| D08AX06 | Potassium permanganate | ||||
| D08AX07 | Sodium hypochlorite | ||||
| D08AX08 | Ethanol | ||||
| D08AX53 | Propanol, combinations | ||||
| D09 | Medicated dressings | ||||
| D09A | Medicated dressings | ||||
| D09AA | Medicated dressings with antiinfectives | ||||
| D09AA01 | Framycetin | ||||
| D09AA02 | Fusidic acid | ||||
| D09AA03 | Nitrofural | ||||
| D09AA04 | Phenylmercuric nitrate | ||||
| D09AA05 | Benzododecinium | ||||
| D09AA06 | Triclosan | ||||
| D09AA07 | Cetylpyridinium | ||||
| D09AA08 | Aluminium chlorohydrate | ||||
| D09AA09 | Povidone-iodine | ||||
| D09AA10 | Clioquinol | ||||
| D09AA11 | Benzalkonium | ||||
| D09AA12 | Chlorhexidine | ||||
| D09AA13 | Iodoform | ||||
| D09AB | Zinc bandages | ||||
| D09AB01 | Zinc bandage without supplements | ||||
| D09AB02 | Zinc bandage with supplements | ||||
| D09AX | Soft paraffin dressings | ||||
| empty | |||||
| D10 | Anti-acne preparations | ||||
| D10A | Anti-acne preparations for topical use | ||||
| D10AA | Corticosteroids, combinations for treatment of acne | ||||
| D10AA01 | Fluorometholone | ||||
| D10AA02 | Methylprednisolone | ||||
| D10AA03 | Dexamethasone | ||||
| D10AB | Preparations containing sulfur | ||||
| D10AB01 | Bithionol | ||||
| D10AB02 | Sulfur | ||||
| D10AB03 | Tioxolone | ||||
| D10AB05 | Mesulfen | ||||
| D10AD | Retinoids for topical use in acne | ||||
| D10AD01 | Tretinoin | ||||
| D10AD02 | Retinol | ||||
| D10AD03 | Adapalene | ||||
| D10AD04 | Isotretinoin | ||||
| D10AD05 | Motretinide | ||||
| D10AD06 | trifarotene | ||||
| D10AD51 | Tretinoin, combinations | ||||
| D10AD53 | Adapalene, combinations | ||||
| D10AD54 | Isotretinoin, combinations | ||||
| D10AE | Peroxides | ||||
| D10AE01 | Benzoyl peroxide | ||||
| D10AE51 | Benzoyl peroxide, combinations | ||||
| D10AF | Anti-infectives for treatment of acne | ||||
| D10AF01 | Clindamycin | ||||
| D10AF02 | Erythromycin | ||||
| D10AF03 | Chloramphenicol | ||||
| D10AF04 | Meclocycline | ||||
| D10AF51 | Clindamycin, combinations | ||||
| D10AF52 | Erythromycin, combinations | ||||
| D10AX | Other anti-acne preparations for topical use | ||||
| D10AX01 | Aluminium chloride | ||||
| D10AX02 | Resorcinol | ||||
| D10AX03 | Azelaic acid | ||||
| D10AX04 | Aluminium oxide | ||||
| D10AX05 | Dapsone | ||||
| D10AX30 | Various combinations | ||||
| D10B | Anti-acne preparations for systemic use | ||||
| D10BA | Retinoids for treatment of acne | ||||
| D10BA01 | Isotretinoin | ||||
| D10BX | Other anti-acne preparations for systemic use | ||||
| D10BX01 | Ichtasol | ||||
| D11 | Other dermatological preparations | ||||
| D11A | Other dermatological preparations | ||||
| D11AA | Antihidrotics | ||||
| empty | |||||
| D11AC | Medicated shampoos | ||||
| D11AC01 | Cetrimide | ||||
| D11AC02 | Cadmium compounds | ||||
| D11AC03 | Selenium compounds | ||||
| D11AC06 | Povidone-iodine | ||||
| D11AC08 | Sulfur compounds | ||||
| D11AC09 | Xenysalate | ||||
| D11AC30 | Others | ||||
| D11AE | Androgens for topical use | ||||
| D11AE01 | Metandienone | ||||
| D11AF | Wart and anti-corn preparations | ||||
| empty | |||||
| D11AH | Agents for dermatitis, excluding corticosteroids | ||||
| D11AH01 | Tacrolimus | ||||
| D11AH02 | Pimecrolimus | ||||
| D11AH03 | Cromoglicic acid | ||||
| D11AH04 | Alitretinoin | ||||
| D11AH05 | Dupilumab | ||||
| D11AH06 | Crisaborole | ||||
| D11AH07 | Tralokinumab | ||||
| D11AH08 | abrocitinib | ||||
| D11AH09 | ruxolitinib | ||||
| D11AH10 | lebrikizumab | ||||
| D11AH11 | delgocitinib | ||||
| D11AH12 | nemolizumab | ||||
| D11AX | Other dermatologicals | ||||
| D11AX01 | Minoxidil | ||||
| D11AX02 | Gamolenic acid | ||||
| D11AX03 | Calcium gluconate | ||||
| D11AX04 | Lithium succinate | ||||
| D11AX05 | Magnesium sulfate | ||||
| D11AX06 | Mequinol | ||||
| D11AX08 | Tiratricol | ||||
| D11AX09 | Oxaceprol | ||||
| D11AX10 | Finasteride | ||||
| D11AX11 | Hydroquinone | ||||
| D11AX12 | Pyrithione zinc | ||||
| D11AX13 | Monobenzone | ||||
| D11AX14 | Tacrolimus (בוטל, קוד חדש D11AH01) | ||||
| D11AX15 | Pimecrolimus (בוטל, קוד חדש D11AH02) | ||||
| D11AX16 | Eflornithine | ||||
| D11AX17 | cromoglicic acid (בוטל, קוד חדש D11AH03) | ||||
| D11AX18 | Diclofenac | ||||
| D11AX19 | alitretinoin (בוטל, קוד חדש D11AH04) | ||||
| D11AX52 | Gamolenic acid, combinations | ||||
| D11AX57 | Collagen, combinations | ||||
| G | Genito-urinary system and sex hormones | ||||
| G01 | Gynecological antiinfectives and antiseptics | ||||
| G01A | Antiinfectives and antiseptics, excluding combinations with corticosteroids | ||||
| G01AA | Antibiotics | ||||
| G01AA01 | Nystatin | ||||
| G01AA02 | Natamycin | ||||
| G01AA03 | Amphotericin B | ||||
| G01AA04 | Candicidin | ||||
| G01AA05 | Chloramphenicol | ||||
| G01AA06 | Hachimycin | ||||
| G01AA07 | Oxytetracycline | ||||
| G01AA08 | Carfecillin | ||||
| G01AA09 | Mepartricin | ||||
| G01AA10 | Clindamycin | ||||
| G01AA11 | Pentamycin | ||||
| G01AA51 | Nystatin, combinations | ||||
| G01AB | Arsenic compounds | ||||
| G01AB01 | Acetarsol | ||||
| G01AC | Quinoline derivatives | ||||
| G01AC01 | Diiodohydroxyquinoline | ||||
| G01AC02 | Clioquinol | ||||
| G01AC03 | Chlorquinaldol | ||||
| G01AC05 | Dequalinium | ||||
| G01AC06 | Broxyquinoline | ||||
| G01AC30 | Oxyquinoline | ||||
| G01AD | Organic acids | ||||
| G01AD01 | Lactic acid | ||||
| G01AD02 | Acetic acid | ||||
| G01AD03 | Ascorbic acid | ||||
| G01AE | Sulfonamides | ||||
| G01AE01 | Sulfatolamide | ||||
| G01AE10 | Combinations of sulfonamides | ||||
| G01AF | Imidazole derivatives | ||||
| G01AF01 | Metronidazole | ||||
| G01AF02 | Clotrimazole | ||||
| G01AF04 | Miconazole | ||||
| G01AF05 | Econazole | ||||
| G01AF06 | Ornidazole | ||||
| G01AF07 | Isoconazole | ||||
| G01AF08 | Tioconazole | ||||
| G01AF11 | Ketoconazole | ||||
| G01AF12 | Fenticonazole | ||||
| G01AF13 | Azanidazole | ||||
| G01AF14 | Propenidazole | ||||
| G01AF15 | Butoconazole | ||||
| G01AF16 | Omoconazole | ||||
| G01AF17 | Oxiconazole | ||||
| G01AF18 | Flutrimazole | ||||
| G01AF20 | Combinations of imidazole derivatives | ||||
| G01AG | Triazole derivatives | ||||
| G01AG02 | Terconazole | ||||
| G01AX | Other anti-infectives and antiseptics | ||||
| G01AX01 | Clodantoin | ||||
| G01AX02 | Inosine | ||||
| G01AX03 | Policresulen | ||||
| G01AX05 | Nifuratel | ||||
| G01AX06 | Furazolidone | ||||
| G01AX09 | Methylrosaniline | ||||
| G01AX11 | Povidone-iodine | ||||
| G01AX12 | Ciclopirox | ||||
| G01AX13 | Protiofate | ||||
| G01AX14 | Lactobacillus fermentum | ||||
| G01AX15 | Copper usnate | ||||
| G01AX66 | Octenidine, combinations | ||||
| G01B | Antiinfectives/antiseptics in combination with corticosteroids | ||||
| G01BA | Antibiotics and corticosteroids | ||||
| empty | |||||
| G01BC | Quinoline derivatives and corticosteroids | ||||
| empty | |||||
| G01BD | Antiseptics and corticosteroids | ||||
| empty | |||||
| G01BE | Sulfonamides and corticosteroids | ||||
| empty | |||||
| G01BF | Imidazole derivatives and corticosteroids | ||||
| empty | |||||
| G02 | Other gynecologicals | ||||
| G02A | Oxytocics | ||||
| G02AB | Ergot alkaloids | ||||
| G02AB01 | Methylergometrine | ||||
| G02AB02 | Ergot alkaloids | ||||
| G02AB03 | Ergometrine | ||||
| G02AC | Ergot alkaloids and oxytocin including analogues, in combination | ||||
| G02AC01 | Methylergometrine and oxytocin | ||||
| G02AD | Prostaglandins | ||||
| G02AD01 | Dinoprost | ||||
| G02AD02 | Dinoprostone | ||||
| G02AD03 | Gemeprost | ||||
| G02AD04 | Carboprost | ||||
| G02AD05 | Sulprostone | ||||
| G02AD06 | Misoprostol | ||||
| G02AX | Other oxytocics | ||||
| empty | |||||
| G02B | Contraceptives for topical use | ||||
| G02BA | Intrauterine contraceptives | ||||
| G02BA01 | Plastic IUD | ||||
| G02BA02 | Plastic IUD with copper | ||||
| G02BA03 | Plastic IUD with progestogen | ||||
| G02BB | Intravaginal contraceptives | ||||
| G02BB01 | Vaginal ring with progestogen and estrogen | ||||
| G02C | Other gynecologicals | ||||
| G02CA | Sympathomimetics, labour repressants | ||||
| G02CA01 | Ritodrine | ||||
| G02CA02 | Buphenine | ||||
| G02CA03 | Fenoterol | ||||
| G02CB | Prolactin inhibitors | ||||
| G02CB01 | Bromocriptine | ||||
| G02CB02 | Lisuride | ||||
| G02CB03 | Cabergoline | ||||
| G02CB04 | Quinagolide | ||||
| G02CB05 | Metergoline | ||||
| G02CB06 | Terguride | ||||
| G02CC | Anti-inflammatory products for vaginal administration | ||||
| G02CC01 | Ibuprofen | ||||
| G02CC02 | Naproxen | ||||
| G02CC03 | Benzydamine | ||||
| G02CC04 | Flunoxaprofen | ||||
| G02CX | Other gynecologicals | ||||
| G02CX01 | Atosiban | ||||
| G02CX02 | flibanserin | ||||
| G02CX03 | Agni casti fructus | ||||
| G02CX04 | Cimicifugae rhizoma | ||||
| G02CX05 | bremelanotide | ||||
| G02CX06 | fezolinetant | ||||
| G03 | Sex hormones and modulators of the genital system | ||||
| G03A | Hormonal contraceptives for systemic use | ||||
| G03AA | Progestogens and estrogens, fixed combinations | ||||
| G03AA01 | Etynodiol and ethinylestradiol | ||||
| G03AA02 | Quingestanol and ethinylestradiol | ||||
| G03AA03 | Lynestrenol and ethinylestradiol | ||||
| G03AA04 | Megestrol and ethinylestradiol | ||||
| G03AA05 | Norethisterone and ethinylestradiol | ||||
| G03AA06 | Norgestrel and ethinylestradiol | ||||
| G03AA07 | Levonorgestrel and ethinylestradiol | ||||
| G03AA08 | Medroxyprogesterone and ethinylestradiol | ||||
| G03AA09 | Desogestrel and ethinylestradiol | ||||
| G03AA10 | Gestodene and ethinylestradiol | ||||
| G03AA11 | Norgestimate and ethinylestradiol | ||||
| G03AA12 | Drospirenone and ethinylestradiol | ||||
| G03AA13 | Norelgestromin and ethinylestradiol | ||||
| G03AA14 | Nomegestrol and estradiol | ||||
| G03AA15 | Chlormadinone and ethinylestradiol | ||||
| G03AA16 | dienogest and ethinylestradiol | ||||
| G03AA17 | medroxyprogesterone and estradiol | ||||
| G03AA18 | drospirenone and estetrol | ||||
| G03AB | Progestogens and estrogens, sequential preparations | ||||
| G03AB01 | Megestrol and ethinylestradiol | ||||
| G03AB02 | Lynestrenol and ethinylestradiol | ||||
| G03AB03 | Levonorgestrel and ethinylestradiol | ||||
| G03AB04 | Norethisterone and ethinylestradiol | ||||
| G03AB05 | Desogestrel and ethinylestradiol | ||||
| G03AB06 | Gestodene and ethinylestradiol | ||||
| G03AB07 | Chlormadinone and ethinylestradiol | ||||
| G03AB08 | Dienogest and estradiol | ||||
| G03AC | Progestogens | ||||
| G03AC01 | Norethisterone | ||||
| G03AC02 | Lynestrenol | ||||
| G03AC03 | Levonorgestrel | ||||
| G03AC04 | Quingestanol | ||||
| G03AC05 | Megestrol | ||||
| G03AC06 | Medroxyprogesterone | ||||
| G03AC07 | Norgestrienone | ||||
| G03AC08 | Etonogestrel | ||||
| G03AC09 | Desogestrel | ||||
| G03AC10 | drospirenone | ||||
| G03AD | Emergency contraceptives | ||||
| G03AD01 | Levonorgestrel | ||||
| G03AD02 | Ulipristal | ||||
| G03B | Androgens | ||||
| G03BA | 3-oxoandrosten-(4) derivatives | ||||
| G03BA01 | Fluoxymesterone | ||||
| G03BA02 | Methyltestosterone | ||||
| G03BA03 | Testosterone | ||||
| G03BB | 5-androstanon-(3) derivatives | ||||
| G03BB01 | Mesterolone | ||||
| G03BB02 | Androstanolone | ||||
| G03C | Estrogens | ||||
| G03CA | Natural and semisynthetic estrogens, plain | ||||
| G03CA01 | Ethinylestradiol | ||||
| G03CA03 | Estradiol | ||||
| G03CA04 | Estriol | ||||
| G03CA06 | Chlorotrianisene | ||||
| G03CA07 | Estrone | ||||
| G03CA09 | Promestriene | ||||
| G03CA53 | Estradiol, combinations | ||||
| G03CA57 | Conjugated estrogens | ||||
| G03CB | Synthetic estrogens, plain | ||||
| G03CB01 | Dienestrol | ||||
| G03CB02 | Diethylstilbestrol | ||||
| G03CB03 | Methallenestril | ||||
| G03CB04 | Moxestrol | ||||
| G03CC | Estrogens, combinations with other drugs | ||||
| G03CC02 | Dienestrol | ||||
| G03CC03 | Methallenestril | ||||
| G03CC04 | Estrone | ||||
| G03CC05 | Diethylstilbestrol | ||||
| G03CC06 | Estriol | ||||
| G03CX | Other estrogens | ||||
| G03CX01 | Tibolone | ||||
| G03D | Progestogens | ||||
| G03DA | Pregnen-(4) derivatives | ||||
| G03DA01 | Gestonorone | ||||
| G03DA02 | Medroxyprogesterone | ||||
| G03DA03 | Hydroxyprogesterone | ||||
| G03DA04 | Progesterone | ||||
| G03DB | Pregnadien derivatives | ||||
| G03DB01 | Dydrogesterone | ||||
| G03DB02 | Megestrol | ||||
| G03DB03 | Medrogestone | ||||
| G03DB04 | Nomegestrol | ||||
| G03DB05 | Demegestone | ||||
| G03DB06 | Chlormadinone | ||||
| G03DB07 | Promegestone | ||||
| G03DB08 | Dienogest | ||||
| G03DC | Estren derivatives | ||||
| G03DC01 | Allylestrenol | ||||
| G03DC02 | Norethisterone | ||||
| G03DC03 | Lynestrenol | ||||
| G03DC04 | Ethisterone | ||||
| G03DC05 | Tibolone (בוטל, קוד חדש G03CX01) | ||||
| G03DC06 | Etynodiol | ||||
| G03DC31 | Methylestrenolone | ||||
| G03E | Androgens and female sex hormones in combination | ||||
| G03EA | Androgens and estrogens | ||||
| G03EA01 | Methyltestosterone and estrogen | ||||
| G03EA02 | Testosterone and estrogen | ||||
| G03EA03 | Prasterone and estrogen | ||||
| G03EB | Androgen, progestogen and estrogen in combination | ||||
| empty | |||||
| G03EK | Androgens and female sex hormones in combination with other drugs | ||||
| G03EK01 | Methyltestosterone | ||||
| G03F | Progestogens and estrogens in combination | ||||
| G03FA | Progestogens and estrogens, fixed combinations | ||||
| G03FA01 | Norethisterone and estrogen | ||||
| G03FA02 | Hydroxyprogesterone and estrogen | ||||
| G03FA03 | Ethisterone and estrogen | ||||
| G03FA04 | Progesterone and estrogen | ||||
| G03FA05 | Methylnortestosterone and estrogen | ||||
| G03FA06 | Etynodiol and estrogen | ||||
| G03FA07 | Lynestrenol and estrogen | ||||
| G03FA08 | Megestrol and estrogen | ||||
| G03FA09 | Noretynodrel and estrogen | ||||
| G03FA10 | Norgestrel and estrogen | ||||
| G03FA11 | Levonorgestrel and estrogen | ||||
| G03FA12 | Medroxyprogesterone and estrogen | ||||
| G03FA13 | Norgestimate and estrogen | ||||
| G03FA14 | Dydrogesterone and estrogen | ||||
| G03FA15 | Dienogest and estrogen | ||||
| G03FA16 | Trimegestone and estrogen | ||||
| G03FA17 | Drospirenone and estrogen | ||||
| G03FB | Progestogens and estrogens, sequential preparations | ||||
| G03FB01 | Norgestrel and estrogen | ||||
| G03FB02 | Lynestrenol and estrogen | ||||
| G03FB03 | Chlormadinone and estrogen | ||||
| G03FB04 | Megestrol and estrogen | ||||
| G03FB05 | Norethisterone and estrogen | ||||
| G03FB06 | Medroxyprogesterone and estrogen | ||||
| G03FB07 | Medrogestone and estrogen | ||||
| G03FB08 | Dydrogesterone and estrogen | ||||
| G03FB09 | Levonorgestrel and estrogen | ||||
| G03FB10 | Desogestrel and estrogen | ||||
| G03FB11 | Trimegestone and estrogen | ||||
| G03G | Gonadotropins and other ovulation stimulants | ||||
| G03GA | Gonadotropins | ||||
| G03GA01 | chorionic gonadotrophin | ||||
| G03GA02 | Human menopausal gonadotropin | ||||
| G03GA03 | Serum gonadotropin | ||||
| G03GA04 | Urofollitropin | ||||
| G03GA05 | Follitropin alfa | ||||
| G03GA06 | Follitropin beta | ||||
| G03GA07 | Lutropin alfa | ||||
| G03GA08 | Choriogonadotropin alfa | ||||
| G03GA09 | Corifollitropin alfa | ||||
| G03GA10 | follitropin delta | ||||
| G03GA30 | Combinations | ||||
| G03GB | Ovulation stimulants, synthetic | ||||
| G03GB01 | Cyclofenil | ||||
| G03GB02 | Clomifene | ||||
| G03GB03 | Epimestrol | ||||
| G03H | Antiandrogens | ||||
| G03HA | Antiandrogens, plain | ||||
| G03HA01 | Cyproterone | ||||
| G03HB | Antiandrogens and estrogens | ||||
| G03HB01 | Cyproterone and estrogen | ||||
| G03X | Other sex hormones and modulators of the genital system | ||||
| G03XA | Antigonadotropins and similar agents | ||||
| G03XA01 | Danazol | ||||
| G03XA02 | Gestrinone | ||||
| G03XB | Antiprogestogens | ||||
| G03XB01 | Mifepristone | ||||
| G03XC | Selective estrogen receptor modulators | ||||
| G03XC01 | Raloxifene | ||||
| G03XC02 | Bazedoxifene | ||||
| G03XC03 | Lasofoxifene | ||||
| G03XC04 | Ormeloxifene | ||||
| G04 | Urologicals | ||||
| G04B | Urologicals | ||||
| G04BA | Acidifiers | ||||
| G04BA01 | Ammonium chloride | ||||
| G04BA03 | Calcium chloride | ||||
| G04BC | Urinary concrement solvents | ||||
| empty | |||||
| G04BD | Drugs for urinary frequency and incontinence | ||||
| G04BD01 | Emepronium | ||||
| G04BD02 | Flavoxate | ||||
| G04BD03 | Meladrazine | ||||
| G04BD04 | Oxybutynin | ||||
| G04BD05 | Terodiline | ||||
| G04BD06 | Propiverine | ||||
| G04BD07 | Tolterodine | ||||
| G04BD08 | Solifenacin | ||||
| G04BD09 | Trospium | ||||
| G04BD10 | Darifenacin | ||||
| G04BD11 | Fesoterodine | ||||
| G04BD12 | Mirabegron | ||||
| G04BE | Drugs used in erectile dysfunction | ||||
| G04BE01 | Alprostadil | ||||
| G04BE02 | Papaverine | ||||
| G04BE03 | Sildenafil | ||||
| G04BE04 | Yohimbin | ||||
| G04BE05 | phentolamine (בוטל, קוד חדש V03AB36) | ||||
| G04BE06 | Moxisylyte | ||||
| G04BE07 | Apomorphine | ||||
| G04BE08 | Tadalafil | ||||
| G04BE09 | Vardenafil | ||||
| G04BE30 | Combinations | ||||
| G04BE52 | Papaverine, combinations | ||||
| G04BX | Other urologicals | ||||
| G04BX01 | Magnesium hydroxide | ||||
| G04BX03 | Acetohydroxamic acid | ||||
| G04BX06 | Phenazopyridine | ||||
| G04BX10 | Succinimide | ||||
| G04BX11 | Collagen | ||||
| G04BX12 | Phenyl salicylate | ||||
| G04BX13 | Dimethyl sulfoxide | ||||
| G04BX14 | Dapoxetine | ||||
| G04BX15 | Pentosan polysulfate sodium | ||||
| G04BX16 | tiopronin | ||||
| G04BX17 | sodium salicylate and methenamine | ||||
| G04C | Drugs used in benign prostatic hypertrophy | ||||
| G04CA | Alpha-adrenoreceptor antagonists | ||||
| G04CA01 | Alfuzosin | ||||
| G04CA02 | Tamsulosin | ||||
| G04CA03 | Terazosin | ||||
| G04CA04 | Silodosin | ||||
| G04CA51 | Alfuzosin and finasteride | ||||
| G04CA52 | Tamsulosin and dutasteride | ||||
| G04CA53 | Tamsulosin and solifenacin | ||||
| G04CB | Testosterone-5-alpha reductase inhibitors | ||||
| G04CB01 | Finasteride | ||||
| G04CB02 | Dutasteride | ||||
| G04CX | Other drugs used in benign prostatic hypertrophy | ||||
| G04CX01 | Prunus africanae cortex | ||||
| G04CX02 | Sabalis serrulatae fructus | ||||
| G04CX03 | Mepartricin | ||||
| G04CX04 | fexapotide | ||||
| H | Systemic hormonal preparations, excluding sex hormones and insulins | ||||
| H01 | Pituitary and hypothalamic hormones and analogues | ||||
| H01A | Anterior pituitary lobe hormones and analogues | ||||
| H01AA | Adrenocorticotropic hormone | ||||
| H01AA01 | Corticotropin | ||||
| H01AA02 | Tetracosactide | ||||
| H01AB | Thyrotropin | ||||
| H01AB01 | Thyrotropin | ||||
| H01AC | Somatropin and somatropin agonists | ||||
| H01AC01 | Somatropin | ||||
| H01AC02 | Somatrem | ||||
| H01AC03 | Mecasermin | ||||
| H01AC04 | Sermorelin | ||||
| H01AC05 | Mecasermin rinfabate | ||||
| H01AC06 | Tesamorelin | ||||
| H01AC07 | somapacitan | ||||
| H01AC08 | somatrogon | ||||
| H01AC09 | lonapegsomatropin | ||||
| H01AX | Other anterior pituitary lobe hormones and analogues | ||||
| H01AX01 | Pegvisomant | ||||
| H01B | Posterior pituitary lobe hormones | ||||
| H01BA | Vasopressin and analogues | ||||
| H01BA01 | vasopressin (argipressin) | ||||
| H01BA02 | Desmopressin | ||||
| H01BA03 | Lypressin | ||||
| H01BA04 | Terlipressin | ||||
| H01BA05 | Ornipressin | ||||
| H01BA06 | Argipressin (בוטל) | ||||
| H01BB | Oxytocin and analogues | ||||
| H01BB01 | Demoxytocin | ||||
| H01BB02 | Oxytocin | ||||
| H01BB03 | Carbetocin | ||||
| H01C | Hypothalamic hormones | ||||
| H01CA | Gonadotropin-releasing hormones | ||||
| H01CA01 | Gonadorelin | ||||
| H01CA02 | Nafarelin | ||||
| H01CA03 | histrelin (בוטל, קוד חדש L02AE05) | ||||
| H01CB | Somatostatin and analogues | ||||
| H01CB01 | Somatostatin | ||||
| H01CB02 | Octreotide | ||||
| H01CB03 | Lanreotide | ||||
| H01CB04 | Vapreotide | ||||
| H01CB05 | Pasireotide | ||||
| H01CC | Anti-gonadotropin-releasing hormones | ||||
| H01CC01 | Ganirelix | ||||
| H01CC02 | Cetrorelix | ||||
| H01CC03 | elagolix | ||||
| H01CC54 | relugolix, estradiol and norethisterone | ||||
| H02 | Corticosteroids for systemic use | ||||
| H02A | Corticosteroids for systemic use, plain | ||||
| H02AA | Mineralocorticoids | ||||
| H02AA01 | Aldosterone | ||||
| H02AA02 | Fludrocortisone | ||||
| H02AA03 | Desoxycortone | ||||
| H02AB | Glucocorticoids | ||||
| H02AB01 | Betamethasone | ||||
| H02AB02 | Dexamethasone | ||||
| H02AB03 | Fluocortolone | ||||
| H02AB04 | Methylprednisolone | ||||
| H02AB05 | Paramethasone | ||||
| H02AB06 | Prednisolone | ||||
| H02AB07 | Prednisone | ||||
| H02AB08 | Triamcinolone | ||||
| H02AB09 | Hydrocortisone | ||||
| H02AB10 | Cortisone | ||||
| H02AB11 | Prednylidene | ||||
| H02AB12 | Rimexolone | ||||
| H02AB13 | Deflazacort | ||||
| H02AB14 | Cloprednol | ||||
| H02AB15 | Meprednisone | ||||
| H02AB17 | Cortivazol | ||||
| H02B | Corticosteroids for systemic use, combinations | ||||
| H02BX | Corticosteroids for systemic use, combinations | ||||
| H02BX01 | Methylprednisolone, combinations | ||||
| H02C | Antiadrenal preparations | ||||
| H02CA | Anticorticosteroids | ||||
| H02CA01 | Trilostane | ||||
| H02CA02 | osilodrostat | ||||
| H02CA03 | ketoconazole | ||||
| H02CA04 | levoketoconazole | ||||
| H03 | Thyroid therapy | ||||
| H03A | Thyroid preparations | ||||
| H03AA | Thyroid hormones | ||||
| H03AA01 | Levothyroxine sodium | ||||
| H03AA02 | Liothyronine sodium | ||||
| H03AA03 | Combinations of levothyroxine and liothyronine | ||||
| H03AA04 | Tiratricol | ||||
| H03AA05 | Thyroid gland preparations | ||||
| H03B | Antithyroid preparations | ||||
| H03BA | Thiouracils | ||||
| H03BA01 | Methylthiouracil | ||||
| H03BA02 | Propylthiouracil | ||||
| H03BA03 | Benzylthiouracil | ||||
| H03BB | Sulphur-containing imidazole derivatives | ||||
| H03BB01 | Carbimazole | ||||
| H03BB02 | Thiamazole | ||||
| H03BB52 | Thiamazole, combinations | ||||
| H03BC | Perchlorates | ||||
| H03BC01 | Potassium perchlorate | ||||
| H03BX | Other antithyroid preparations | ||||
| H03BX01 | Diiodotyrosine | ||||
| H03BX02 | Dibromotyrosine | ||||
| H03C | Iodine therapy | ||||
| H03CA | Iodine therapy | ||||
| empty | |||||
| H04 | Pancreatic hormones | ||||
| H04A | Glycogenolytic hormones | ||||
| H04AA | Glycogenolytic hormones | ||||
| H04AA01 | Glucagon | ||||
| H05 | Calcium homeostasis | ||||
| H05A | Parathyroid hormones and analogues | ||||
| H05AA | Parathyroid hormones and analogues | ||||
| H05AA01 | Parathyroid gland extract | ||||
| H05AA02 | Teriparatide | ||||
| H05AA03 | Parathyroid hormone | ||||
| H05B | Anti-parathyroid agents | ||||
| H05BA | Calcitonin preparations | ||||
| H05BA01 | Calcitonin (salmon synthetic) | ||||
| H05BA02 | Calcitonin (pork natural) | ||||
| H05BA03 | Calcitonin (human synthetic) | ||||
| H05BA04 | Elcatonin | ||||
| H05BX | Other anti-parathyroid agents | ||||
| H05BX01 | Cinacalcet | ||||
| H05BX02 | Paricalcitol | ||||
| H05BX03 | Doxercalciferol | ||||
| J | Antiinfectives for systemic use | ||||
| J01 | Antibacterials for systemic use | ||||
| J01A | Tetracyclines | ||||
| J01AA | Tetracyclines | ||||
| J01AA01 | Demeclocycline | ||||
| J01AA02 | Doxycycline | ||||
| J01AA03 | Chlortetracycline | ||||
| J01AA04 | Lymecycline | ||||
| J01AA05 | Metacycline | ||||
| J01AA06 | Oxytetracycline | ||||
| J01AA07 | Tetracycline | ||||
| J01AA08 | Minocycline | ||||
| J01AA09 | Rolitetracycline | ||||
| J01AA10 | Penimepicycline | ||||
| J01AA11 | Clomocycline | ||||
| J01AA12 | Tigecycline | ||||
| J01AA20 | Combinations of tetracyclines | ||||
| J01AA56 | Oxytetracycline, combinations | ||||
| J01B | Amphenicols | ||||
| J01BA | Amphenicols | ||||
| J01BA01 | Chloramphenicol | ||||
| J01BA02 | Thiamphenicol | ||||
| J01BA52 | Thiamphenicol, combinations | ||||
| J01C | Beta-lactam antibacterials, penicillins | ||||
| J01CA | Penicillins with extended spectrum | ||||
| J01CA01 | Ampicillin | ||||
| J01CA02 | Pivampicillin | ||||
| J01CA03 | Carbenicillin | ||||
| J01CA04 | Amoxicillin | ||||
| J01CA05 | Carindacillin | ||||
| J01CA06 | Bacampicillin | ||||
| J01CA07 | Epicillin | ||||
| J01CA08 | Pivmecillinam | ||||
| J01CA09 | Azlocillin | ||||
| J01CA10 | Mezlocillin | ||||
| J01CA11 | Mecillinam | ||||
| J01CA12 | Piperacillin | ||||
| J01CA13 | Ticarcillin | ||||
| J01CA14 | Metampicillin | ||||
| J01CA15 | Talampicillin | ||||
| J01CA16 | Sulbenicillin | ||||
| J01CA17 | Temocillin | ||||
| J01CA18 | Hetacillin | ||||
| J01CA19 | Aspoxicillin | ||||
| J01CA20 | Combinations | ||||
| J01CA51 | Ampicillin, combinations | ||||
| J01CE | Beta-lactamase-sensitive penicillins | ||||
| J01CE01 | Benzylpenicillin | ||||
| J01CE02 | Phenoxymethylpenicillin | ||||
| J01CE03 | Propicillin | ||||
| J01CE04 | Azidocillin | ||||
| J01CE05 | Pheneticillin | ||||
| J01CE06 | Penamecillin | ||||
| J01CE07 | Clometocillin | ||||
| J01CE08 | Benzathine benzylpenicillin | ||||
| J01CE09 | Procaine benzylpenicillin | ||||
| J01CE10 | Benzathine phenoxymethylpenicillin | ||||
| J01CE30 | Combinations | ||||
| J01CF | Beta-lactamase-resistant penicillins | ||||
| J01CF01 | Dicloxacillin | ||||
| J01CF02 | Cloxacillin | ||||
| J01CF03 | Methicillin | ||||
| J01CF04 | Oxacillin | ||||
| J01CF05 | Flucloxacillin | ||||
| J01CF06 | Nafcillin | ||||
| J01CG | Beta-lactamase inhibitors | ||||
| J01CG01 | Sulbactam | ||||
| J01CG02 | Tazobactam | ||||
| J01CR | Combinations of penicillins, including beta-lactamase inhibitors | ||||
| J01CR01 | Ampicillin and enzyme inhibitor | ||||
| J01CR02 | Amoxicillin and enzyme inhibitor | ||||
| J01CR03 | Ticarcillin and enzyme inhibitor | ||||
| J01CR04 | Sultamicillin | ||||
| J01CR05 | Piperacillin and enzyme inhibitor | ||||
| J01CR50 | Combinations of penicillins | ||||
| J01D | Other beta-lactam antibacterials | ||||
| J01DB | First-generation cephalosporins | ||||
| J01DB01 | Cefalexin | ||||
| J01DB02 | Cefaloridine | ||||
| J01DB03 | Cefalotin | ||||
| J01DB04 | Cefazolin | ||||
| J01DB05 | Cefadroxil | ||||
| J01DB06 | Cefazedone | ||||
| J01DB07 | Cefatrizine | ||||
| J01DB08 | Cefapirin | ||||
| J01DB09 | Cefradine | ||||
| J01DB10 | Cefacetrile | ||||
| J01DB11 | Cefroxadine | ||||
| J01DB12 | Ceftezole | ||||
| J01DC | Second-generation cephalosporins | ||||
| J01DC01 | Cefoxitin | ||||
| J01DC02 | Cefuroxime | ||||
| J01DC03 | Cefamandole | ||||
| J01DC04 | Cefaclor | ||||
| J01DC05 | Cefotetan | ||||
| J01DC06 | Cefonicide | ||||
| J01DC07 | Cefotiam | ||||
| J01DC08 | Loracarbef | ||||
| J01DC09 | Cefmetazole | ||||
| J01DC10 | Cefprozil | ||||
| J01DC11 | Ceforanide | ||||
| J01DC12 | Cefminox | ||||
| J01DC13 | Cefbuperazone | ||||
| J01DC14 | Flomoxef | ||||
| J01DD | Third-generation cephalosporins | ||||
| J01DD01 | Cefotaxime | ||||
| J01DD02 | Ceftazidime | ||||
| J01DD03 | Cefsulodin | ||||
| J01DD04 | Ceftriaxone | ||||
| J01DD05 | Cefmenoxime | ||||
| J01DD06 | Latamoxef | ||||
| J01DD07 | Ceftizoxime | ||||
| J01DD08 | Cefixime | ||||
| J01DD09 | Cefodizime | ||||
| J01DD10 | Cefetamet | ||||
| J01DD11 | Cefpiramide | ||||
| J01DD12 | Cefoperazone | ||||
| J01DD13 | Cefpodoxime | ||||
| J01DD14 | Ceftibuten | ||||
| J01DD15 | Cefdinir | ||||
| J01DD16 | Cefditoren | ||||
| J01DD17 | Cefcapene | ||||
| J01DD18 | cefteram | ||||
| J01DD51 | cefotaxime and beta-lactamase inhibitor | ||||
| J01DD52 | ceftazidime and beta-lactamase inhibitor | ||||
| J01DD54 | Ceftriaxone, combinations (בוטל, קוד חדש J01DD63) | ||||
| J01DD62 | Cefoperazone, combinations | ||||
| J01DD63 | ceftriaxone and beta-lactamase inhibitor | ||||
| J01DD64 | cefpodoxime and beta-lactamase inhibitor | ||||
| J01DE | Fourth-generation cephalosporins | ||||
| J01DE01 | Cefepime | ||||
| J01DE02 | Cefpirome | ||||
| J01DE03 | Cefozopran | ||||
| J01DF | Monobactams | ||||
| J01DF01 | Aztreonam | ||||
| J01DF02 | Carumonam | ||||
| J01DH | Carbapenems | ||||
| J01DH02 | Meropenem | ||||
| J01DH03 | Ertapenem | ||||
| J01DH04 | Doripenem | ||||
| J01DH05 | Biapenem | ||||
| J01DH06 | tebipenem pivoxil | ||||
| J01DH51 | Imipenem and enzyme inhibitor | ||||
| J01DH52 | meropenem and vaborbactam | ||||
| J01DH55 | Panipenem and betamipron | ||||
| J01DH56 | imipenem, cilastatin and relebactam | ||||
| J01DI | Other cephalosporins and penems | ||||
| J01DI01 | Ceftobiprole medocaril | ||||
| J01DI02 | Ceftaroline fosamil | ||||
| J01DI03 | Faropenem | ||||
| J01DI04 | cefiderocol | ||||
| J01DI54 | ceftolozane and beta-lactamase inhibitor | ||||
| J01E | Sulfonamides and trimethoprim | ||||
| J01EA | Trimethoprim and derivatives | ||||
| J01EA01 | Trimethoprim | ||||
| J01EA02 | Brodimoprim | ||||
| J01EA03 | Iclaprim | ||||
| J01EB | Short-acting sulfonamides | ||||
| J01EB01 | Sulfaisodimidine | ||||
| J01EB02 | Sulfamethizole | ||||
| J01EB03 | Sulfadimidine | ||||
| J01EB04 | Sulfapyridine | ||||
| J01EB05 | Sulfafurazole | ||||
| J01EB06 | Sulfanilamide | ||||
| J01EB07 | Sulfathiazole | ||||
| J01EB08 | Sulfathiourea | ||||
| J01EB20 | Combinations | ||||
| J01EC | Intermediate-acting sulfonamides | ||||
| J01EC01 | Sulfamethoxazole | ||||
| J01EC02 | Sulfadiazine | ||||
| J01EC03 | Sulfamoxole | ||||
| J01EC20 | Combinations | ||||
| J01ED | Long-acting sulfonamides | ||||
| J01ED01 | Sulfadimethoxine | ||||
| J01ED02 | Sulfalene | ||||
| J01ED03 | Sulfametomidine | ||||
| J01ED04 | Sulfametoxydiazine | ||||
| J01ED05 | Sulfamethoxypyridazine | ||||
| J01ED06 | Sulfaperin | ||||
| J01ED07 | Sulfamerazine | ||||
| J01ED08 | Sulfaphenazole | ||||
| J01ED09 | Sulfamazon | ||||
| J01ED20 | Combinations | ||||
| J01EE | Combinations of sulfonamides and trimethoprim, including derivatives | ||||
| J01EE01 | Sulfamethoxazole and trimethoprim | ||||
| J01EE02 | Sulfadiazine and trimethoprim | ||||
| J01EE03 | Sulfametrole and trimethoprim | ||||
| J01EE04 | Sulfamoxole and trimethoprim | ||||
| J01EE05 | Sulfadimidine and trimethoprim | ||||
| J01EE06 | Sulfadiazine and tetroxoprim | ||||
| J01EE07 | Sulfamerazine and trimethoprim | ||||
| J01F | Macrolides, lincosamides and streptogramins | ||||
| J01FA | Macrolides | ||||
| J01FA01 | Erythromycin | ||||
| J01FA02 | Spiramycin | ||||
| J01FA03 | Midecamycin | ||||
| J01FA05 | Oleandomycin | ||||
| J01FA06 | Roxithromycin | ||||
| J01FA07 | Josamycin | ||||
| J01FA08 | Troleandomycin | ||||
| J01FA09 | Clarithromycin | ||||
| J01FA10 | Azithromycin | ||||
| J01FA11 | Miocamycin | ||||
| J01FA12 | Rokitamycin | ||||
| J01FA13 | Dirithromycin | ||||
| J01FA14 | Flurithromycin | ||||
| J01FA15 | Telithromycin | ||||
| J01FF | Lincosamides | ||||
| J01FF01 | Clindamycin | ||||
| J01FF02 | Lincomycin | ||||
| J01FG | Streptogramins | ||||
| J01FG01 | Pristinamycin | ||||
| J01FG02 | Quinupristin/dalfopristin | ||||
| J01G | Aminoglycoside antibacterials | ||||
| J01GA | Streptomycins | ||||
| J01GA01 | Streptomycin | ||||
| J01GA02 | Streptoduocin | ||||
| J01GB | Other aminoglycosides | ||||
| J01GB01 | Tobramycin | ||||
| J01GB03 | Gentamicin | ||||
| J01GB04 | Kanamycin | ||||
| J01GB05 | Neomycin | ||||
| J01GB06 | Amikacin | ||||
| J01GB07 | Netilmicin | ||||
| J01GB08 | Sisomicin | ||||
| J01GB09 | Dibekacin | ||||
| J01GB10 | Ribostamycin | ||||
| J01GB11 | Isepamicin | ||||
| J01GB12 | Arbekacin | ||||
| J01GB13 | Bekanamycin | ||||
| J01M | Quinolone antibacterials | ||||
| J01MA | Fluoroquinolones | ||||
| J01MA01 | Ofloxacin | ||||
| J01MA02 | Ciprofloxacin | ||||
| J01MA03 | Pefloxacin | ||||
| J01MA04 | Enoxacin | ||||
| J01MA05 | Temafloxacin | ||||
| J01MA06 | Norfloxacin | ||||
| J01MA07 | Lomefloxacin | ||||
| J01MA08 | Fleroxacin | ||||
| J01MA09 | Sparfloxacin | ||||
| J01MA10 | Rufloxacin | ||||
| J01MA11 | Grepafloxacin | ||||
| J01MA12 | Levofloxacin | ||||
| J01MA13 | Trovafloxacin | ||||
| J01MA14 | Moxifloxacin | ||||
| J01MA15 | Gemifloxacin | ||||
| J01MA16 | Gatifloxacin | ||||
| J01MA17 | Prulifloxacin | ||||
| J01MA18 | Pazufloxacin | ||||
| J01MA19 | Garenoxacin | ||||
| J01MA21 | Sitafloxacin | ||||
| J01MB | Other quinolones | ||||
| J01MB01 | Rosoxacin | ||||
| J01MB02 | Nalidixic acid | ||||
| J01MB03 | Piromidic acid | ||||
| J01MB04 | Pipemidic acid | ||||
| J01MB05 | Oxolinic acid | ||||
| J01MB06 | Cinoxacin | ||||
| J01MB07 | Flumequine | ||||
| J01R | Combinations of antibacterials | ||||
| J01RA | Combinations of antbacterials | ||||
| J01RA01 | Penicillins, combinations with other antibacterials | ||||
| J01RA02 | Sulfonamides, combinations with other antibacterials (excluding trimethoprim) | ||||
| J01RA03 | Cefuroxime, combinations with other antibacterials | ||||
| J01RA04 | Spiramycin, combinations with other antibacterials | ||||
| J01X | Other antibacterials | ||||
| J01XA | Glycopeptide antibacterials | ||||
| J01XA01 | Vancomycin | ||||
| J01XA02 | Teicoplanin | ||||
| J01XA03 | Telavancin | ||||
| J01XA04 | Dalbavancin | ||||
| J01XA05 | Oritavancin | ||||
| J01XB | Polymyxins | ||||
| J01XB01 | Colistin | ||||
| J01XB02 | Polymyxin B | ||||
| J01XC | Steroid antibacterials | ||||
| J01XC01 | Fusidic acid | ||||
| J01XD | Imidazole derivatives | ||||
| J01XD01 | Metronidazole | ||||
| J01XD02 | Tinidazole | ||||
| J01XD03 | Ornidazole | ||||
| J01XE | Nitrofuran derivatives | ||||
| J01XE01 | Nitrofurantoin | ||||
| J01XE02 | Nifurtoinol | ||||
| J01XE03 | furazidin | ||||
| J01XE51 | nitrofurantoin, combinations | ||||
| J01XX | Other antibacterials | ||||
| J01XX01 | Fosfomycin | ||||
| J01XX02 | Xibornol | ||||
| J01XX03 | Clofoctol | ||||
| J01XX04 | Spectinomycin | ||||
| J01XX05 | Methenamine | ||||
| J01XX06 | Mandelic acid | ||||
| J01XX07 | Nitroxoline | ||||
| J01XX08 | Linezolid | ||||
| J01XX09 | Daptomycin | ||||
| J01XX10 | Bacitracin | ||||
| J01XX11 | tedizolid | ||||
| J01XX12 | lefamulin | ||||
| J02 | Antimycotics for systemic use | ||||
| J02A | Antimycotics for systemic use | ||||
| J02AA | Antibiotics | ||||
| J02AA01 | Amphotericin B | ||||
| J02AA02 | Hachimycin | ||||
| J02AB | Imidazole derivatives | ||||
| J02AB01 | Miconazole | ||||
| J02AB02 | Ketoconazole | ||||
| J02AC | Triazole derivatives | ||||
| J02AC01 | Fluconazole | ||||
| J02AC02 | Itraconazole | ||||
| J02AC03 | Voriconazole | ||||
| J02AC04 | Posaconazole | ||||
| J02AX | Other antimycotics for systemic use | ||||
| J02AX01 | Flucytosine | ||||
| J02AX04 | Caspofungin | ||||
| J02AX05 | Micafungin | ||||
| J02AX06 | Anidulafungin | ||||
| J04 | Antimycobacterials | ||||
| J04A | Drugs for treatment of tuberculosis | ||||
| J04AA | Aminosalicylic acid and derivatives | ||||
| J04AA01 | Aminosalicylic acid | ||||
| J04AA02 | Sodium aminosalicylate | ||||
| J04AA03 | Calcium aminosalicylate | ||||
| J04AB | Antibiotics | ||||
| J04AB01 | Cycloserine | ||||
| J04AB02 | Rifampicin | ||||
| J04AB03 | Rifamycin | ||||
| J04AB04 | Rifabutin | ||||
| J04AB05 | Rifapentin | ||||
| J04AB30 | Capreomycin | ||||
| J04AC | Hydrazides | ||||
| J04AC01 | Isoniazid | ||||
| J04AC51 | Isoniazid, combinations | ||||
| J04AD | Thiocarbamide derivatives | ||||
| J04AD01 | Protionamide | ||||
| J04AD02 | Tiocarlide | ||||
| J04AD03 | Ethionamide | ||||
| J04AK | Other drugs for treatment of tuberculosis | ||||
| J04AK01 | Pyrazinamide | ||||
| J04AK02 | Ethambutol | ||||
| J04AK03 | Terizidone | ||||
| J04AK04 | Morinamide | ||||
| J04AM | Combinations of drugs for treatment of tuberculosis | ||||
| J04AM01 | Streptomycin and isoniazid | ||||
| J04AM02 | Rifampicin and isoniazid | ||||
| J04AM03 | Ethambutol and isoniazid | ||||
| J04AM04 | Thioacetazone and isoniazid | ||||
| J04AM05 | Rifampicin, pyrazinamide and isoniazid | ||||
| J04AM06 | Rifampicin, pyrazinamide, ethambutol and isoniazid | ||||
| J04B | Drugs for treatment of lepra | ||||
| J04BA | Drugs for treatment of lepra | ||||
| J04BA01 | Clofazimine | ||||
| J04BA02 | Dapsone | ||||
| J04BA03 | Aldesulfone sodium | ||||
| J05 | Antivirals for systemic use | ||||
| J05A | Direct acting antiviral drugs | ||||
| J05AA | Thiosemicarbazones | ||||
| J05AA01 | Metisazone | ||||
| J05AB | Nucleosides and nucleotides excluding reverse transcriptase inhibitors | ||||
| J05AB01 | Aciclovir | ||||
| J05AB02 | Idoxuridine | ||||
| J05AB03 | Vidarabine | ||||
| J05AB04 | Ribavirin (בוטל, קוד חדש J05AP01) | ||||
| J05AB06 | Ganciclovir | ||||
| J05AB09 | Famciclovir | ||||
| J05AB11 | Valaciclovir | ||||
| J05AB12 | Cidofovir | ||||
| J05AB13 | Penciclovir | ||||
| J05AB14 | Valganciclovir | ||||
| J05AB15 | Brivudine | ||||
| J05AB16 | remdesivir | ||||
| J05AB17 | brincidofovir | ||||
| J05AB54 | Ribavirin, combinations (בוטל, קוד חדש L03AB60) | ||||
| J05AC | Cyclic amines | ||||
| J05AC02 | Rimantadine | ||||
| J05AC03 | Tromantadine | ||||
| J05AD | Phosphonic acid derivatives | ||||
| J05AD01 | Foscarnet | ||||
| J05AD02 | Fosfonet | ||||
| J05AE | Protease inhibitors | ||||
| J05AE01 | Saquinavir | ||||
| J05AE02 | Indinavir | ||||
| J05AE03 | Ritonavir | ||||
| J05AE04 | Nelfinavir | ||||
| J05AE05 | Amprenavir | ||||
| J05AE06 | lopinavir and ritonavir (בוטל, קוד חדש J05AR10) | ||||
| J05AE07 | Fosamprenavir | ||||
| J05AE08 | Atazanavir | ||||
| J05AE09 | Tipranavir | ||||
| J05AE10 | Darunavir | ||||
| J05AE11 | Telaprevir (בוטל, קוד חדש J05AP02) | ||||
| J05AE12 | Boceprevir (בוטל, קוד חדש J05AP03) | ||||
| J05AE13 | faldaprevir (בוטל, קוד חדש J05AP04) | ||||
| J05AE14 | simeprevir (בוטל, קוד חדש J05AP05) | ||||
| J05AE15 | asunaprevir (בוטל, קוד חדש J05AP06) | ||||
| J05AE16 | ensitrelvir | ||||
| J05AE30 | nirmatrelvir and ritonavir | ||||
| J05AF | Nucleoside and nucleotide reverse transcriptase inhibitors | ||||
| J05AF01 | Zidovudine | ||||
| J05AF02 | Didanosine | ||||
| J05AF03 | Zalcitabine | ||||
| J05AF04 | Stavudine | ||||
| J05AF05 | Lamivudine | ||||
| J05AF06 | Abacavir | ||||
| J05AF07 | Tenofovir disoproxil | ||||
| J05AF08 | Adefovir dipivoxil | ||||
| J05AF09 | Emtricitabine | ||||
| J05AF10 | Entecavir | ||||
| J05AF11 | Telbivudine | ||||
| J05AF12 | Clevudine | ||||
| J05AF13 | tenofovir alafenamide | ||||
| J05AG | Non-nucleoside reverse transcriptase inhibitors | ||||
| J05AG01 | Nevirapine | ||||
| J05AG02 | Delavirdine | ||||
| J05AG03 | Efavirenz | ||||
| J05AG04 | Etravirine | ||||
| J05AG05 | Rilpivirine | ||||
| J05AH | Neuraminidase inhibitors | ||||
| J05AH01 | Zanamivir | ||||
| J05AH02 | Oseltamivir | ||||
| J05AJ | Integrase inhibitors | ||||
| J05AJ01 | raltegravir | ||||
| J05AJ02 | elvitegravir | ||||
| J05AJ03 | dolutegravir | ||||
| J05AJ04 | cabotegravir | ||||
| J05AP | Antivirals for treatment of HCV infections | ||||
| J05AP01 | ribavirin | ||||
| J05AP02 | telaprevir | ||||
| J05AP03 | boceprevir | ||||
| J05AP04 | faldaprevir | ||||
| J05AP05 | simeprevir | ||||
| J05AP06 | asunaprevir | ||||
| J05AP07 | daclatasvir | ||||
| J05AP08 | sofosbuvir | ||||
| J05AP09 | dasabuvir | ||||
| J05AP10 | elbasvir | ||||
| J05AP11 | grazoprevir | ||||
| J05AP51 | sofosbuvir and ledipasvir | ||||
| J05AP52 | dasabuvir, ombitasvir, paritaprevir and ritonavir | ||||
| J05AP53 | ombitasvir, paritaprevir and ritonavir | ||||
| J05AP54 | elbasvir and grazoprevir | ||||
| J05AP55 | sofosbuvir and velpatasvir | ||||
| J05AP56 | sofosbuvir, velpatasvir and voxilaprevir | ||||
| J05AP57 | glecaprevir and pibrentasvir | ||||
| J05AP58 | daclatasvir, asunaprevir and beclabuvir | ||||
| J05AR | Antivirals for treatment of HIV infections, combinations | ||||
| J05AR01 | Zidovudine and lamivudine | ||||
| J05AR02 | Lamivudine and abacavir | ||||
| J05AR03 | Tenofovir disoproxil and emtricitabine | ||||
| J05AR04 | Zidovudine, lamivudine and abacavir | ||||
| J05AR05 | Zidovudine, lamivudine and nevirapine | ||||
| J05AR06 | Emtricitabine, tenofovir disoproxil and efavirenz | ||||
| J05AR07 | Stavudine, lamivudine and nevirapine | ||||
| J05AR08 | Emtricitabine, tenofovir disoproxil and rilpivirine | ||||
| J05AR09 | Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat | ||||
| J05AR10 | Lopinavir and ritonavir | ||||
| J05AR11 | lamivudine, tenofovir disoproxil and efavirenz | ||||
| J05AR12 | lamivudine and tenofovir disoproxil | ||||
| J05AR13 | lamivudine, abacavir and dolutegravir | ||||
| J05AR14 | darunavir and cobicistat | ||||
| J05AR15 | atazanavir and cobicistat | ||||
| J05AR16 | lamivudine and raltegravir | ||||
| J05AR17 | emtricitabine and tenofovir alafenamide | ||||
| J05AR18 | emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat | ||||
| J05AR19 | emtricitabine, tenofovir alafenamide and rilpivirine | ||||
| J05AR20 | emtricitabine, tenofovir alafenamide and bictegravir | ||||
| J05AR21 | dolutegravir and rilpivirine | ||||
| J05AR22 | emtricitabine, tenofovir alafenamide, darunavir and cobicistat | ||||
| J05AR23 | atazanavir and ritonavir | ||||
| J05AR24 | lamivudine, tenofovir disoproxil and doravirine | ||||
| J05AR25 | lamivudine and dolutegravir | ||||
| J05AR26 | darunavir and ritonavir | ||||
| J05AR27 | lamivudine, tenofovir disoproxil and dolutegravir | ||||
| J05AX | Other antivirals | ||||
| J05AX01 | Moroxydine | ||||
| J05AX02 | Lysozyme | ||||
| J05AX05 | Inosine pranobex | ||||
| J05AX06 | Pleconaril | ||||
| J05AX07 | Enfuvirtide | ||||
| J05AX08 | Raltegravir (בוטל, קוד חדש J05AJ01) | ||||
| J05AX09 | Maraviroc | ||||
| J05AX10 | Maribavir | ||||
| J05AX11 | Elvitegravir (בוטל, קוד חדש J05AJ02) | ||||
| J05AX12 | dolutegravir (בוטל, קוד חדש J05AJ03) | ||||
| J05AX13 | umifenovir | ||||
| J05AX14 | daclatasvir (בוטל, קוד חדש J05AP07) | ||||
| J05AX15 | sofosbuvir (בוטל, קוד חדש J05AP08) | ||||
| J05AX16 | dasabuvir (בוטל, קוד חדש J05AP09) | ||||
| J05AX17 | enisamium iodide | ||||
| J05AX18 | letermovir | ||||
| J05AX19 | tilorone | ||||
| J05AX21 | pentanedioic acid imidazolyl ethanamide | ||||
| J05AX23 | ibalizumab | ||||
| J05AX24 | tecovirimat | ||||
| J05AX25 | baloxavir marboxil | ||||
| J05AX26 | amenamevir | ||||
| J05AX27 | favipiravir | ||||
| J05AX28 | bulevirtide | ||||
| J05AX29 | fostemsavir | ||||
| J05AX31 | lenacapavir | ||||
| J05AX65 | sofosbuvir and ledipasvir (בוטל, קוד חדש J05AP51) | ||||
| J05AX66 | dasabuvir, ombitasvir, paritaprevir and ritonavir (בוטל, קוד חדש J05AP52) | ||||
| J05AX67 | ombitasvir, paritaprevir and ritonavir (בוטל, קוד חדש J05AP53) | ||||
| J05AX68 | elbasvir and grazoprevir (בוטל, קוד חדש J05AP54) | ||||
| J05AX69 | sofosbuvir and velpatasvir (בוטל, קוד חדש J05AP55) | ||||
| J06 | Immune sera and immunoglobulins | ||||
| J06A | Immune sera | ||||
| J06AA | Immune sera | ||||
| J06AA01 | Diphtheria antitoxin | ||||
| J06AA02 | Tetanus antitoxin | ||||
| J06AA03 | Snake venom antiserum | ||||
| J06AA04 | Botulinum antitoxin | ||||
| J06AA05 | Gas-gangrene sera | ||||
| J06AA06 | Rabies serum | ||||
| J06B | Immunoglobulins | ||||
| J06BA | Immunoglobulins, normal human | ||||
| J06BA01 | Immunoglobulins, normal human, for extravascular administration | ||||
| J06BA02 | Immunoglobulins, normal human, for intravascular administration | ||||
| J06BB | Specific immunoglobulins | ||||
| J06BB01 | Anti-D (rh) immunoglobulin | ||||
| J06BB02 | Tetanus immunoglobulin | ||||
| J06BB03 | Varicella/zoster immunoglobulin | ||||
| J06BB04 | Hepatitis B immunoglobulin | ||||
| J06BB05 | Rabies immunoglobulin | ||||
| J06BB06 | Rubella immunoglobulin | ||||
| J06BB07 | Vaccinia immunoglobulin | ||||
| J06BB08 | Staphylococcus immunoglobulin | ||||
| J06BB09 | Cytomegalovirus immunoglobulin | ||||
| J06BB10 | Diphtheria immunoglobulin | ||||
| J06BB11 | Hepatitis A immunoglobulin | ||||
| J06BB12 | Encephalitis, tick borne immunoglobulin | ||||
| J06BB13 | Pertussis immunoglobulin | ||||
| J06BB14 | Morbilli immunoglobulin | ||||
| J06BB15 | Parotitis immunoglobulin | ||||
| J06BB16 | Palivizumab (New ATC code J06BD01) | ||||
| J06BB17 | Motavizumab (New ATC code J06BD02) | ||||
| J06BB18 | raxibacumab (New ATC code J06BC02) | ||||
| J06BB21 | bezlotoxumab (New ATC code J06BC03) | ||||
| J06BB22 | obiltoxaximab (New ATC code J06BC04) | ||||
| J06BB30 | Combinations | ||||
| J06BC | Antibacterial monoclonal antibodies | ||||
| J06BC01 | Nebacumab | ||||
| J06BC02 | raxibacumab | ||||
| J06BC03 | bezlotoxumab | ||||
| J06BC04 | obiltoxaximab | ||||
| J06BD | Antiviral monoclonal antibodies | ||||
| J06BD01 | palivizumab | ||||
| J06BD02 | motavizumab | ||||
| J06BD03 | tixagevimab and cilgavimab | ||||
| J06BD04 | ansuvimab | ||||
| J06BD05 | sotrovimab | ||||
| J06BD06 | regdanvimab | ||||
| J06BD07 | casirivimab and imdevimab | ||||
| J06BD08 | nirsevimab | ||||
| J07 | Vaccines | ||||
| J07A | Bacterial vaccines | ||||
| J07AC | Anthrax vaccines | ||||
| J07AC01 | Anthrax antigen | ||||
| J07AD | Brucellosis vaccines | ||||
| J07AD01 | Brucella antigen | ||||
| J07AE | Cholera vaccines | ||||
| J07AE01 | Cholera, inactivated, whole cell | ||||
| J07AE02 | Cholera, live attenuated | ||||
| J07AE51 | Cholera, combinations with typhoid vaccine, inactivated, whole cell | ||||
| J07AF | Diphtheria vaccines | ||||
| J07AF01 | Diphtheria toxoid | ||||
| J07AG | Haemophilus influenzae B vaccines | ||||
| J07AG01 | Hemophilus influenzae B, purified antigen conjugated | ||||
| J07AG51 | Hemophilus influenzae B, combinations with toxoids | ||||
| J07AG52 | Hemophilus influenzae B, combinations with pertussis and toxoids | ||||
| J07AG53 | Hemophilus influenzae B, combinations with meningococcus C, conjugated | ||||
| J07AH | Meningococcal vaccines | ||||
| J07AH01 | Meningococcus A, purified polysaccharides antigen | ||||
| J07AH02 | Other meningococcal monovalent purified polysaccharides antigen | ||||
| J07AH03 | Meningococcus A, C, bivalent purified polysaccharides antigen | ||||
| J07AH04 | Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen | ||||
| J07AH05 | Other meningococcal polyvalent purified polysaccharides antigen | ||||
| J07AH06 | Meningococcus B, outer membrane vesicle vaccine | ||||
| J07AH07 | Meningococcus C, purified polysaccharides antigen conjugated | ||||
| J07AH08 | Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated | ||||
| J07AH09 | Meningococcus B, multicomponent vaccine | ||||
| J07AH10 | Meningococcus A, purified polysaccharides antigen conjugated | ||||
| J07AJ | Pertussis vaccines | ||||
| J07AJ01 | Pertussis, inactivated, whole cell | ||||
| J07AJ02 | Pertussis, purified antigen | ||||
| J07AJ51 | Pertussis, inactivated, whole cell, combinations with toxoids | ||||
| J07AJ52 | Pertussis, purified antigen, combinations with toxoids | ||||
| J07AK | Plague vaccines | ||||
| J07AK01 | Plague, inactivated, whole cell | ||||
| J07AL | Pneumococcal vaccines | ||||
| J07AL01 | Pneumococcus, purified polysaccharides antigen | ||||
| J07AL02 | Pneumococcus, purified polysaccharides antigen conjugated | ||||
| J07AL52 | Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated | ||||
| J07AM | Tetanus vaccines | ||||
| J07AM01 | Tetanus toxoid | ||||
| J07AM51 | Tetanus toxoid, combinations with diphtheria toxoid | ||||
| J07AM52 | Tetanus toxoid, combinations with tetanus immunoglobulin | ||||
| J07AN | Tuberculosis vaccines | ||||
| J07AN01 | Tuberculosis, live attenuated | ||||
| J07AP | Typhoid vaccines | ||||
| J07AP01 | Typhoid, oral, live attenuated | ||||
| J07AP02 | Typhoid, inactivated, whole cell | ||||
| J07AP03 | Typhoid, purified polysaccharide antigen | ||||
| J07AP10 | Typhoid, combinations with paratyphi types | ||||
| J07AR | Typhus (exanthematicus) vaccines | ||||
| J07AR01 | Typhus exanthematicus, inactivated, whole cell | ||||
| J07AX | Other bacterial vaccines | ||||
| empty | |||||
| J07B | Viral vaccines | ||||
| J07BA | Encephalitis vaccines | ||||
| J07BA01 | Encephalitis, tick borne, inactivated, whole virus | ||||
| J07BA02 | Encephalitis, Japanese, inactivated, whole virus | ||||
| J07BA03 | encephalitis, Japanese, live attenuated | ||||
| J07BB | Influenza vaccines | ||||
| J07BB01 | Influenza, inactivated, whole virus | ||||
| J07BB02 | Influenza, purified antigen | ||||
| J07BB03 | Influenza, live attenuated | ||||
| J07BB04 | influenza, virus like particles | ||||
| J07BC | Hepatitis vaccines | ||||
| J07BC01 | Hepatitis B, purified antigen | ||||
| J07BC02 | Hepatitis A, inactivated, whole virus | ||||
| J07BC20 | Combinations | ||||
| J07BD | Measles vaccines | ||||
| J07BD01 | Measles, live attenuated | ||||
| J07BD51 | Measles, combinations with mumps, live attenuated | ||||
| J07BD52 | Measles, combinations with mumps and rubella, live attenuated | ||||
| J07BD53 | Measles, combinations with rubella, live attenuated | ||||
| J07BD54 | Measles, combinations with mumps, rubella and varicella, live attenuated | ||||
| J07BE | Mumps vaccines | ||||
| J07BE01 | Mumps, live attenuated | ||||
| J07BF | Poliomyelitis vaccines | ||||
| J07BF01 | Poliomyelitis oral, monovalent live attenuated | ||||
| J07BF02 | Poliomyelitis oral, trivalent, live attenuated | ||||
| J07BF03 | Poliomyelitis, trivalent, inactivated, whole virus | ||||
| J07BF04 | Poliomyelitis oral, bivalent, live attenuated | ||||
| J07BG | Rabies vaccines | ||||
| J07BG01 | Rabies, inactivated, whole virus | ||||
| J07BH | Rotavirus diarrhea vaccines | ||||
| J07BH01 | Rota virus, live attenuated | ||||
| J07BH02 | Rota virus, pentavalent, live, reassorted | ||||
| J07BJ | Rubella vaccines | ||||
| J07BJ01 | Rubella, live attenuated | ||||
| J07BJ51 | Rubella, combinations with mumps, live attenuated | ||||
| J07BK | Varicella zoster vaccines | ||||
| J07BK01 | Varicella, live attenuated | ||||
| J07BK02 | Zoster, live attenuated | ||||
| J07BK03 | zoster, purified antigen | ||||
| J07BL | Yellow fever vaccines | ||||
| J07BL01 | Yellow fever, live attenuated | ||||
| J07BM | Papillomavirus vaccines | ||||
| J07BM01 | Papillomavirus (human types 6, 11, 16, 18) (Gardasil) | ||||
| J07BM02 | Papillomavirus (human types 16, 18) (Cervarix) | ||||
| J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) | ||||
| J07BN | Covid-19 vaccines | ||||
| J07BN01 | covid-19, RNA-based vaccine | ||||
| J07BN02 | covid-19, viral vector, non-replicating | ||||
| J07BN03 | covid-19, inactivated virus | ||||
| J07BN04 | covid-19, protein subunit | ||||
| J07BN05 | covid-19, virus-like particles | ||||
| J07BX | Other viral vaccines | ||||
| J07BX01 | smallpox and monkeypox vaccines | ||||
| J07BX02 | ebola vaccines | ||||
| J07BX03 | covid-19 vaccines (deleted) | ||||
| J07BX04 | dengue virus vaccines | ||||
| J07BX05 | respiratory syncytial virus vaccines | ||||
| J07BX06 | enterovirus 71 vaccines | ||||
| J07C | Bacterial and viral vaccines | ||||
| J07CA | Bacterial and viral vaccines, combined | ||||
| J07CA01 | Diphtheria-poliomyelitis-tetanus | ||||
| J07CA02 | Diphtheria-pertussis-poliomyelitis-tetanus | ||||
| J07CA03 | Diphtheria-rubella-tetanus | ||||
| J07CA04 | Hemophilus influenzae B and poliomyelitis | ||||
| J07CA05 | Diphtheria-hepatitis B-pertussis-tetanus | ||||
| J07CA06 | Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus | ||||
| J07CA07 | Diphtheria-hepatitis B-tetanus | ||||
| J07CA08 | Hemophilus influenzae B and hepatitis B | ||||
| J07CA09 | Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B | ||||
| J07CA10 | Typhoid-hepatitis A | ||||
| J07CA11 | Diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B | ||||
| J07CA12 | Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B | ||||
| J07CA13 | Diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C | ||||
| J07X | Other vaccines | ||||
| empty | |||||
| L | Antineoplastic and immunomodulating agents | ||||
| L01 | Antineoplastic agents | ||||
| L01A | Alkylating agents | ||||
| L01AA | Nitrogen mustard analogues | ||||
| L01AA01 | Cyclophosphamide | ||||
| L01AA02 | Chlorambucil | ||||
| L01AA03 | Melphalan | ||||
| L01AA05 | Chlormethine | ||||
| L01AA06 | Ifosfamide | ||||
| L01AA07 | Trofosfamide | ||||
| L01AA08 | Prednimustine | ||||
| L01AA09 | Bendamustine | ||||
| L01AB | Alkyl sulfonates | ||||
| L01AB01 | Busulfan | ||||
| L01AB02 | Treosulfan | ||||
| L01AB03 | Mannosulfan | ||||
| L01AC | Ethylene imines | ||||
| L01AC01 | Thiotepa | ||||
| L01AC02 | Triaziquone | ||||
| L01AC03 | Carboquone | ||||
| L01AD | Nitrosoureas | ||||
| L01AD01 | Carmustine | ||||
| L01AD02 | Lomustine | ||||
| L01AD03 | Semustine | ||||
| L01AD04 | Streptozocin | ||||
| L01AD05 | Fotemustine | ||||
| L01AD06 | Nimustine | ||||
| L01AD07 | Ranimustine | ||||
| L01AG | Epoxides | ||||
| L01AG01 | Etoglucid | ||||
| L01AX | Other alkylating agents | ||||
| L01AX01 | Mitobronitol | ||||
| L01AX02 | Pipobroman | ||||
| L01AX03 | Temozolomide | ||||
| L01AX04 | Dacarbazine | ||||
| L01B | Antimetabolites | ||||
| L01BA | Folic acid analogues | ||||
| L01BA01 | Methotrexate (בוטל, קוד חדש L04AX03) | ||||
| L01BA03 | Raltitrexed | ||||
| L01BA04 | Pemetrexed | ||||
| L01BA05 | Pralatrexate | ||||
| L01BB | Purine analogues | ||||
| L01BB02 | Mercaptopurine | ||||
| L01BB03 | Tioguanine | ||||
| L01BB04 | Cladribine | ||||
| L01BB05 | Fludarabine | ||||
| L01BB06 | Clofarabine | ||||
| L01BB07 | Nelarabine | ||||
| L01BC | Pyrimidine analogues | ||||
| L01BC01 | Cytarabine | ||||
| L01BC02 | Fluorouracil | ||||
| L01BC03 | Tegafur | ||||
| L01BC04 | Carmofur | ||||
| L01BC05 | Gemcitabine | ||||
| L01BC06 | Capecitabine | ||||
| L01BC07 | Azacitidine | ||||
| L01BC08 | Decitabine | ||||
| L01BC52 | Fluorouracil, combinations | ||||
| L01BC53 | Tegafur, combinations | ||||
| L01C | Plant alkaloids and other natural products | ||||
| L01CA | Vinca alkaloids and analogues | ||||
| L01CA01 | Vinblastine | ||||
| L01CA02 | Vincristine | ||||
| L01CA03 | Vindesine | ||||
| L01CA04 | Vinorelbine | ||||
| L01CA05 | Vinflunine | ||||
| L01CB | Podophyllotoxin derivatives | ||||
| L01CB01 | Etoposide | ||||
| L01CB02 | Teniposide | ||||
| L01CC | Colchicine derivatives | ||||
| L01CC01 | Demecolcine | ||||
| L01CD | Taxanes | ||||
| L01CD01 | Paclitaxel | ||||
| L01CD02 | Docetaxel | ||||
| L01CD03 | Paclitaxel poliglumex | ||||
| L01CD04 | Cabazitaxel | ||||
| L01CE | Topoisomerase 1 (TOP1) inhibitors | ||||
| L01CE01 | topotecan | ||||
| L01CE02 | irinotecan | ||||
| L01CE03 | etirinotecan pegol | ||||
| L01CE04 | belotecan | ||||
| L01CX | Other plant alkaloids and natural products | ||||
| L01CX01 | Trabectedin | ||||
| L01D | Cytotoxic antibiotics and related substances | ||||
| L01DA | Actinomycines | ||||
| L01DA01 | Dactinomycin | ||||
| L01DB | Anthracyclines and related substances | ||||
| L01DB01 | Doxorubicin | ||||
| L01DB02 | Daunorubicin | ||||
| L01DB03 | Epirubicin | ||||
| L01DB04 | Aclarubicin | ||||
| L01DB05 | Zorubicin | ||||
| L01DB06 | Idarubicin | ||||
| L01DB07 | Mitoxantrone | ||||
| L01DB08 | Pirarubicin | ||||
| L01DB09 | Valrubicin | ||||
| L01DB10 | Amrubicin | ||||
| L01DB11 | Pixantrone | ||||
| L01DC | Other cytotoxic antibiotics | ||||
| L01DC01 | Bleomycin | ||||
| L01DC02 | Plicamycin | ||||
| L01DC03 | Mitomycin | ||||
| L01DC04 | Ixabepilone | ||||
| L01E | Protein kinase inhibitors | ||||
| L01EA | BCR-ABL tyrosine kinase inhibitors | ||||
| L01EA01 | imatinib | ||||
| L01EA02 | dasatinib | ||||
| L01EA03 | nilotinib | ||||
| L01EA04 | bosutinib | ||||
| L01EA05 | ponatinib | ||||
| L01EA06 | asciminib | ||||
| L01EB | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors | ||||
| L01EB01 | gefitinib | ||||
| L01EB02 | erlotinib | ||||
| L01EB03 | afatinib | ||||
| L01EB04 | osimertinib | ||||
| L01EB05 | rociletinib | ||||
| L01EB06 | olmutinib | ||||
| L01EB07 | dacomitinib | ||||
| L01EB08 | icotinib | ||||
| L01EC | B-Raf serine-threonine kinase (BRAF) inhibitors | ||||
| L01EC01 | vemurafenib | ||||
| L01EC02 | dabrafenib | ||||
| L01EC03 | encorafenib | ||||
| L01ED | Anaplastic lymphoma kinase (ALK) inhibitors | ||||
| L01ED01 | crizotinib | ||||
| L01ED02 | ceritinib | ||||
| L01ED03 | alectinib | ||||
| L01ED04 | brigatinib | ||||
| L01ED05 | lorlatinib | ||||
| L01EE | Mitogen-activated protein kinase (MEK) inhibitors | ||||
| L01EE01 | trametinib | ||||
| L01EE02 | cobimetinib | ||||
| L01EE03 | binimetinib | ||||
| L01EE04 | selumetinib | ||||
| L01EF | Cyclin-dependent kinase (CDK) inhibitors | ||||
| L01EF01 | palbociclib | ||||
| L01EF02 | ribociclib | ||||
| L01EF03 | abemaciclib | ||||
| L01EG | Mammalian target of rapamycin (mTOR) kinase inhibitors | ||||
| L01EG01 | temsirolimus | ||||
| L01EG02 | everolimus | ||||
| L01EG03 | ridaforolimus | ||||
| L01EH | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors | ||||
| L01EH01 | lapatinib | ||||
| L01EH02 | neratinib | ||||
| L01EH03 | tucatinib | ||||
| L01EJ | Janus-associated kinase (JAK) inhibitors | ||||
| L01EJ01 | ruxolitinib | ||||
| L01EJ02 | fedratinib | ||||
| L01EJ03 | pacritinib | ||||
| L01EK | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors | ||||
| L01EK01 | axitinib | ||||
| L01EK02 | cediranib | ||||
| L01EK03 | tivozanib | ||||
| L01EL | Bruton's tyrosine kinase (BTK) inhibitors | ||||
| L01EL01 | ibrutinib | ||||
| L01EL02 | acalabrutinib | ||||
| L01EL03 | zanubrutinib | ||||
| L01EL04 | orelabrutinib | ||||
| L01EL05 | pirtobrutinib | ||||
| L01EM | Phosphatidylinositol-3-kinase (Pi3K) inhibitors | ||||
| L01EM01 | idelalisib | ||||
| L01EM02 | copanlisib | ||||
| L01EM03 | alpelisib | ||||
| L01EM04 | duvelisib | ||||
| L01EN | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors | ||||
| L01EN01 | erdafitinib | ||||
| L01EN02 | pemigatinib | ||||
| L01EN03 | infigratinib | ||||
| L01EN04 | futibatinib | ||||
| L01EX | Other protein kinase inhibitors | ||||
| L01EX01 | sunitinib | ||||
| L01EX02 | sorafenib | ||||
| L01EX03 | pazopanib | ||||
| L01EX04 | vandetanib | ||||
| L01EX05 | regorafenib | ||||
| L01EX06 | masitinib | ||||
| L01EX07 | cabozantinib | ||||
| L01EX08 | lenvatinib | ||||
| L01EX09 | nintedanib | ||||
| L01EX10 | midostaurin | ||||
| L01EX11 | quizartinib | ||||
| L01EX12 | larotrectinib | ||||
| L01EX13 | gilteritinib | ||||
| L01EX14 | entrectinib | ||||
| L01EX15 | pexidartinib | ||||
| L01EX16 | erdafitinib (New ATC code L01EN01) | ||||
| L01EX17 | capmatinib | ||||
| L01EX18 | avapritinib | ||||
| L01EX19 | ripretinib | ||||
| L01EX20 | pemigatinib (New ATC code L01EN02) | ||||
| L01EX21 | tepotinib | ||||
| L01EX22 | selpercatinib | ||||
| L01EX23 | pralsetinib | ||||
| L01EX24 | surufatinib | ||||
| L01EX25 | umbralisib | ||||
| L01EX26 | sitravatinib | ||||
| L01EX27 | capivasertib | ||||
| L01F | Monoclonal antibodies and antibody drug conjugates | ||||
| L01FA | CD20 (Clusters of Differentiation 20) inhibitors | ||||
| L01FA01 | rituximab | ||||
| L01FA02 | ofatumumab | ||||
| L01FA03 | obinutuzumab | ||||
| L01FB | CD22 (Clusters of Differentiation 22) inhibitors | ||||
| L01FB01 | inotuzumab ozogamicin | ||||
| L01FB02 | moxetumomab pasudotox | ||||
| L01FC | CD38 (Clusters of Differentiation 38) inhibitors | ||||
| L01FC01 | daratumumab | ||||
| L01FC02 | isatuximab | ||||
| L01FD | HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors | ||||
| L01FD01 | trastuzumab | ||||
| L01FD02 | pertuzumab | ||||
| L01FD03 | trastuzumab emtansine | ||||
| L01FD04 | trastuzumab deruxtecan | ||||
| L01FD05 | trastuzumab duocarmazine | ||||
| L01FD06 | margetuximab | ||||
| L01FE | EGFR (Epidermal Growth Factor Receptor) inhibitors | ||||
| L01FE01 | cetuximab | ||||
| L01FE02 | panitumumab | ||||
| L01FE03 | necitumumab | ||||
| L01FF | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors | ||||
| L01FF01 | nivolumab | ||||
| L01FF02 | pembrolizumab | ||||
| L01FF03 | durvalumab | ||||
| L01FF04 | avelumab | ||||
| L01FF05 | atezolizumab | ||||
| L01FF06 | cemiplimab | ||||
| L01FF07 | dostarlimab | ||||
| L01FF08 | prolgolimab | ||||
| L01FF09 | tislelizumab | ||||
| L01FF10 | retifanlimab | ||||
| L01FF11 | sugemalimab | ||||
| L01FF12 | serplulimab | ||||
| L01FF13 | toripalimab | ||||
| L01FG | VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors | ||||
| L01FG01 | bevacizumab | ||||
| L01FG02 | ramucirumab | ||||
| L01FX | Other monoclonal antibodies and antibody drug conjugates | ||||
| L01FX01 | edrecolomab | ||||
| L01FX02 | gemtuzumab ozogamicin | ||||
| L01FX03 | catumaxomab | ||||
| L01FX04 | ipilimumab | ||||
| L01FX05 | brentuximab vedotin | ||||
| L01FX06 | dinutuximab beta | ||||
| L01FX07 | blinatumomab | ||||
| L01FX08 | elotuzumab | ||||
| L01FX09 | mogamulizumab | ||||
| L01FX10 | olaratumab | ||||
| L01FX11 | bermekimab | ||||
| L01FX12 | tafasitamab | ||||
| L01FX13 | enfortumab vedotin | ||||
| L01FX14 | polatuzumab vedotin | ||||
| L01FX15 | belantamab mafodotin | ||||
| L01FX16 | oportuzumab monatox | ||||
| L01FX17 | sacituzumab govitecan | ||||
| L01FX18 | amivantamab | ||||
| L01FX19 | sabatolimab | ||||
| L01FX20 | tremelimumab | ||||
| L01FX21 | naxitamab | ||||
| L01FX22 | loncastuximab tesirine | ||||
| L01FX23 | tisotumab vedotin | ||||
| L01FX24 | teclistamab | ||||
| L01FX25 | mosunetuzumab | ||||
| L01FX26 | mirvetuximab soravtansine | ||||
| L01FX27 | epcoritamab | ||||
| L01FX28 | glofitamab | ||||
| L01FX29 | talquetamab | ||||
| L01FX32 | elranatamab | ||||
| L01FY | Combinations of monoclonal antibodies and antibody drug conjugates | ||||
| L01FY01 | pertuzumab and trastuzumab | ||||
| L01FY02 | nivolumab and relatlimab | ||||
| L01FY03 | prolgolimab and nurulimab | ||||
| L01X | Other antineoplastic agents | ||||
| L01XA | Platinum compounds | ||||
| L01XA01 | Cisplatin | ||||
| L01XA02 | Carboplatin | ||||
| L01XA03 | Oxaliplatin | ||||
| L01XA04 | Satraplatin | ||||
| L01XA05 | Polyplatillen | ||||
| L01XB | Methylhydrazines | ||||
| L01XB01 | Procarbazine | ||||
| L01XC | Monoclonal antibodies | ||||
| L01XC01 | Edrecolomab (New ATC code L01FX01) | ||||
| L01XC02 | Rituximab (New ATC code L01FA01) | ||||
| L01XC03 | Trastuzumab (New ATC code L01FD01) | ||||
| L01XC04 | Alemtuzumab (New ATC code L04AG06) | ||||
| L01XC05 | Gemtuzumab (New ATC code L01FX02) | ||||
| L01XC06 | Cetuximab (New ATC code L01FE01) | ||||
| L01XC07 | Bevacizumab (New ATC code L01FG01) | ||||
| L01XC08 | Panitumumab (בוטל, קוד חדש L01FE02) | ||||
| L01XC09 | Catumaxomab (בוטל, קוד חדש L01FX03) | ||||
| L01XC10 | Ofatumumab (בוטל, קוד חדש L01FA02) | ||||
| L01XC11 | Ipilimumab (בוטל, קוד חדש L01FX04) | ||||
| L01XC12 | Brentuximab vedotin (בוטל, קוד חדש L01FX05) | ||||
| L01XC13 | Pertuzumab (בוטל, קוד חדש L01FD02) | ||||
| L01XC14 | trastuzumab emtansine (בוטל, קוד חדש L01FD03) | ||||
| L01XC15 | obinutuzumab (בוטל, קוד חדש L01FA03) | ||||
| L01XC16 | dinutuximab beta (בוטל, קוד חדש L01FX06) | ||||
| L01XC17 | nivolumab (בוטל, קוד חדש L01FF01) | ||||
| L01XC18 | pembrolizumab (בוטל, קוד חדש L01FF02) | ||||
| L01XC19 | blinatumomab (בוטל, קוד חדש L01FX07) | ||||
| L01XC21 | ramucirumab (בוטל, קוד חדש L01FG02) | ||||
| L01XC22 | necitumumab (בוטל, קוד חדש L01FE03) | ||||
| L01XC23 | elotuzumab (בוטל, קוד חדש L01FX08) | ||||
| L01XC24 | daratumumab (בוטל, קוד חדש L01FC01) | ||||
| L01XC25 | mogamulizumab (בוטל, קוד חדש L01FX09) | ||||
| L01XC26 | inotuzumab ozogamicin (בוטל, קוד חדש L01FB01) | ||||
| L01XC27 | olaratumab (בוטל, קוד חדש L01FX10) | ||||
| L01XC28 | durvalumab (בוטל, קוד חדש L01FF03) | ||||
| L01XC29 | bermekimab (בוטל, קוד חדש L01FX11) | ||||
| L01XC31 | avelumab (בוטל, קוד חדש L01FF04) | ||||
| L01XC32 | atezolizumab (בוטל, קוד חדש L01FF05) | ||||
| L01XC33 | cemiplimab (בוטל, קוד חדש L01FF06) | ||||
| L01XC34 | moxetumomab pasudotox (בוטל, קוד חדש L01FB02) | ||||
| L01XC35 | tafasitamab (בוטל, קוד חדש L01FX12) | ||||
| L01XC36 | enfortumab vedotin (בוטל, קוד חדש L01FX13) | ||||
| L01XC37 | polatuzumab vedotin (בוטל, קוד חדש L01FX14) | ||||
| L01XC38 | isatuximab (בוטל, קוד חדש L01FC02) | ||||
| L01XC39 | belantamab mafodotin (בוטל, קוד חדש L01FX15) | ||||
| L01XC40 | dostarlimab (בוטל, קוד חדש L01FF07) | ||||
| L01XC41 | trastuzumab deruxtecan (בוטל, קוד חדש L01FD04) | ||||
| L01XD | Sensitizers used in photodynamic/radiation therapy | ||||
| L01XD01 | Porfimer sodium | ||||
| L01XD02 | verteporfin (בוטל, קוד חדש S01LA01) | ||||
| L01XD03 | Methyl aminolevulinate | ||||
| L01XD04 | Aminolevulinic acid | ||||
| L01XD05 | Temoporfin | ||||
| L01XD06 | Efaproxiral | ||||
| L01XD07 | padeliporfin | ||||
| L01XE | Protein kinase inhibitors (בוטל) | ||||
| L01XE01 | Imatinib (בוטל, קוד חדש L01EA01) | ||||
| L01XE02 | Gefitinib (בוטל, קוד חדש L01EB01) | ||||
| L01XE03 | Erlotinib (בוטל, קוד חדש L01EB02) | ||||
| L01XE04 | Sunitinib (בוטל, קוד חדש L01EX01) | ||||
| L01XE05 | Sorafenib (בוטל, קוד חדש L01EX02) | ||||
| L01XE06 | Dasatinib (בוטל, קוד חדש L01EA02) | ||||
| L01XE07 | Lapatinib (בוטל, קוד חדש L01EH01) | ||||
| L01XE08 | Nilotinib (בוטל, קוד חדש L01EA03) | ||||
| L01XE09 | Temsirolimus (בוטל, קוד חדש L01EG01) | ||||
| L01XE10 | Everolimus (בוטל, קוד חדש L01EG02) | ||||
| L01XE11 | Pazopanib (בוטל, קוד חדש L01EX03) | ||||
| L01XE12 | Vandetanib (בוטל, קוד חדש L01EX04) | ||||
| L01XE13 | Afatinib (בוטל, קוד חדש L01EB03) | ||||
| L01XE14 | Bosutinib (בוטל, קוד חדש L01EA04) | ||||
| L01XE15 | Vemurafenib (בוטל, קוד חדש L01EC01) | ||||
| L01XE16 | Crizotinib (בוטל, קוד חדש L01ED01) | ||||
| L01XE17 | Axitinib (בוטל, קוד חדש L01EK01) | ||||
| L01XE18 | Ruxolitinib (בוטל, קוד חדש L01EJ01) | ||||
| L01XE19 | Ridaforolimus (בוטל, קוד חדש L01EG03) | ||||
| L01XE21 | Regorafenib (בוטל, קוד חדש L01EX05) | ||||
| L01XE22 | Masitinib (בוטל, קוד חדש L01EX06) | ||||
| L01XE23 | dabrafenib (בוטל, קוד חדש L01EC02) | ||||
| L01XE24 | ponatinib (בוטל, קוד חדש L01EA05) | ||||
| L01XE25 | trametinib (בוטל, קוד חדש L01EE01) | ||||
| L01XE26 | cabozantinib (בוטל, קוד חדש L01EX07) | ||||
| L01XE27 | ibrutinib (בוטל, קוד חדש L01EL01) | ||||
| L01XE28 | ceritinib (בוטל, קוד חדש L01ED02) | ||||
| L01XE29 | lenvatinib (בוטל, קוד חדש L01EX08) | ||||
| L01XE31 | nintedanib (בוטל, קוד חדש L01EX09) | ||||
| L01XE32 | cediranib (בוטל, קוד חדש L01EK02) | ||||
| L01XE33 | palbociclib (בוטל, קוד חדש L01EF01) | ||||
| L01XE34 | tivozanib (בוטל, קוד חדש L01EK03) | ||||
| L01XE35 | osimertinib (בוטל, קוד חדש L01EB04) | ||||
| L01XE36 | alectinib (בוטל, קוד חדש L01ED03) | ||||
| L01XE37 | rociletinib (בוטל, קוד חדש L01EB05) | ||||
| L01XE38 | cobimetinib (בוטל, קוד חדש L01EE02) | ||||
| L01XE39 | midostaurin (בוטל, קוד חדש L01EX10) | ||||
| L01XE40 | olmutinib (בוטל, קוד חדש L01EB06) | ||||
| L01XE41 | binimetinib (בוטל, קוד חדש L01EE03) | ||||
| L01XE42 | ribociclib (בוטל, קוד חדש L01EF02) | ||||
| L01XE43 | brigatinib (בוטל, קוד חדש L01ED04) | ||||
| L01XE44 | lorlatinib (בוטל, קוד חדש L01ED05) | ||||
| L01XE45 | neratinib (בוטל, קוד חדש L01EH02) | ||||
| L01XE46 | encorafenib (בוטל, קוד חדש L01EC03) | ||||
| L01XE47 | dacomitinib (בוטל, קוד חדש L01EB07) | ||||
| L01XE48 | icotinib (בוטל, קוד חדש L01EB08) | ||||
| L01XE50 | abemaciclib (בוטל, קוד חדש L01EF03) | ||||
| L01XE51 | acalabrutinib (בוטל, קוד חדש L01EL02) | ||||
| L01XE52 | quizartinib (בוטל, קוד חדש L01EX11) | ||||
| L01XE53 | larotrectinib (בוטל, קוד חדש L01EX12) | ||||
| L01XE54 | gilteritinib (בוטל, קוד חדש L01EX13) | ||||
| L01XE56 | entrectinib (בוטל, קוד חדש L01EX14) | ||||
| L01XE57 | fedratinib (בוטל, קוד חדש L01EJ02) | ||||
| L01XF | Retinoids for cancer treatment | ||||
| L01XF01 | tretinoin | ||||
| L01XF02 | alitretinoin | ||||
| L01XF03 | bexarotene | ||||
| L01XG | Proteasome inhibitors | ||||
| L01XG01 | bortezomib | ||||
| L01XG02 | carfilzomib | ||||
| L01XG03 | ixazomib | ||||
| L01XH | Histone deacetylase (HDAC) inhibitors | ||||
| L01XH01 | vorinostat | ||||
| L01XH02 | romidepsin | ||||
| L01XH03 | panobinostat | ||||
| L01XH04 | belinostat | ||||
| L01XH05 | entinostat | ||||
| L01XJ | Hedgehog pathway inhibitors | ||||
| L01XJ01 | vismodegib | ||||
| L01XJ02 | sonidegib | ||||
| L01XJ03 | glasdegib | ||||
| L01XK | Poly (ADP-ribose) polymerase (PARP) inhibitors | ||||
| L01XK01 | olaparib | ||||
| L01XK02 | niraparib | ||||
| L01XK03 | rucaparib | ||||
| L01XK04 | talazoparib | ||||
| L01XK05 | veliparib | ||||
| L01XL | Antineoplastic cell and gene therapy | ||||
| L01XL01 | sitimagene ceradenovec | ||||
| L01XL02 | talimogene laherparepvec | ||||
| L01XL03 | axicabtagene ciloleucel | ||||
| L01XL04 | tisagenlecleucel | ||||
| L01XL05 | ciltacabtagene autoleucel | ||||
| L01XL06 | brexucabtagene autoleucel | ||||
| L01XL07 | idecabtagene vicleucel | ||||
| L01XL08 | lisocabtagene maraleucel | ||||
| L01XL09 | tabelecleucel | ||||
| L01XL10 | nadofaragene firadenovec | ||||
| L01XL11 | lifileucel | ||||
| L01XX | Other antineoplastic agents | ||||
| L01XX01 | Amsacrine | ||||
| L01XX02 | Asparaginase | ||||
| L01XX03 | Altretamine | ||||
| L01XX05 | Hydroxycarbamide | ||||
| L01XX07 | Lonidamine | ||||
| L01XX08 | Pentostatin | ||||
| L01XX09 | Miltefosine (בוטל, קוד חדש P01CX04) | ||||
| L01XX10 | Masoprocol | ||||
| L01XX11 | Estramustine | ||||
| L01XX14 | Tretinoin (בוטל, קוד חדש L01XF01) | ||||
| L01XX16 | Mitoguazone | ||||
| L01XX17 | Topotecan (בוטל, קוד חדש L01CE01) | ||||
| L01XX18 | Tiazofurine | ||||
| L01XX19 | Irinotecan (בוטל, קוד חדש L01CE02) | ||||
| L01XX22 | Alitretinoin (בוטל, קוד חדש L01XF02) | ||||
| L01XX23 | Mitotane | ||||
| L01XX24 | Pegaspargase | ||||
| L01XX25 | Bexarotene (בוטל, קוד חדש L01XF03) | ||||
| L01XX27 | Arsenic trioxide | ||||
| L01XX28 | imatinib (בוטל, קוד חדש L01XE01) | ||||
| L01XX29 | Denileukin diftitox | ||||
| L01XX31 | gefitinib (בוטל, קוד חדש L01EB01) | ||||
| L01XX32 | Bortezomib (בוטל, קוד חדש L01XG01) | ||||
| L01XX33 | Celecoxib | ||||
| L01XX34 | erlotinib (בוטל, קוד חדש L01XE03) | ||||
| L01XX35 | Anagrelide | ||||
| L01XX36 | Oblimersen | ||||
| L01XX37 | Sitimagene ceradenovec (New ATC code L01XL01) | ||||
| L01XX38 | Vorinostat (New ATC code L01XH01) | ||||
| L01XX39 | Romidepsin (New ATC code L01XH02) | ||||
| L01XX40 | Omacetaxine mepesuccinate | ||||
| L01XX41 | Eribulin | ||||
| L01XX42 | Panobinostat (בוטל, קוד חדש L01XH03) | ||||
| L01XX43 | Vismodegib (בוטל, קוד חדש L01XJ01) | ||||
| L01XX44 | aflibercept | ||||
| L01XX45 | carfilzomib (בוטל, קוד חדש L01XG02) | ||||
| L01XX46 | olaparib (בוטל, קוד חדש L01XK01) | ||||
| L01XX47 | idelalisib (בוטל, קוד חדש L01EM01) | ||||
| L01XX48 | sonidegib (בוטל, קוד חדש L01XJ02) | ||||
| L01XX49 | belinostat (בוטל, קוד חדש L01XH04) | ||||
| L01XX50 | ixazomib (New ATC code L01XG03) | ||||
| L01XX51 | talimogene laherparepvec (New ATC code L01XL02) | ||||
| L01XX52 | venetoclax | ||||
| L01XX53 | vosaroxin | ||||
| L01XX54 | niraparib (New ATC code L01XK02) | ||||
| L01XX55 | rucaparib (בוטל, קוד חדש L01XK03) | ||||
| L01XX56 | etirinotecan pegol (בוטל, קוד חדש L01CE03) | ||||
| L01XX57 | plitidepsin | ||||
| L01XX58 | epacadostat | ||||
| L01XX59 | enasidenib | ||||
| L01XX60 | talazoparib (בוטל, קוד חדש L01XK04) | ||||
| L01XX61 | copanlisib (New ATC code L01EM02) | ||||
| L01XX62 | ivosidenib | ||||
| L01XX63 | glasdegib (New ATC code L01XJ03) | ||||
| L01XX64 | entinostat (New ATC code L01XH05) | ||||
| L01XX65 | alpelisib (New ATC code L01EM03) | ||||
| L01XX66 | selinexor | ||||
| L01XX67 | tagraxofusp | ||||
| L01XX68 | belotecan (New ATC code L01CE04) | ||||
| L01XX69 | lurbinectedin | ||||
| L01XX70 | axicabtagene ciloleucel (New ATC code L01XL03) | ||||
| L01XX71 | tisagenlecleucel (New ATC code L01XL04) | ||||
| L01XX72 | tazemetostat | ||||
| L01XX73 | sotorasib | ||||
| L01XX74 | belzutifan | ||||
| L01XX75 | tebentafusp | ||||
| L01XX77 | adagrasib | ||||
| L01XY |
Combinations of antineoplastic agents | ||||
| L01XY01 | cytarabine and daunorubicin | ||||
| L01XY02 | pertuzumab and trastuzumab (New ATC code L01FY01) | ||||
| L01XY03 | nivolumab and relatlimab (New ATC code L01FY02) | ||||
| L02 | Endocrine therapy | ||||
| L02A | Hormones and related agents | ||||
| L02AA | Estrogens | ||||
| L02AA01 | Diethylstilbestrol | ||||
| L02AA02 | Polyestradiol phosphate | ||||
| L02AA03 | Ethinylestradiol | ||||
| L02AA04 | Fosfestrol | ||||
| L02AB | Progestogens | ||||
| L02AB01 | Megestrol | ||||
| L02AB02 | Medroxyprogesterone | ||||
| L02AB03 | Gestonorone | ||||
| L02AE | Gonadotropin-releasing hormone analogues | ||||
| L02AE01 | Buserelin | ||||
| L02AE02 | Leuprorelin | ||||
| L02AE03 | Goserelin | ||||
| L02AE04 | Triptorelin | ||||
| L02AE05 | Histrelin | ||||
| L02AX | Other hormones | ||||
| empty | |||||
| L02B | Hormone antagonists and related agents | ||||
| L02BA | Anti-estrogens | ||||
| L02BA01 | Tamoxifen | ||||
| L02BA02 | Toremifene | ||||
| L02BA03 | Fulvestrant | ||||
| L02BA04 | elacestrant | ||||
| L02BB | Anti-androgens | ||||
| L02BB01 | Flutamide | ||||
| L02BB02 | Nilutamide | ||||
| L02BB03 | Bicalutamide | ||||
| L02BB04 | enzalutamide | ||||
| L02BB05 | apalutamide | ||||
| L02BB06 | darolutamide | ||||
| L02BG | Aromatase inhibitors | ||||
| L02BG01 | Aminogluthetimide | ||||
| L02BG02 | Formestane | ||||
| L02BG03 | Anastrozole | ||||
| L02BG04 | Letrozole | ||||
| L02BG05 | Vorozole | ||||
| L02BG06 | Exemestane | ||||
| L02BX | Other hormone antagonists and related agents | ||||
| L02BX01 | Abarelix | ||||
| L02BX02 | Degarelix | ||||
| L02BX03 | Abiraterone | ||||
| L03 | Immunostimulants | ||||
| L03A | Immunostimulants | ||||
| L03AA | Colony stimulating factors | ||||
| L03AA02 | Filgrastim | ||||
| L03AA03 | Molgramostim | ||||
| L03AA09 | Sargramostim | ||||
| L03AA10 | Lenograstim | ||||
| L03AA12 | Ancestim | ||||
| L03AA13 | Pegfilgrastim | ||||
| L03AA14 | Lipegfilgrastim | ||||
| L03AB | Interferons | ||||
| L03AB01 | Interferon alfa natural | ||||
| L03AB02 | Interferon beta natural | ||||
| L03AB03 | Interferon gamma | ||||
| L03AB04 | Interferon alfa-2a | ||||
| L03AB05 | Interferon alfa-2b | ||||
| L03AB06 | Interferon alfa-n1 | ||||
| L03AB07 | Interferon beta-1a | ||||
| L03AB08 | Interferon beta-1b | ||||
| L03AB09 | Interferon alfacon-1 | ||||
| L03AB10 | Peginterferon alfa-2b | ||||
| L03AB11 | Peginterferon alfa-2a | ||||
| L03AB12 | Albinterferon alfa-2b | ||||
| L03AB13 | peginterferon beta-1a | ||||
| L03AB14 | cepeginterferon alfa-2b | ||||
| L03AB15 | ropeginterferon alfa-2b | ||||
| L03AB16 | peginterferon alfacon-2 | ||||
| L03AB17 | sampeginterferon beta-1a | ||||
| L03AB60 | Peginterferon alfa-2b, combinations | ||||
| L03AB61 | Peginterferon alfa-2a, combinations | ||||
| L03AC | Interleukins | ||||
| L03AC01 | Aldesleukin | ||||
| L03AC02 | Oprelvekin | ||||
| L03AX | Other immunostimulants | ||||
| L03AX01 | Lentinan | ||||
| L03AX02 | Roquinimex | ||||
| L03AX03 | BCG vaccine | ||||
| L03AX04 | Pegademase | ||||
| L03AX05 | Pidotimod | ||||
| L03AX07 | Poly I:C | ||||
| L03AX08 | Poly ICLC | ||||
| L03AX09 | Thymopentin | ||||
| L03AX10 | Immunocyanin | ||||
| L03AX11 | Tasonermin | ||||
| L03AX12 | Melanoma vaccine | ||||
| L03AX13 | Glatiramer acetate | ||||
| L03AX14 | Histamine dihydrochloride | ||||
| L03AX15 | Mifamurtide | ||||
| L03AX16 | Plerixafor | ||||
| L03AX17 | Sipuleucel-T | ||||
| L03AX18 | cridanimod | ||||
| L03AX19 | dasiprotimut-T | ||||
| L03AX21 | elapegademase | ||||
| L03AX22 | leniolisib | ||||
| L04 | Immunosuppressants | ||||
| L04A | Immunosuppressants | ||||
| L04AA | Selective immunosuppressants | ||||
| L04AA01 | ciclosporin (בוטל, קוד חדש L04AD01) | ||||
| L04AA02 | Muromonab-CD3 (בוטל, קוד חדש L04AG01) | ||||
| L04AA03 | Antilymphocyte immunoglobulin (horse) | ||||
| L04AA04 | Antithymocyte immunoglobulin (rabbit) | ||||
| L04AA05 | tacrolimus (בוטל, קוד חדש L04AD02) | ||||
| L04AA06 | Mycophenolic acid | ||||
| L04AA08 | daclizumab (בוטל, קוד חדש L04AC01) | ||||
| L04AA09 | basiliximab (בוטל, קוד חדש L04AC02) | ||||
| L04AA10 | Sirolimus (בוטל, קוד חדש L04AH01) | ||||
| L04AA11 | etanercept (בוטל, קוד חדש L04AB01) | ||||
| L04AA12 | infliximab (בוטל, קוד חדש L04AB02) | ||||
| L04AA13 | Leflunomide (בוטל, קוד חדש L04AK01) | ||||
| L04AA14 | anakinra (בוטל, קוד חדש L04AC03) | ||||
| L04AA15 | Alefacept | ||||
| L04AA16 | afelimomab (בוטל, קוד חדש L04AB03) | ||||
| L04AA17 | adalimumab (בוטל, קוד חדש L04AB04) | ||||
| L04AA18 | Everolimus (בוטל, קוד חדש L04AH02) | ||||
| L04AA19 | Gusperimus | ||||
| L04AA21 | Efalizumab (בוטל, קוד חדש L04AG02) | ||||
| L04AA22 | Abetimus | ||||
| L04AA23 | Natalizumab (בוטל, קוד חדש L04AG03) | ||||
| L04AA24 | Abatacept | ||||
| L04AA25 | Eculizumab (בוטל, קוד חדש L04AJ01) | ||||
| L04AA26 | Belimumab (בוטל, קוד חדש L04AG04) | ||||
| L04AA27 | Fingolimod (New ATC code L04AE01) | ||||
| L04AA28 | Belatacept | ||||
| L04AA29 | Tofacitinib (New ATC code L04AF01) | ||||
| L04AA31 | teriflunomide (New ATC code L04AK02) | ||||
| L04AA32 | apremilast | ||||
| L04AA33 | vedolizumab (New ATC code L04AG05) | ||||
| L04AA34 | alemtuzumab (New ATC code L04AG06) | ||||
| L04AA35 | begelomab (New ATC code L04AG07) | ||||
| L04AA36 | ocrelizumab (New ATC code L04AG08) | ||||
| L04AA37 | baricitinib (New ATC code L04AF02) | ||||
| L04AA38 | ozanimod (New ATC code L04AE02) | ||||
| L04AA39 | emapalumab (New ATC code L04AG09) | ||||
| L04AA40 | cladribine | ||||
| L04AA41 | imlifidase | ||||
| L04AA42 | siponimod (New ATC code L04AE03) | ||||
| L04AA43 | ravulizumab (New ATC code L04AJ02) | ||||
| L04AA44 | upadacitinib (New ATC code L04AF03) | ||||
| L04AA45 | filgotinib (New ATC code L04AF04) | ||||
| L04AA46 | itacitinib (New ATC code L04AF05) | ||||
| L04AA47 | inebilizumab (New ATC code L04AG10) | ||||
| L04AA48 | belumosudil | ||||
| L04AA49 | peficitinib (New ATC code L04AF06) | ||||
| L04AA50 | ponesimod (New ATC code L04AE04) | ||||
| L04AA51 | anifrolumab (New ATC code L04AG11) | ||||
| L04AA52 | ofatumumab (New ATC code L04AG12) | ||||
| L04AA53 | teprotumumab (New ATC code L04AG13) | ||||
| L04AA54 | pegcetacoplan (New ATC code L04AJ03) | ||||
| L04AA55 | sutimlimab (New ATC code L04AJ04) | ||||
| L04AA56 | deucravacitinib (New ATC code L04AF07) | ||||
| L04AA57 | ublituximab (New ATC code L04AG14) | ||||
| L04AA58 | efgartigimod alfa | ||||
| L04AA59 | avacopan (New ATC code L04AJ05) | ||||
| L04AB | Tumor necrosis factor alpha (TNF-α) inhibitors | ||||
| L04AB01 | Etanercept | ||||
| L04AB02 | Infliximab | ||||
| L04AB03 | Afelimomab | ||||
| L04AB04 | Adalimumab | ||||
| L04AB05 | Certolizumab pegol | ||||
| L04AB06 | Golimumab | ||||
| L04AB07 | opinercept | ||||
| L04AC | Interleukin inhibitors | ||||
| L04AC01 | Daclizumab | ||||
| L04AC02 | Basiliximab | ||||
| L04AC03 | Anakinra | ||||
| L04AC04 | Rilonacept | ||||
| L04AC05 | Ustekinumab | ||||
| L04AC06 | Mepolizumab (New ATC code R03DX09) | ||||
| L04AC07 | Tocilizumab | ||||
| L04AC08 | Canakinumab | ||||
| L04AC09 | Briakinumab | ||||
| L04AC10 | Secukinumab | ||||
| L04AC11 | siltuximab | ||||
| L04AC12 | brodalumab | ||||
| L04AC13 | ixekizumab | ||||
| L04AC14 | sarilumab | ||||
| L04AC15 | sirukumab | ||||
| L04AC16 | guselkumab | ||||
| L04AC17 | tildrakizumab | ||||
| L04AC18 | risankizumab | ||||
| L04AC19 | satralizumab | ||||
| L04AC20 | netakimab | ||||
| L04AC21 | bimekizumab | ||||
| L04AC22 | spesolimab | ||||
| L04AC23 | olokizumab | ||||
| L04AC24 | mirikizumab | ||||
| L04AC25 | levilimab | ||||
| L04AD | Calcineurin inhibitors | ||||
| L04AD01 | Ciclosporin | ||||
| L04AD02 | Tacrolimus | ||||
| L04AD03 | Voclosporin | ||||
| L04AE | Sphingosine-1-phosphate (S1P) receptor modulators | ||||
| L04AE01 | fingolimod | ||||
| L04AE02 | ozanimod | ||||
| L04AE03 | siponimod | ||||
| L04AE04 | ponesimod | ||||
| L04AE05 | etrasimod | ||||
| L04AF | Janus-associated kinase (JAK) inhibitors | ||||
| L04AF01 | tofacitinib | ||||
| L04AF02 | baricitinib | ||||
| L04AF03 | upadacitinib | ||||
| L04AF04 | filgotinib | ||||
| L04AF05 | itacitinib | ||||
| L04AF06 | peficitinib | ||||
| L04AF07 | deucravacitinib | ||||
| L04AF08 | ritlecitinib | ||||
| L04AG | Monoclonal antibodies | ||||
| L04AG01 | muromonab-CD3 | ||||
| L04AG02 | efalizumab | ||||
| L04AG03 | natalizumab | ||||
| L04AG04 | belimumab | ||||
| L04AF05 | vedolizumab | ||||
| L04AG06 | alemtuzumab | ||||
| L04AG07 | begelomab | ||||
| L04AG08 | ocrelizumab | ||||
| L04AG09 | emapalumab | ||||
| L04AG10 | inebilizumab | ||||
| L04AG11 | anifrolumab | ||||
| L04AG12 | ofatumumab | ||||
| L04AF13 | teprotumumab | ||||
| L04AG14 | ublituximab | ||||
| L04AG15 | divozilimab | ||||
| L04AG16 | rozanolixizumab | ||||
| L04AH | Mammalian target of rapamycin (mTOR) kinase inhibitors | ||||
| L04AH01 | sirolimus | ||||
| L04AH02 | everolimus | ||||
| L04AJ | Complement inhibitors | ||||
| L04AJ01 | eculizumab | ||||
| L04AJ02 | ravulizumab | ||||
| L04AJ03 | pegcetacoplan | ||||
| L04AJ04 | sutimlimab | ||||
| L04AJ05 | avacopan | ||||
| L04AJ06 | zilucoplan | ||||
| L04AJ07 | crovalimab | ||||
| L04AJ08 | iptacopan | ||||
| L04AJ09 | danicopan | ||||
| L04AK | Dihydroorotate dehydrogenase (DHODH) inhibitors | ||||
| L04AK01 | leflunomide | ||||
| L04AK02 | teriflunomide | ||||
| L04AX | Other immunosuppressants | ||||
| L04AX01 | Azathioprine | ||||
| L04AX02 | Thalidomide | ||||
| L04AX03 | Methotrexate | ||||
| L04AX04 | Lenalidomide | ||||
| L04AX05 | Pirfenidone | ||||
| L04AX06 | pomalidomide | ||||
| L04AX07 | dimethyl fumarate | ||||
| L04AX08 | darvadstrocel | ||||
| M | Musculo-skeletal system | ||||
| M01 | Anti-inflammatory and antirheumatic products | ||||
| M01A | Anti-inflammatory and antirheumatic products, non-steroids | ||||
| M01AA | Butylpyrazolidines | ||||
| M01AA01 | Phenylbutazone | ||||
| M01AA02 | Mofebutazone | ||||
| M01AA03 | Oxyphenbutazone | ||||
| M01AA05 | Clofezone | ||||
| M01AA06 | Kebuzone | ||||
| M01AB | Acetic acid derivatives and related substances | ||||
| M01AB01 | Indometacin | ||||
| M01AB02 | Sulindac | ||||
| M01AB03 | Tolmetin | ||||
| M01AB04 | Zomepirac | ||||
| M01AB05 | Diclofenac | ||||
| M01AB06 | Alclofenac | ||||
| M01AB07 | Bumadizone | ||||
| M01AB08 | Etodolac | ||||
| M01AB09 | Lonazolac | ||||
| M01AB10 | Fentiazac | ||||
| M01AB11 | Acemetacin | ||||
| M01AB12 | Difenpiramide | ||||
| M01AB13 | Oxametacin | ||||
| M01AB14 | Proglumetacin | ||||
| M01AB15 | Ketorolac | ||||
| M01AB16 | Aceclofenac | ||||
| M01AB17 | Bufexamac | ||||
| M01AB51 | Indometacin, combinations | ||||
| M01AB55 | Diclofenac, combinations | ||||
| M01AC | Oxicams | ||||
| M01AC01 | Piroxicam | ||||
| M01AC02 | Tenoxicam | ||||
| M01AC04 | Droxicam | ||||
| M01AC05 | Lornoxicam | ||||
| M01AC06 | Meloxicam | ||||
| M01AC56 | Meloxicam, combinations | ||||
| M01AE | Propionic acid derivatives | ||||
| M01AE01 | Ibuprofen | ||||
| M01AE02 | Naproxen | ||||
| M01AE03 | Ketoprofen | ||||
| M01AE04 | Fenoprofen | ||||
| M01AE05 | Fenbufen | ||||
| M01AE06 | Benoxaprofen | ||||
| M01AE07 | Suprofen | ||||
| M01AE08 | Pirprofen | ||||
| M01AE09 | Flurbiprofen | ||||
| M01AE10 | Indoprofen | ||||
| M01AE11 | Tiaprofenic acid | ||||
| M01AE12 | Oxaprozin | ||||
| M01AE13 | Ibuproxam | ||||
| M01AE14 | Dexibuprofen | ||||
| M01AE15 | Flunoxaprofen | ||||
| M01AE16 | Alminoprofen | ||||
| M01AE17 | Dexketoprofen | ||||
| M01AE18 | Naproxcinod | ||||
| M01AE51 | Ibuprofen, combinations (New ATC code N02AJ03) | ||||
| M01AE52 | Naproxen and esomeprazole | ||||
| M01AE53 | Ketoprofen, combinations | ||||
| M01AE56 | Naproxen and misoprostol | ||||
| M01AG | Fenamates | ||||
| M01AG01 | Mefenamic acid | ||||
| M01AG02 | Tolfenamic acid | ||||
| M01AG03 | Flufenamic acid | ||||
| M01AG04 | Meclofenamic acid | ||||
| M01AH | Coxibs | ||||
| M01AH01 | Celecoxib | ||||
| M01AH02 | Rofecoxib | ||||
| M01AH03 | Valdecoxib | ||||
| M01AH04 | Parecoxib | ||||
| M01AH05 | Etoricoxib | ||||
| M01AH06 | Lumiracoxib | ||||
| M01AX | Other anti-inflammatory and antirheumatic agents, non-steroids | ||||
| M01AX01 | Nabumetone | ||||
| M01AX02 | Niflumic acid | ||||
| M01AX04 | Azapropazone | ||||
| M01AX05 | Glucosamine | ||||
| M01AX07 | Benzydamine | ||||
| M01AX12 | Glucosaminoglycan polysulfate | ||||
| M01AX13 | Proquazone | ||||
| M01AX14 | Orgotein | ||||
| M01AX17 | Nimesulide | ||||
| M01AX18 | Feprazone | ||||
| M01AX21 | Diacerein | ||||
| M01AX22 | Morniflumate | ||||
| M01AX23 | Tenidap | ||||
| M01AX24 | Oxaceprol | ||||
| M01AX25 | Chondroitin sulfate | ||||
| M01AX26 | Avocado and soyabean oil, unsaponifiables | ||||
| M01AX68 | Feprazone, combinations | ||||
| M01B | Anti-inflammatory/antirheumatic agents in combination | ||||
| M01BA | Anti-inflammatory/antirheumatic agents in combination with corticosteroids | ||||
| M01BA01 | Phenylbutazone and corticosteroids | ||||
| M01BA02 | Dipyrocetyl and corticosteroids | ||||
| M01BA03 | Acetylsalicylic acid and corticosteroids | ||||
| M01BX | Other anti-inflammatory/antirheumatic agents in combination with other drugs | ||||
| empty | |||||
| M01C | Specific antirheumatic agents | ||||
| M01CA | Quinolines | ||||
| M01CA03 | Oxycinchophen | ||||
| M01CB | Gold preparations | ||||
| M01CB01 | Sodium aurothiomalate | ||||
| M01CB02 | Sodium aurothiosulfate | ||||
| M01CB03 | Auranofin | ||||
| M01CB04 | Aurothioglucose | ||||
| M01CB05 | Aurotioprol | ||||
| M01CC | Penicillamine and similar agents | ||||
| M01CC01 | Penicillamine | ||||
| M01CC02 | Bucillamine | ||||
| M01CX | Other specific antirheumatic agents | ||||
| empty | |||||
| M02 | Topical products for joint and muscular pain | ||||
| M02A | Topical products for joint and muscular pain | ||||
| M02AA | Anti-inflammatory preparations, non-steroids for topical use | ||||
| M02AA01 | Phenylbutazone | ||||
| M02AA02 | Mofebutazone | ||||
| M02AA03 | Clofezone | ||||
| M02AA04 | Oxyphenbutazone | ||||
| M02AA05 | Benzydamine | ||||
| M02AA06 | Etofenamate | ||||
| M02AA07 | Piroxicam | ||||
| M02AA08 | Felbinac | ||||
| M02AA09 | Bufexamac | ||||
| M02AA10 | Ketoprofen | ||||
| M02AA11 | Bendazac | ||||
| M02AA12 | Naproxen | ||||
| M02AA13 | Ibuprofen | ||||
| M02AA14 | Fentiazac | ||||
| M02AA15 | Diclofenac | ||||
| M02AA16 | Feprazone | ||||
| M02AA17 | Niflumic acid | ||||
| M02AA18 | Meclofenamic acid | ||||
| M02AA19 | Flurbiprofen | ||||
| M02AA21 | Tolmetin | ||||
| M02AA22 | Suxibuzone | ||||
| M02AA23 | Indometacin | ||||
| M02AA24 | Nifenazone | ||||
| M02AA25 | Aceclofenac | ||||
| M02AA26 | Nimesulide | ||||
| M02AB | Capsaicin and similar agents | ||||
| M02AB01 | Capsaicin | ||||
| M02AB02 | Zucapsaicin | ||||
| M02AC | Preparations with salicylic acid derivatives | ||||
| empty | |||||
| M02AX | Other topical products for joint and muscular pain | ||||
| M02AX02 | Tolazoline | ||||
| M02AX03 | Dimethyl sulfoxide | ||||
| M02AX05 | Idrocilamide | ||||
| M02AX10 | Various | ||||
| M03 | Muscle relaxants | ||||
| M03A | Muscle relaxants, peripherally acting agents | ||||
| M03AA | Curare alkaloids | ||||
| M03AA01 | Alcuronium | ||||
| M03AA02 | Tubocurarine | ||||
| M03AA04 | Dimethyltubocurarine | ||||
| M03AB | Choline derivatives | ||||
| M03AB01 | Suxamethonium | ||||
| M03AC | Other quaternary ammonium compounds | ||||
| M03AC01 | Pancuronium | ||||
| M03AC02 | Gallamine | ||||
| M03AC03 | Vecuronium | ||||
| M03AC04 | Atracurium | ||||
| M03AC05 | Hexafluronium | ||||
| M03AC06 | Pipecuronium bromide | ||||
| M03AC07 | Doxacurium chloride | ||||
| M03AC08 | Fazadinium bromide | ||||
| M03AC09 | Rocuronium bromide | ||||
| M03AC10 | Mivacurium chloride | ||||
| M03AC11 | Cisatracurium | ||||
| M03AX | Other muscle relaxants, peripherally acting agents | ||||
| M03AX01 | Botulinum toxin | ||||
| M03B | Muscle relaxants, centrally acting agents | ||||
| M03BA | Carbamic acid esters | ||||
| M03BA01 | Phenprobamate | ||||
| M03BA02 | Carisoprodol | ||||
| M03BA03 | Methocarbamol | ||||
| M03BA04 | Styramate | ||||
| M03BA05 | Febarbamate | ||||
| M03BA51 | Phenprobamate, combinations excluding psycholeptics | ||||
| M03BA52 | Carisoprodol, combinations excluding psycholeptics | ||||
| M03BA53 | Methocarbamol, combinations excluding psycholeptics | ||||
| M03BA71 | Phenprobamate, combinations with psycholeptics | ||||
| M03BA72 | Carisoprodol, combinations with psycholeptics | ||||
| M03BA73 | Methocarbamol, combinations with psycholeptics | ||||
| M03BB | Oxazol, thiazine, and triazine derivatives | ||||
| M03BB02 | Chlormezanone | ||||
| M03BB03 | Chlorzoxazone | ||||
| M03BB52 | Chlormezanone, combinations excluding psycholeptics | ||||
| M03BB53 | Chlorzoxazone, combinations excluding psycholeptics | ||||
| M03BB72 | Chlormezanone, combinations with psycholeptics | ||||
| M03BB73 | Chlorzoxazone, combinations with psycholeptics | ||||
| M03BC | Ethers, chemically close to antihistamines | ||||
| M03BC01 | Orphenadrine (citrate) | ||||
| M03BC51 | Orphenadrine, combinations | ||||
| M03BX | Other centrally acting agents | ||||
| M03BX01 | Baclofen | ||||
| M03BX02 | Tizanidine | ||||
| M03BX03 | Pridinol | ||||
| M03BX04 | Tolperisone | ||||
| M03BX05 | Thiocolchicoside | ||||
| M03BX06 | Mephenesin | ||||
| M03BX07 | Tetrazepam | ||||
| M03BX08 | Cyclobenzaprine | ||||
| M03BX09 | Eperisone | ||||
| M03BX30 | Phenyramidol | ||||
| M03C | Muscle relaxants, directly acting agents | ||||
| M03CA | Dantrolene and derivatives | ||||
| M03CA01 | Dantrolene | ||||
| M04 | Antigout preparations | ||||
| M04A | Antigout preparations | ||||
| M04AA | Preparations inhibiting uric acid production | ||||
| M04AA01 | Allopurinol | ||||
| M04AA02 | Tisopurine | ||||
| M04AA03 | Febuxostat | ||||
| M04AA51 | Allopurinol, combinations | ||||
| M04AB | Preparations increasing uric acid excretion | ||||
| M04AB01 | Probenecid | ||||
| M04AB02 | Sulfinpyrazone | ||||
| M04AB03 | Benzbromarone | ||||
| M04AB04 | Isobromindione | ||||
| M04AC | Preparations with no effect on uric acid metabolism | ||||
| M04AC01 | Colchicine | ||||
| M04AC02 | Cinchophen | ||||
| M04AX | Other antigout preparations | ||||
| M04AX01 | Urate oxidase | ||||
| M04AX02 | Pegloticase | ||||
| M05 | Drugs for treatment of bone diseases | ||||
| M05B | Drugs affecting bone structure and mineralization | ||||
| M05BA | Bisphosphonates | ||||
| M05BA01 | Etidronic acid | ||||
| M05BA02 | Clodronic acid | ||||
| M05BA03 | Pamidronic acid | ||||
| M05BA04 | Alendronic acid | ||||
| M05BA05 | Tiludronic acid | ||||
| M05BA06 | Ibandronic acid | ||||
| M05BA07 | Risedronic acid | ||||
| M05BA08 | Zoledronic acid | ||||
| M05BB | Bisphosphonates, combinations | ||||
| M05BB01 | Etidronic acid and calcium, sequential | ||||
| M05BB02 | Risedronic acid and calcium, sequential | ||||
| M05BB03 | Alendronic acid and colecalciferol | ||||
| M05BB04 | Risedronic acid, calcium and colecalciferol, sequential | ||||
| M05BB05 | Alendronic acid, calcium and colecalciferol, sequential | ||||
| M05BB06 | Alendronic acid and alfacalcidol, sequential | ||||
| M05BC | Bone morphogenetic proteins | ||||
| M05BC01 | Dibotermin alfa | ||||
| M05BC02 | Eptotermin alfa | ||||
| M05BX | Other drugs affecting bone structure and mineralization | ||||
| M05BX01 | Ipriflavone | ||||
| M05BX02 | aluminium chlorohydrate | ||||
| M05BX03 | Strontium ranelate | ||||
| M05BX04 | Denosumab | ||||
| M05BX05 | burosumab | ||||
| M05BX06 | romosozumab | ||||
| M05BX07 | vosoritide | ||||
| M05BX08 | menatetrenone | ||||
| M05BX53 | strontium ranelate and colecalciferol | ||||
| M09 | Other drugs for disorders of the musculo-skeletal system | ||||
| M09A | Other drugs for disorders of the musculo-skeletal system | ||||
| M09AA | Quinine and derivatives | ||||
| M09AA01 | Hydroquinine | ||||
| M09AA72 | Quinine, combinations with psycholeptics | ||||
| M09AB | Enzymes | ||||
| M09AB01 | Chymopapain | ||||
| M09AB02 | Collagenase clostridium histolyticum | ||||
| M09AB52 | Trypsin, combinations | ||||
| M09AX | Other drugs for disorders of the musculo-skeletal system | ||||
| M09AX01 | Hyaluronic acid | ||||
| M09AX02 | Chondrocytes, autologous | ||||
| M09AX03 | ataluren | ||||
| M09AX04 | drisapersen | ||||
| M09AX05 | aceneuramic acid | ||||
| M09AX06 | eteplirsen | ||||
| M09AX07 | nusinersen | ||||
| M09AX08 | golodirsen | ||||
| M09AX09 | onasemnogene abeparvovec | ||||
| M09AX10 | risdiplam | ||||
| M09AX11 | palovarotene | ||||
| M09AX12 | viltolarsen | ||||
| M09AX13 | casimersen | ||||
| M09AX14 | givinostat | ||||
| M09AX15 | delandistrogene moxeparvovec | ||||
| N | Nervous system | ||||
| N01 | Anesthetics | ||||
| N01A | Anesthetics, general | ||||
| N01AA | Ethers | ||||
| N01AA01 | Diethyl ether | ||||
| N01AA02 | Vinyl ether | ||||
| N01AB | Halogenated hydrocarbons | ||||
| N01AB01 | Halothane | ||||
| N01AB02 | Chloroform | ||||
| N01AB03 | methoxyflurane (בוטל, קוד חדש N02BG09) | ||||
| N01AB04 | Enflurane | ||||
| N01AB05 | Trichloroethylene | ||||
| N01AB06 | Isoflurane | ||||
| N01AB07 | Desflurane | ||||
| N01AB08 | Sevoflurane | ||||
| N01AF | Barbiturates, plain | ||||
| N01AF01 | Methohexital | ||||
| N01AF02 | Hexobarbital | ||||
| N01AF03 | Thiopental | ||||
| N01AG | Barbiturates in combination with other drugs | ||||
| N01AG01 | Narcobarbital | ||||
| N01AH | Opioid anesthetics | ||||
| N01AH01 | Fentanyl | ||||
| N01AH02 | Alfentanil | ||||
| N01AH03 | Sufentanil | ||||
| N01AH04 | Phenoperidine | ||||
| N01AH05 | Anileridine | ||||
| N01AH06 | Remifentanil | ||||
| N01AH51 | Fentanyl, combinations | ||||
| N01AX | Other general anesthetics | ||||
| N01AX01 | droperidol (בוטל, קוד חדש N05AD08) | ||||
| N01AX03 | Ketamine | ||||
| N01AX04 | Propanidid | ||||
| N01AX05 | Alfaxalone | ||||
| N01AX07 | Etomidate | ||||
| N01AX10 | Propofol | ||||
| N01AX11 | Sodium oxybate | ||||
| N01AX13 | Nitrous oxide | ||||
| N01AX14 | Esketamine | ||||
| N01AX15 | Xenon | ||||
| N01AX63 | Nitrous oxide, combinations | ||||
| N01B | Anesthetics, local | ||||
| N01BA | Esters of aminobenzoic acid | ||||
| N01BA01 | Metabutethamine | ||||
| N01BA02 | Procaine | ||||
| N01BA03 | Tetracaine | ||||
| N01BA04 | Chloroprocaine | ||||
| N01BA05 | Benzocaine | ||||
| N01BA52 | Procaine, combinations | ||||
| N01BB | Amides | ||||
| N01BB01 | Bupivacaine | ||||
| N01BB02 | Lidocaine | ||||
| N01BB03 | Mepivacaine | ||||
| N01BB04 | Prilocaine | ||||
| N01BB05 | Butanilicaine | ||||
| N01BB06 | Cinchocaine | ||||
| N01BB07 | Etidocaine | ||||
| N01BB08 | Articaine | ||||
| N01BB09 | Ropivacaine | ||||
| N01BB10 | Levobupivacaine | ||||
| N01BB20 | Combinations | ||||
| N01BB51 | Bupivacaine, combinations | ||||
| N01BB52 | Lidocaine, combinations | ||||
| N01BB53 | Mepivacaine, combinations | ||||
| N01BB54 | Prilocaine, combinations | ||||
| N01BB57 | Etidocaine, combinations | ||||
| N01BB58 | Articaine, combinations | ||||
| N01BC | Esters of benzoic acid | ||||
| N01BC01 | Cocaine | ||||
| N01BX | Other local anesthetics | ||||
| N01BX01 | Ethyl chloride | ||||
| N01BX02 | Dyclonine | ||||
| N01BX03 | Phenol | ||||
| N01BX04 | Capsaicin | ||||
| N02 | Analgesics | ||||
| N02A | Opioids | ||||
| N02AA | Natural opium alkaloids | ||||
| N02AA01 | Morphine | ||||
| N02AA02 | Opium | ||||
| N02AA03 | Hydromorphone | ||||
| N02AA04 | Nicomorphine | ||||
| N02AA05 | Oxycodone | ||||
| N02AA08 | Dihydrocodeine | ||||
| N02AA09 | diamorphine (בוטל, קוד חדש N07BC06) | ||||
| N02AA10 | Papaveretum | ||||
| N02AA51 | Morphine, combinations | ||||
| N02AA55 | Oxycodone, combinations (בוטל, קוד חדש N02AJ17 - N02AJ19) | ||||
| N02AA58 | Dihydrocodeine, combinations (בוטל, קוד חדש N02AJ01 - N02AJ03) | ||||
| N02AA59 | Codeine, combinations excluding psycholeptics (בוטל, קוד חדש N02AJ06 - N02AJ09) | ||||
| N02AA79 | Codeine, combinations with psycholeptics | ||||
| N02AB | Phenylpiperidine derivatives | ||||
| N02AB01 | Ketobemidone | ||||
| N02AB02 | Pethidine | ||||
| N02AB03 | Fentanyl | ||||
| N02AB52 | Pethidine, combinations excluding psycholeptics | ||||
| N02AB72 | Pethidine, combinations with psycholeptics | ||||
| N02AC | Diphenylpropylamine derivatives | ||||
| N02AC01 | Dextromoramide | ||||
| N02AC03 | Piritramide | ||||
| N02AC04 | Dextropropoxyphene | ||||
| N02AC05 | Bezitramide | ||||
| N02AC52 | Methadone, combinations excluding psycholeptics | ||||
| N02AC54 | Dextropropoxyphene, combinations excluding psycholeptics | ||||
| N02AC74 | Dextropropoxyphene, combinations with psycholeptics | ||||
| N02AD | Benzomorphan derivatives | ||||
| N02AD01 | Pentazocine | ||||
| N02AD02 | Phenazocine | ||||
| N02AE | Oripavine derivatives | ||||
| N02AE01 | Buprenorphine | ||||
| N02AF | Morphinan derivatives | ||||
| N02AF01 | Butorphanol | ||||
| N02AF02 | Nalbuphine | ||||
| N02AG | Opioids in combination with antispasmodics | ||||
| N02AG01 | Morphine and antispasmodics | ||||
| N02AG02 | Ketobemidone and antispasmodics | ||||
| N02AG03 | Pethidine and antispasmodics | ||||
| N02AG04 | Hydromorphone and antispasmodics | ||||
| N02AJ | Opioids in combination with non-opioid analgesics | ||||
| N02AJ01 | dihydrocodeine and paracetamol | ||||
| N02AJ02 | dihydrocodeine and acetylsalicylic acid | ||||
| N02AJ03 | dihydrocodeine and other non-opioid analgesics | ||||
| N02AJ06 | codeine and paracetamol | ||||
| N02AJ07 | codeine and acetylsalicylic acid | ||||
| N02AJ08 | codeine and ibuprofen | ||||
| N02AJ09 | codeine and other non-opioid analgesics | ||||
| N02AJ13 | tramadol and paracetamol | ||||
| N02AJ14 | tramadol and dexketoprofen | ||||
| N02AJ15 | tramadol and other non-opioid analgesics | ||||
| N02AJ17 | oxycodone and paracetamol | ||||
| N02AJ18 | oxycodone and acetylsalicylic acid | ||||
| N02AJ19 | oxycodone and ibuprofen | ||||
| N02AX | Other opioids | ||||
| N02AX01 | Tilidine | ||||
| N02AX02 | Tramadol | ||||
| N02AX03 | Dezocine | ||||
| N02AX05 | Meptazinol | ||||
| N02AX06 | Tapentadol | ||||
| N02AX52 | Tramadol, combinations (New ATC code N02AJ13) | ||||
| N02B | Other analgesics and antipyretics | ||||
| N02BA | Salicylic acid and derivatives | ||||
| N02BA01 | Acetylsalicylic acid | ||||
| N02BA02 | Aloxiprin | ||||
| N02BA03 | Choline salicylate | ||||
| N02BA04 | Sodium salicylate | ||||
| N02BA05 | Salicylamide | ||||
| N02BA06 | Salsalate | ||||
| N02BA07 | Ethenzamide | ||||
| N02BA08 | Morpholine salicylate | ||||
| N02BA09 | Dipyrocetyl | ||||
| N02BA10 | Benorilate | ||||
| N02BA11 | Diflunisal | ||||
| N02BA12 | Potassium salicylate | ||||
| N02BA14 | Guacetisal | ||||
| N02BA15 | Carbasalate calcium | ||||
| N02BA16 | Imidazole salicylate | ||||
| N02BA51 | Acetylsalicylic acid, combinations excluding psycholeptics (בוטל, קוד חדש N02AJ02 - N02AJ17) | ||||
| N02BA55 | Salicylamide, combinations excluding psycholeptics | ||||
| N02BA57 | Ethenzamide, combinations excluding psycholeptics | ||||
| N02BA59 | Dipyrocetyl, combinations excluding psycholeptics | ||||
| N02BA65 | Carbasalate calcium combinations excluding psycholeptics | ||||
| N02BA71 | Acetylsalicylic acid, combinations with psycholeptics | ||||
| N02BA75 | Salicylamide, combinations with psycholeptics | ||||
| N02BA77 | Ethenzamide, combinations with psycholeptics | ||||
| N02BA79 | Dipyrocetyl, combinations with psycholeptics | ||||
| N02BB | Pyrazolones | ||||
| N02BB01 | Phenazone | ||||
| N02BB02 | Metamizole | ||||
| N02BB03 | Aminophenazone | ||||
| N02BB04 | Propyphenazone | ||||
| N02BB05 | Nifenazone | ||||
| N02BB51 | Phenazone, combinations excluding psycholeptics | ||||
| N02BB52 | Metamizole sodium, combinations excluding psycholeptics | ||||
| N02BB53 | Aminophenazone, combinations excluding psycholeptics | ||||
| N02BB54 | Propyphenazone, combinations excluding psycholeptics | ||||
| N02BB71 | Phenazone, combinations with psycholeptics | ||||
| N02BB72 | Metamizole sodium, combinations with psycholeptics | ||||
| N02BB73 | Aminophenazone, combinations with psycholeptics | ||||
| N02BB74 | Propyphenazone, combinations with psycholeptics | ||||
| N02BE | Anilides | ||||
| N02BE01 | Paracetamol | ||||
| N02BE03 | Phenacetin | ||||
| N02BE04 | Bucetin | ||||
| N02BE05 | Propacetamol | ||||
| N02BE51 | Paracetamol, combinations excluding psycholeptics | ||||
| N02BE53 | Phenacetin, combinations excluding psycholeptics | ||||
| N02BE54 | Bucetin, combinations excluding psycholeptics | ||||
| N02BE71 | Paracetamol, combinations with psycholeptics | ||||
| N02BE73 | Phenacetin, combinations with psycholeptics | ||||
| N02BE74 | Bucetin, combinations with psycholeptics | ||||
| N02BF | Gabapentinoids | ||||
| N02BF01 | gabapentin | ||||
| N02BF02 | pregabalin | ||||
| N02BF03 | mirogabalin | ||||
| N02BG | Other analgesics and antipyretics | ||||
| N02BG02 | Rimazolium | ||||
| N02BG03 | Glafenine | ||||
| N02BG04 | Floctafenine | ||||
| N02BG05 | Viminol | ||||
| N02BG06 | Nefopam | ||||
| N02BG07 | Flupirtine | ||||
| N02BG08 | Ziconotide | ||||
| N02BG09 | Methoxyflurane | ||||
| N02BG10 | Nabiximols | ||||
| N02BG11 | mirogabalin (New ATC code N02BF03) | ||||
| N02C | Antimigraine preparations | ||||
| N02CA | Ergot alkaloids | ||||
| N02CA01 | Dihydroergotamine | ||||
| N02CA02 | Ergotamine | ||||
| N02CA04 | Methysergide | ||||
| N02CA07 | Lisuride | ||||
| N02CA51 | Dihydroergotamine, combinations | ||||
| N02CA52 | Ergotamine, combinations excluding psycholeptics | ||||
| N02CA72 | Ergotamine, combinations with psycholeptics | ||||
| N02CB | Corticosteroid derivatives | ||||
| N02CB01 | Flumedroxone | ||||
| N02CC | Selective serotonin (5-HT1) agonists | ||||
| N02CC01 | Sumatriptan | ||||
| N02CC02 | Naratriptan | ||||
| N02CC03 | Zolmitriptan | ||||
| N02CC04 | Rizatriptan | ||||
| N02CC05 | Almotriptan | ||||
| N02CC06 | Eletriptan | ||||
| N02CC07 | Frovatriptan | ||||
| N02CD | Calcitonin gene-related peptide (CGRP) antagonists | ||||
| N02CD01 | erenumab | ||||
| N02CD02 | galcanezumab | ||||
| N02CD03 | fremanezumab | ||||
| N02CD04 | ubrogepant | ||||
| N02CD05 | eptinezumab | ||||
| N02CD06 | rimegepant | ||||
| N02CD07 | atogepant | ||||
| N02CX | Other antimigraine preparations | ||||
| N02CX01 | Pizotifen | ||||
| N02CX02 | Clonidine | ||||
| N02CX03 | Iprazochrome | ||||
| N02CX05 | Dimetotiazine | ||||
| N02CX06 | Oxetorone | ||||
| N02CX07 | erenumab (New ATC code N02CD01) | ||||
| N02CX08 | galcanezumab (New ATC code N02CD02) | ||||
| N03 | Antiepileptics | ||||
| N03A | Antiepileptics | ||||
| N03AA | Barbiturates and derivatives | ||||
| N03AA01 | Methylphenobarbital | ||||
| N03AA02 | Phenobarbital | ||||
| N03AA03 | Primidone | ||||
| N03AA04 | Barbexaclone | ||||
| N03AA30 | Metharbital | ||||
| N03AB | Hydantoin derivatives | ||||
| N03AB01 | Ethotoin | ||||
| N03AB02 | Phenytoin | ||||
| 03AB03 | Amino(diphenylhydantoin) valeric acid | ||||
| N03AB04 | Mephenytoin | ||||
| N03AB05 | Fosphenytoin | ||||
| N03AB52 | Phenytoin, combinations | ||||
| N03AB54 | Mephenytoin, combinations | ||||
| N03AC | Oxazolidine derivatives | ||||
| N03AC01 | Paramethadione | ||||
| N03AC02 | Trimethadione | ||||
| N03AC03 | Ethadione | ||||
| N03AD | Succinimide derivatives | ||||
| N03AD01 | Ethosuximide | ||||
| N03AD02 | Phensuximide | ||||
| N03AD03 | Mesuximide | ||||
| N03AD51 | Ethosuximide, combinations | ||||
| N03AE | Benzodiazepine derivatives | ||||
| N03AE01 | Clonazepam | ||||
| N03AF | Carboxamide derivatives | ||||
| N03AF01 | Carbamazepine | ||||
| N03AF02 | Oxcarbazepine | ||||
| N03AF03 | Rufinamide | ||||
| N03AF04 | Eslicarbazepine | ||||
| N03AG | Fatty acid derivatives | ||||
| N03AG01 | Valproic acid | ||||
| N03AG02 | Valpromide | ||||
| N03AG03 | Aminobutyric acid | ||||
| N03AG04 | Vigabatrin | ||||
| N03AG05 | Progabide | ||||
| N03AG06 | Tiagabine | ||||
| N03AX | Other antiepileptics | ||||
| N03AX03 | Sultiame | ||||
| N03AX07 | Phenacemide | ||||
| N03AX09 | Lamotrigine | ||||
| N03AX10 | Felbamate | ||||
| N03AX11 | Topiramate | ||||
| N03AX12 | Gabapentin (New ATC code N02BF01) | ||||
| N03AX13 | Pheneturide | ||||
| N03AX14 | Levetiracetam | ||||
| N03AX15 | Zonisamide | ||||
| N03AX16 | Pregabalin (New ATC code N02BF02) | ||||
| N03AX17 | Stiripentol | ||||
| N03AX18 | Lacosamide | ||||
| N03AX19 | Carisbamate | ||||
| N03AX21 | Retigabine | ||||
| N03AX22 | Perampanel | ||||
| N03AX23 | brivaracetam | ||||
| N03AX24 | cannabidiol | ||||
| N03AX25 | cenobamate | ||||
| N03AX26 | fenfluramine | ||||
| N03AX27 | ganaxolone | ||||
| N03AX30 | Beclamide | ||||
| N04 | Anti-parkinson drugs | ||||
| N04A | Anticholinergic agents | ||||
| N04AA | Tertiary amines | ||||
| N04AA01 | Trihexyphenidyl | ||||
| N04AA02 | Biperiden | ||||
| N04AA03 | Metixene | ||||
| N04AA04 | Procyclidine | ||||
| N04AA05 | Profenamine | ||||
| N04AA08 | Dexetimide | ||||
| N04AA09 | Phenglutarimide | ||||
| N04AA10 | Mazaticol | ||||
| N04AA11 | Bornaprine | ||||
| N04AA12 | Tropatepine | ||||
| N04AB | Ethers chemically close to antihistamines | ||||
| N04AB01 | Etanautine | ||||
| N04AB02 | Orphenadrine (chloride) | ||||
| N04AC | Ethers of tropine or tropine derivatives | ||||
| N04AC01 | Benzatropine | ||||
| N04AC30 | Etybenzatropine | ||||
| N04B | Dopaminergic agents | ||||
| N04BA | Dopa and dopa derivatives | ||||
| N04BA01 | Levodopa | ||||
| N04BA02 | Levodopa and decarboxylase inhibitor | ||||
| N04BA03 | Levodopa, decarboxylase inhibitor and COMT inhibitor | ||||
| N04BA04 | Melevodopa | ||||
| N04BA05 | Melevodopa and decarboxylase inhibitor | ||||
| N04BA06 | Etilevodopa and decarboxylase inhibitor | ||||
| N04BA07 | foslevodopa and decarboxylase inhibitor | ||||
| N04BB | Adamantane derivatives | ||||
| N04BB01 | Amantadine | ||||
| N04BC | Dopamine agonists | ||||
| N04BC01 | Bromocriptine | ||||
| N04BC02 | Pergolide | ||||
| N04BC03 | Dihydroergocryptine mesylate | ||||
| N04BC04 | Ropinirole | ||||
| N04BC05 | Pramipexole | ||||
| N04BC06 | Cabergoline | ||||
| N04BC07 | Apomorphine | ||||
| N04BC08 | Piribedil | ||||
| N04BC09 | Rotigotine | ||||
| N04BD | Monoamine oxidase B inhibitors | ||||
| N04BD01 | Selegiline | ||||
| N04BD02 | Rasagiline | ||||
| N04BD03 | safinamide | ||||
| N04BX | Other dopaminergic agents | ||||
| N04BX01 | Tolcapone | ||||
| N04BX02 | Entacapone | ||||
| N04BX03 | Budipine | ||||
| N05 | Psycholeptics | ||||
| N05A | Antipsychotics | ||||
| N05AA | Phenothiazines with aliphatic side-chain | ||||
| N05AA01 | Chlorpromazine | ||||
| N05AA02 | Levomepromazine | ||||
| N05AA03 | Promazine | ||||
| N05AA04 | Acepromazine | ||||
| N05AA05 | Triflupromazine | ||||
| N05AA06 | Cyamemazine | ||||
| N05AA07 | Chlorproethazine | ||||
| N05AB | Phenothiazines with piperazine structure | ||||
| N05AB01 | Dixyrazine | ||||
| N05AB02 | Fluphenazine | ||||
| N05AB03 | Perphenazine | ||||
| N05AB04 | Prochlorperazine | ||||
| N05AB05 | Thiopropazate | ||||
| N05AB06 | Trifluoperazine | ||||
| N05AB07 | Acetophenazine | ||||
| N05AB08 | Thioproperazine | ||||
| N05AB09 | Butaperazine | ||||
| N05AB10 | Perazine | ||||
| N05AC | Phenothiazines with piperidine structure | ||||
| N05AC01 | Periciazine | ||||
| N05AC02 | Thioridazine | ||||
| N05AC03 | Mesoridazine | ||||
| N05AC04 | Pipotiazine | ||||
| N05AD | Butyrophenone derivatives | ||||
| N05AD01 | Haloperidol | ||||
| N05AD02 | Trifluperidol | ||||
| N05AD03 | Melperone | ||||
| N05AD04 | Moperone | ||||
| N05AD05 | Pipamperone | ||||
| N05AD06 | Bromperidol | ||||
| N05AD07 | Benperidol | ||||
| N05AD08 | Droperidol | ||||
| N05AD09 | Fluanisone | ||||
| N05AE | Indole derivatives | ||||
| N05AE01 | Oxypertine | ||||
| N05AE02 | Molindone | ||||
| N05AE03 | Sertindole | ||||
| N05AE04 | Ziprasidone | ||||
| N05AE05 | Lurasidone | ||||
| N05AF | Thioxanthene derivative | ||||
| N05AF01 | Flupentixol | ||||
| N05AF02 | Clopenthixol | ||||
| N05AF03 | Chlorprothixene | ||||
| N05AF04 | Thiothixene | ||||
| N05AF05 | Zuclopenthixol | ||||
| N05AG | Diphenylbutylpiperidine derivatives | ||||
| N05AG01 | Fluspirilene | ||||
| N05AG02 | Pimozide | ||||
| N05AG03 | Penfluridol | ||||
| N05AH | Diazepines, oxazepines, thiazepines and oxepines | ||||
| N05AH01 | Loxapine | ||||
| N05AH02 | Clozapine | ||||
| N05AH03 | Olanzapine | ||||
| N05AH04 | Quetiapine | ||||
| N05AH05 | Asenapine | ||||
| N05AH06 | Clotiapine | ||||
| N05AK | Neuroleptics, in tardive dyskinesia | ||||
| N05AK01 | tetrabenazine (בוטל, קוד חדש N07XX06) | ||||
| N05AL | Benzamides | ||||
| N05AL01 | Sulpiride | ||||
| N05AL02 | Sultopride | ||||
| N05AL03 | Tiapride | ||||
| N05AL04 | Remoxipride | ||||
| N05AL05 | Amisulpride | ||||
| N05AL06 | Veralipride | ||||
| N05AL07 | Levosulpiride | ||||
| N05AN | Lithium | ||||
| N05AN01 | Lithium | ||||
| N05AX | Other antipsychotics | ||||
| N05AX07 | Prothipendyl | ||||
| N05AX08 | Risperidone | ||||
| N05AX09 | clotiapine (בוטל, קוד חדש N05AH06) | ||||
| N05AX10 | Mosapramine | ||||
| N05AX11 | Zotepine | ||||
| N05AX12 | Aripiprazole | ||||
| N05AX13 | Paliperidone | ||||
| N05AX14 | Iloperidone | ||||
| N05AX15 | cariprazine | ||||
| N05AX16 | brexpiprazole | ||||
| N05AX17 | pimavanserin | ||||
| N05B | Anxiolytics | ||||
| N05BA | Benzodiazepine derivatives | ||||
| N05BA01 | Diazepam | ||||
| N05BA02 | Chlordiazepoxide | ||||
| N05BA03 | Medazepam | ||||
| N05BA04 | Oxazepam | ||||
| N05BA05 | Potassium clorazepate | ||||
| N05BA06 | Lorazepam | ||||
| N05BA07 | Adinazolam | ||||
| N05BA08 | Bromazepam | ||||
| N05BA09 | Clobazam | ||||
| N05BA10 | Ketazolam | ||||
| N05BA11 | Prazepam | ||||
| N05BA12 | Alprazolam | ||||
| N05BA13 | Halazepam | ||||
| N05BA14 | Pinazepam | ||||
| N05BA15 | Camazepam | ||||
| N05BA16 | Nordazepam | ||||
| N05BA17 | Fludiazepam | ||||
| N05BA18 | Ethyl loflazepate | ||||
| N05BA19 | Etizolam | ||||
| N05BA21 | Clotiazepam | ||||
| N05BA22 | Cloxazolam | ||||
| N05BA23 | Tofisopam | ||||
| N05BA56 | Lorazepam, combinations | ||||
| N05BB | Diphenylmethane derivatives | ||||
| N05BB01 | Hydroxyzine | ||||
| N05BB02 | Captodiame | ||||
| N05BB51 | Hydroxyzine, combinations | ||||
| N05BC | Carbamates | ||||
| N05BC01 | Meprobamate | ||||
| N05BC03 | Emylcamate | ||||
| N05BC04 | Mebutamate | ||||
| N05BC51 | Meprobamate, combinations | ||||
| N05BD | Dibenzo-bicyclo-octadiene derivatives | ||||
| N05BD01 | Benzoctamine | ||||
| N05BE | Azaspirodecanedione derivatives | ||||
| N05BE01 | Buspirone | ||||
| N05BX | Other anxiolytics | ||||
| N05BX01 | Mephenoxalone | ||||
| N05BX02 | Gedocarnil | ||||
| N05BX03 | Etifoxine | ||||
| N05C | Hypnotics and sedatives | ||||
| N05CA | Barbiturates, plain | ||||
| N05CA01 | Pentobarbital | ||||
| N05CA02 | Amobarbital | ||||
| N05CA03 | Butobarbital | ||||
| N05CA04 | Barbital | ||||
| N05CA05 | Aprobarbital | ||||
| N05CA06 | Secobarbital | ||||
| N05CA07 | Talbutal | ||||
| N05CA08 | Vinylbital | ||||
| N05CA09 | Vinbarbital | ||||
| N05CA10 | Cyclobarbital | ||||
| N05CA11 | Heptabarbital | ||||
| N05CA12 | Reposal | ||||
| N05CA15 | Methohexital | ||||
| N05CA16 | Hexobarbital | ||||
| N05CA19 | Thiopental | ||||
| N05CA20 | Ethallobarbital | ||||
| N05CA21 | Allobarbital | ||||
| N05CA22 | Proxibarbal | ||||
| N05CB | Barbiturates, combinations | ||||
| N05CB01 | Combinations of barbiturates | ||||
| N05CB02 | Barbiturates in combination with other drugs | ||||
| N05CC | Aldehydes and derivatives | ||||
| N05CC01 | Chloral hydrate | ||||
| N05CC02 | Chloralodol | ||||
| N05CC03 | Acetylglycinamide chloral hydrate | ||||
| N05CC04 | Dichloralphenazone | ||||
| N05CC05 | Paraldehyde | ||||
| N05CD | Benzodiazepine derivatives | ||||
| N05CD01 | Flurazepam | ||||
| N05CD02 | Nitrazepam | ||||
| N05CD03 | Flunitrazepam | ||||
| N05CD04 | Estazolam | ||||
| N05CD05 | Triazolam | ||||
| N05CD06 | Lormetazepam | ||||
| N05CD07 | Temazepam | ||||
| N05CD08 | Midazolam | ||||
| N05CD09 | Brotizolam | ||||
| N05CD10 | Quazepam | ||||
| N05CD11 | Loprazolam | ||||
| N05CD12 | Doxefazepam | ||||
| N05CD13 | Cinolazepam | ||||
| N05CD14 | remimazolam | ||||
| N05CD15 | nimetazepam | ||||
| N05CE | Piperidinedione derivatives | ||||
| N05CE01 | Glutethimide | ||||
| N05CE02 | Methyprylon | ||||
| N05CE03 | Pyrithyldione | ||||
| N05CF | Benzodiazepine related drugs | ||||
| N05CF01 | Zopiclone | ||||
| N05CF02 | Zolpidem | ||||
| N05CF03 | Zaleplon | ||||
| N05CF04 | Eszopiclone | ||||
| N05CH | Melatonin receptor agonists | ||||
| N05CH01 | Melatonin | ||||
| N05CH02 | Ramelteon | ||||
| N05CH03 | tasimelteon | ||||
| N05CJ | Orexin receptor antagonists | ||||
| N05CJ01 | suvorexant | ||||
| N05CJ02 | lemborexant | ||||
| N05CJ03 | daridorexant | ||||
| N05CM | Other hypnotics and sedatives | ||||
| N05CM01 | Methaqualone | ||||
| N05CM02 | Clomethiazole | ||||
| N05CM03 | Bromisoval | ||||
| N05CM04 | Carbromal | ||||
| N05CM05 | Scopolamine | ||||
| N05CM06 | Propiomazine | ||||
| N05CM07 | Triclofos | ||||
| N05CM08 | Ethchlorvynol | ||||
| N05CM09 | Valerianae radix | ||||
| N05CM10 | Hexapropymate | ||||
| N05CM11 | Bromides | ||||
| N05CM12 | Apronal | ||||
| N05CM13 | Valnoctamide | ||||
| N05CM15 | Methylpentynol | ||||
| N05CM16 | Niaprazine | ||||
| N05CM17 | melatonin (בוטל, קוד חדש N05CH01) | ||||
| N05CM18 | Dexmedetomidine | ||||
| N05CM19 | suvorexant (בוטל, קוד חדש N05CJ01) | ||||
| N05CM21 | lemborexant (בוטל, קוד חדש N05CJ02) | ||||
| N05CX | Hypnotics and sedatives in combination, excluding barbiturates | ||||
| N05CX01 | Meprobamate, combinations | ||||
| N05CX02 | Methaqualone, combinations | ||||
| N05CX03 | Methylpentynol, combinations | ||||
| N05CX04 | Clomethiazole, combinations | ||||
| N05CX05 | Emepronium, combinations | ||||
| N05CX06 | Dipiperonylaminoethanol, combinations | ||||
| N06 | Psychoanaleptics | ||||
| N06A | Antidepressants | ||||
| N06AA | Non-selective monoamine reuptake inhibitors | ||||
| N06AA01 | Desipramine | ||||
| N06AA02 | Imipramine | ||||
| N06AA03 | Imipramine oxide | ||||
| N06AA04 | Clomipramine | ||||
| N06AA05 | Opipramol | ||||
| N06AA06 | Trimipramine | ||||
| N06AA07 | Lofepramine | ||||
| N06AA08 | Dibenzepin | ||||
| N06AA09 | Amitriptyline | ||||
| N06AA10 | Nortriptyline | ||||
| N06AA11 | Protriptyline | ||||
| N06AA12 | Doxepin | ||||
| N06AA13 | Iprindole | ||||
| N06AA14 | Melitracen | ||||
| N06AA15 | Butriptyline | ||||
| N06AA16 | Dosulepin | ||||
| N06AA17 | Amoxapine | ||||
| N06AA18 | Dimetacrine | ||||
| N06AA19 | Amineptine | ||||
| N06AA21 | Maprotiline | ||||
| N06AA23 | Quinupramine | ||||
| N06AB | Selective serotonin reuptake inhibitors | ||||
| N06AB02 | Zimelidine | ||||
| N06AB03 | Fluoxetine | ||||
| N06AB04 | Citalopram | ||||
| N06AB05 | Paroxetine | ||||
| N06AB06 | Sertraline | ||||
| N06AB07 | Alaproclate | ||||
| N06AB08 | Fluvoxamine | ||||
| N06AB09 | Etoperidone | ||||
| N06AB10 | Escitalopram | ||||
| N06AF | Monoamine oxidase inhibitors, non-selective | ||||
| N06AF01 | Isocarboxazid | ||||
| N06AF02 | Nialamide | ||||
| N06AF03 | Phenelzine | ||||
| N06AF04 | Tranylcypromine | ||||
| N06AF05 | Iproniazide | ||||
| N06AF06 | Iproclozide | ||||
| N06AG | Monoamine oxidase A inhibitors | ||||
| N06AG02 | Moclobemide | ||||
| N06AG03 | Toloxatone | ||||
| N06AX | Other antidepressants | ||||
| N06AX01 | Oxitriptan | ||||
| N06AX02 | Tryptophan | ||||
| N06AX03 | Mianserin | ||||
| N06AX04 | Nomifensine | ||||
| N06AX05 | Trazodone | ||||
| N06AX06 | Nefazodone | ||||
| N06AX07 | Minaprine | ||||
| N06AX08 | Bifemelane | ||||
| N06AX09 | Viloxazine | ||||
| N06AX10 | Oxaflozane | ||||
| N06AX11 | Mirtazapine | ||||
| N06AX12 | Bupropion | ||||
| N06AX13 | Medifoxamine | ||||
| N06AX14 | Tianeptine | ||||
| N06AX15 | Pivagabine | ||||
| N06AX16 | Venlafaxine | ||||
| N06AX17 | Milnacipran | ||||
| N06AX18 | Reboxetine | ||||
| N06AX19 | Gepirone | ||||
| N06AX21 | Duloxetine | ||||
| N06AX22 | Agomelatine | ||||
| N06AX23 | Desvenlafaxine | ||||
| N06AX24 | Vilazodone | ||||
| N06AX25 | Hyperici herba | ||||
| N06AX26 | Vortioxetine (proposed code) | ||||
| N06B | Psychostimulants, agents used for ADHD and nootropics | ||||
| N06BA | Centrally acting sympathomimetics | ||||
| N06BA01 | Amphetamine | ||||
| N06BA02 | Dexamphetamine | ||||
| N06BA03 | Dextromethamphetamine | ||||
| N06BA04 | Methylphenidate | ||||
| N06BA05 | Pemoline | ||||
| N06BA06 | Fencamfamin | ||||
| N06BA07 | Modafinil | ||||
| N06BA08 | Fenozolone | ||||
| N06BA09 | Atomoxetine | ||||
| N06BA10 | Fenetylline | ||||
| N06BA11 | Dexmethylphenidate | ||||
| N06BA12 | Lisdexamfetamine | ||||
| N06BA13 | armodafinil | ||||
| N06BA14 | solriamfetol | ||||
| N06BC | Xanthine derivatives | ||||
| N06BC01 | Caffeine | ||||
| N06BC02 | Propentofylline | ||||
| N06BX | Other psychostimulants and nootropics | ||||
| N06BX01 | Meclofenoxate | ||||
| N06BX02 | Pyritinol | ||||
| N06BX03 | Piracetam | ||||
| N06BX04 | Deanol | ||||
| N06BX05 | Fipexide | ||||
| N06BX06 | Citicoline | ||||
| N06BX07 | Oxiracetam | ||||
| N06BX08 | Pirisudanol | ||||
| N06BX09 | Linopirdine | ||||
| N06BX10 | Nizofenone | ||||
| N06BX11 | Aniracetam | ||||
| N06BX12 | Acetylcarnitine | ||||
| N06BX13 | Idebenone | ||||
| N06BX14 | Prolintane | ||||
| N06BX15 | Pipradrol | ||||
| N06BX16 | Pramiracetam | ||||
| N06BX17 | Adrafinil | ||||
| N06BX18 | Vinpocetine | ||||
| N06C | Psycholeptics and psychoanaleptics in combination | ||||
| N06CA | Antidepressants in combination with psycholeptics | ||||
| N06CA01 | Amitriptyline and psycholeptics | ||||
| N06CA02 | Melitracen and psycholeptics | ||||
| N06CA03 | Fluoxetine and psycholeptics | ||||
| N06CB | Psychostimulants in combination with psycholeptics | ||||
| empty | |||||
| N06D | Anti-dementia drugs | ||||
| N06DA | Anticholinesterases | ||||
| N06DA01 | Tacrine | ||||
| N06DA02 | Donepezil | ||||
| N06DA03 | Rivastigmine | ||||
| N06DA04 | Galantamine | ||||
| N06DA52 | Donepezil and memantine | ||||
| N06DX | Other anti-dementia drugs | ||||
| N06DX01 | Memantine | ||||
| N06DX02 | Ginkgo folium | ||||
| N06DX03 | aducanumab | ||||
| N06DX04 | lecanemab | ||||
| N06DX05 | donanemab | ||||
| N06DX30 | combinations | ||||
| N07 | Other nervous system drugs | ||||
| N07A | Parasympathomimetics | ||||
| N07AA | Anticholinesterases | ||||
| N07AA01 | Neostigmine | ||||
| N07AA02 | Pyridostigmine | ||||
| N07AA03 | Distigmine | ||||
| N07AA30 | Ambenonium | ||||
| N07AA51 | Neostigmine, combinations | ||||
| N07AB | Choline esters | ||||
| N07AB01 | Carbachol | ||||
| N07AB02 | Bethanechol | ||||
| N07AX | Other parasympathomimetics | ||||
| N07AX01 | Pilocarpine | ||||
| N07AX02 | Choline alfoscerate | ||||
| N07AX03 | Cevimeline | ||||
| N07B | Drugs used in addictive disorders | ||||
| N07BA | Drugs used in nicotine dependence | ||||
| N07BA01 | Nicotine | ||||
| N07BA02 | bupropion (בוטל, קוד חדש N06AX12) | ||||
| N07BA03 | Varenicline | ||||
| N07BB | Drugs used in alcohol dependence | ||||
| N07BB01 | Disulfiram | ||||
| N07BB02 | Calcium carbimide | ||||
| N07BB03 | Acamprosate | ||||
| N07BB04 | Naltrexone | ||||
| N07BB05 | nalmefene | ||||
| N07BC | Drugs used in opioid dependence | ||||
| N07BC01 | Buprenorphine | ||||
| N07BC02 | Methadone | ||||
| N07BC03 | Levacetylmethadol | ||||
| N07BC04 | Lofexidine | ||||
| N07BC05 | Levomethadone | ||||
| N07BC06 | Diamorphine | ||||
| N07BC51 | Buprenorphine, combinations | ||||
| N07C | Antivertigo preparations | ||||
| N07CA | Antivertigo preparations | ||||
| N07CA01 | Betahistine | ||||
| N07CA02 | Cinnarizine | ||||
| N07CA03 | Flunarizine | ||||
| N07CA04 | Acetylleucine | ||||
| N07CA52 | Cinnarizine, combinations | ||||
| N07X | Other nervous system drugs | ||||
| N07XA | Gangliosides and ganglioside derivatives | ||||
| empty | |||||
| N07XX | Other nervous system drugs | ||||
| N07XX01 | Tirilazad | ||||
| N07XX02 | Riluzole | ||||
| N07XX03 | Xaliproden | ||||
| N07XX04 | Sodium oxybate | ||||
| N07XX05 | Amifampridine | ||||
| N07XX06 | Tetrabenazine | ||||
| N07XX07 | Fampridine | ||||
| N07XX08 | Tafamidis | ||||
| N07XX09 | dimethyl fumarate (בוטל, קוד חדש L04AX07) | ||||
| N07XX10 | laquinimod | ||||
| N07XX11 | pitolisant | ||||
| N07XX12 | patisiran | ||||
| N07XX13 | valbenazine | ||||
| N07XX14 | edaravone | ||||
| N07XX15 | inotersen | ||||
| N07XX16 | deutetrabenazine | ||||
| N07XX17 | arimoclomol | ||||
| N07XX18 | vutrisiran | ||||
| N07XX19 | sodium phenylbutyrate and ursodoxicoltaurine | ||||
| N07XX21 | eplontersen | ||||
| N07XX22 | tofersen | ||||
| N07XX23 | troriluzole | ||||
| N07XX59 | Dextromethorphan, combinations | ||||
| P | Antiparasitic products, insecticides and repellents | ||||
| P01 | Antiprotozoals | ||||
| P01A | Agents against amoebiasis and other protozoal diseases | ||||
| P01AA | Hydroxyquinoline derivatives | ||||
| P01AA01 | Broxyquinoline | ||||
| P01AA02 | Clioquinol | ||||
| P01AA04 | Chlorquinaldol | ||||
| P01AA05 | Tilbroquinol | ||||
| P01AA52 | Clioquinol, combinations | ||||
| P01AB | Nitroimidazole derivatives | ||||
| P01AB01 | Metronidazole | ||||
| P01AB02 | Tinidazole | ||||
| P01AB03 | Ornidazole | ||||
| P01AB04 | Azanidazole | ||||
| P01AB05 | Propenidazole | ||||
| P01AB06 | Nimorazole | ||||
| P01AB07 | Secnidazole | ||||
| P01AC | Dichloroacetamide derivatives | ||||
| P01AC01 | Diloxanide | ||||
| P01AC02 | Clefamide | ||||
| P01AC03 | Etofamide | ||||
| P01AC04 | Teclozan | ||||
| P01AR | Arsenic compounds | ||||
| P01AR01 | Arsthinol | ||||
| P01AR02 | Difetarsone | ||||
| P01AR03 | Glycobiarsol | ||||
| P01AR53 | Glycobiarsol, combinations | ||||
| P01AX | Other agents against amoebiasis and other protozoal diseases | ||||
| P01AX01 | Chiniofon | ||||
| P01AX02 | Emetine | ||||
| P01AX04 | Phanquinone | ||||
| P01AX05 | Mepacrine | ||||
| P01AX06 | Atovaquone | ||||
| P01AX07 | Trimetrexate | ||||
| P01AX08 | Tenonitrozole | ||||
| P01AX09 | Dehydroemetine | ||||
| P01AX10 | Fumagillin | ||||
| P01AX52 | Emetine, combinations | ||||
| P01B | Antimalarials | ||||
| P01BA | Aminoquinolines | ||||
| P01BA01 | Chloroquine | ||||
| P01BA02 | Hydroxychloroquine | ||||
| P01BA03 | Primaquine | ||||
| P01BA06 | Amodiaquine | ||||
| P01BB | Biguanides | ||||
| P01BB01 | Proguanil | ||||
| P01BB02 | Cycloguanil embonate | ||||
| P01BB51 | Proguanil, combinations | ||||
| P01BC | Methanolquinolines | ||||
| P01BC01 | Quinine | ||||
| P01BC02 | Mefloquine | ||||
| P01BD | Diaminopyrimidines | ||||
| P01BD01 | Pyrimethamine | ||||
| P01BD51 | Pyrimethamine, combinations | ||||
| P01BE | Artemisinin and derivatives, plain | ||||
| P01BE01 | Artemisinin | ||||
| P01BE02 | Artemether | ||||
| P01BE03 | Artesunate | ||||
| P01BE04 | Artemotil | ||||
| P01BE05 | Artenimol | ||||
| P01BE52 | artemether and lumefantrine (בוטל, קוד חדש P01BF01) | ||||
| P01BF | Artemisinin and derivatives, combinations | ||||
| P01BF01 | Artemether and lumefantrine | ||||
| P01BF02 | Artesunate and mefloquine | ||||
| P01BF03 | Artesunate and amodiaquine | ||||
| P01BF04 | Artesunate, sulphamethopyrazine and pyrimethamine | ||||
| P01BF05 | Artenimol and piperaquine | ||||
| P01BF06 | Artesunate and pyronaridine | ||||
| P01BX | Other antimalarials | ||||
| P01BX01 | Halofantrine | ||||
| P01C | Agents against leishmaniasis and trypanosomiasis | ||||
| P01CA | Nitroimidazole derivatives | ||||
| P01CA02 | Benznidazole | ||||
| P01CB | Antimony compounds | ||||
| P01CB01 | Meglumine antimonate | ||||
| P01CB02 | Sodium stibogluconate | ||||
| P01CC | Nitrofuran derivatives | ||||
| P01CC01 | Nifurtimox | ||||
| P01CC02 | Nitrofural | ||||
| P01CD | Arsenic compounds | ||||
| P01CD01 | Melarsoprol | ||||
| P01CD02 | Acetarsol | ||||
| P01CX | Other agents against leishmaniasis and trypanosomiasis | ||||
| P01CX01 | Pentamidine isethionate | ||||
| P01CX02 | Suramin sodium | ||||
| P01CX03 | Eflornithine | ||||
| P01CX04 | miltefosine | ||||
| P02 | Anthelmintics | ||||
| P02B | Antitrematodals | ||||
| P02BA | Quinoline derivatives and related substances | ||||
| P02BA01 | Praziquantel | ||||
| P02BA02 | Oxamniquine | ||||
| P02BB | Organophosphorous compounds | ||||
| P02BB01 | Metrifonate | ||||
| P02BX | Other antitrematodal agents | ||||
| P02BX01 | Bithionol | ||||
| P02BX02 | Niridazole | ||||
| P02BX03 | Stibophen | ||||
| P02BX04 | Triclabendazole | ||||
| P02C | Antinematodal agents | ||||
| P02CA | Benzimidazole derivatives | ||||
| P02CA01 | Mebendazole | ||||
| P02CA02 | Tiabendazole | ||||
| P02CA03 | Albendazole | ||||
| P02CA04 | Ciclobendazole | ||||
| P02CA05 | Flubendazole | ||||
| P02CA06 | Fenbendazole | ||||
| P02CA51 | Mebendazole, combinations | ||||
| P02CB | Piperazine and derivatives | ||||
| P02CB01 | Piperazine | ||||
| P02CB02 | Diethylcarbamazine | ||||
| P02CC | Tetrahydropyrimidine derivatives | ||||
| P02CC01 | Pyrantel | ||||
| P02CC02 | Oxantel | ||||
| P02CE | Imidazothiazole derivatives | ||||
| P02CE01 | Levamisole | ||||
| P02CF | Avermectines | ||||
| P02CF01 | Ivermectin | ||||
| P02CX | Other antinematodals | ||||
| P02CX01 | Pyrvinium | ||||
| P02CX02 | Bephenium | ||||
| P02D | Anticestodals | ||||
| P02DA | Salicylic acid derivatives | ||||
| P02DA01 | Niclosamide | ||||
| P02DX | Other anticestodals | ||||
| P02DX01 | Desaspidin | ||||
| P02DX02 | Dichlorophen | ||||
| P03 | Ectoparasiticides, including scabicides, insecticides and repellents | ||||
| P03A | Ectoparasiticides, including scabicides | ||||
| P03AA | Sulfur containing products | ||||
| P03AA01 | Dixanthogen | ||||
| P03AA02 | Potassium polysulfide | ||||
| P03AA03 | Mesulfen | ||||
| P03AA04 | Disulfiram | ||||
| P03AA05 | Thiram | ||||
| P03AA54 | Disulfiram, combinations | ||||
| P03AB | Chlorine containing products | ||||
| P03AB01 | Clofenotane | ||||
| P03AB02 | Lindane | ||||
| P03AB51 | Clofenotane, combinations | ||||
| P03AC | Pyrethrines, including synthetic compounds | ||||
| P03AC01 | Pyrethrum | ||||
| P03AC02 | Bioallethrin | ||||
| P03AC03 | Phenothrin | ||||
| P03AC04 | Permethrin | ||||
| P03AC51 | Pyrethrum, combinations | ||||
| P03AC52 | Bioallethrin, combinations | ||||
| P03AC53 | Phenothrin, combinations | ||||
| P03AC54 | Permethrin, combinations | ||||
| P03AX | Other ectoparasiticides, including scabicides | ||||
| P03AX01 | Benzyl benzoate | ||||
| P03AX02 | Copper oleinate | ||||
| P03AX03 | Malathion | ||||
| P03AX04 | Quassia | ||||
| P03AX05 | Dimeticone | ||||
| P03B | Insecticides and repellents | ||||
| P03BA | Pyrethrines | ||||
| P03BA01 | Cyfluthrin | ||||
| P03BA02 | Cypermethrin | ||||
| P03BA03 | Decamethrin | ||||
| P03BA04 | Tetramethrin | ||||
| P03BX | Other insecticides and repellents | ||||
| P03BX01 | Diethyltoluamide | ||||
| P03BX02 | Dimethylphthalate | ||||
| P03BX03 | Dibutylphthalate | ||||
| P03BX04 | Dibutylsuccinate | ||||
| P03BX05 | Dimethylcarbate | ||||
| P03BX06 | Etohexadiol | ||||
| R | Respiratory system | ||||
| R01 | Nasal preparations | ||||
| R01A | Decongestants and other nasal preparations for topical use | ||||
| R01AA | Sympathomimetics, plain | ||||
| R01AA02 | Cyclopentamine | ||||
| R01AA03 | Ephedrine | ||||
| R01AA04 | Phenylephrine | ||||
| R01AA05 | Oxymetazoline | ||||
| R01AA06 | Tetryzoline | ||||
| R01AA07 | Xylometazoline | ||||
| R01AA08 | Naphazoline | ||||
| R01AA09 | Tramazoline | ||||
| R01AA10 | Metizoline | ||||
| R01AA11 | Tuaminoheptane | ||||
| R01AA12 | Fenoxazoline | ||||
| R01AA13 | Tymazoline | ||||
| R01AA14 | Epinephrine | ||||
| R01AB | Sympathomimetics, combinations excluding corticosteroids | ||||
| R01AB01 | Phenylephrine | ||||
| R01AB02 | Naphazoline | ||||
| R01AB03 | Tetryzoline | ||||
| R01AB05 | Ephedrine | ||||
| R01AB06 | Xylometazoline | ||||
| R01AB07 | Oxymetazoline | ||||
| R01AB08 | Tuaminoheptane | ||||
| R01AC | Antiallergic agents, excluding corticosteroids | ||||
| R01AC01 | Cromoglicic acid | ||||
| R01AC02 | Levocabastine | ||||
| R01AC03 | Azelastine | ||||
| R01AC04 | Antazoline | ||||
| R01AC05 | Spaglumic acid | ||||
| R01AC06 | Thonzylamine | ||||
| R01AC07 | Nedocromil | ||||
| R01AC08 | Olopatadine | ||||
| R01AC51 | Cromoglicic acid, combinations | ||||
| R01AD | Corticosteroids | ||||
| R01AD01 | Beclometasone | ||||
| R01AD02 | Prednisolone | ||||
| R01AD03 | Dexamethasone | ||||
| R01AD04 | Flunisolide | ||||
| R01AD05 | Budesonide | ||||
| R01AD06 | Betamethasone | ||||
| R01AD07 | Tixocortol | ||||
| R01AD08 | Fluticasone | ||||
| R01AD09 | Mometasone furoate | ||||
| R01AD11 | Triamcinolone | ||||
| R01AD12 | Fluticasone furoate | ||||
| R01AD13 | Ciclesonide | ||||
| R01AD52 | Prednisolone, combinations | ||||
| R01AD53 | Dexamethasone, combinations | ||||
| R01AD57 | Tixocortol, combinations | ||||
| R01AD58 | Fluticasone, combinations | ||||
| R01AD59 | mometasone, combinations | ||||
| R01AD60 | Hydrocortisone, combinations | ||||
| R01AX | Other nasal preparations | ||||
| R01AX01 | Calcium hexamine thiocyanate | ||||
| R01AX02 | Retinol | ||||
| R01AX03 | Ipratropium bromide | ||||
| R01AX05 | Ritiometan | ||||
| R01AX06 | Mupirocin | ||||
| R01AX07 | Hexamidine | ||||
| R01AX08 | Framycetin | ||||
| R01AX09 | Hyaluronic acid | ||||
| R01AX10 | Various | ||||
| R01AX30 | Combinations | ||||
| R01B | Nasal decongestants for systemic use | ||||
| R01BA | Sympathomimetics | ||||
| R01BA01 | Phenylpropanolamine | ||||
| R01BA02 | Pseudoephedrine | ||||
| R01BA03 | Phenylephrine | ||||
| R01BA51 | Phenylpropanolamine, combinations | ||||
| R01BA52 | Pseudoephedrine, combinations | ||||
| R01BA53 | Phenylephrine, combinations | ||||
| R02 | Throat preparations | ||||
| R02A | Throat preparations | ||||
| R02AA | Antiseptics | ||||
| R02AA01 | Ambazone | ||||
| R02AA02 | Dequalinium | ||||
| R02AA03 | Dichlorobenzyl alcohol | ||||
| R02AA05 | Chlorhexidine | ||||
| R02AA06 | Cetylpyridinium | ||||
| R02AA09 | Benzethonium | ||||
| R02AA10 | Myristyl-benzalkonium | ||||
| R02AA11 | Chlorquinaldol | ||||
| R02AA12 | Hexylresorcinol | ||||
| R02AA13 | Acriflavinium chloride | ||||
| R02AA14 | Oxyquinoline | ||||
| R02AA15 | Povidone-iodine | ||||
| R02AA16 | Benzalkonium | ||||
| R02AA17 | Cetrimonium | ||||
| R02AA18 | Hexamidine | ||||
| R02AA19 | Phenol | ||||
| R02AA20 | Various | ||||
| R02AB | Antibiotics | ||||
| R02AB01 | Neomycin | ||||
| R02AB02 | Tyrothricin | ||||
| R02AB03 | Fusafungine | ||||
| R02AB04 | Bacitracin | ||||
| R02AB30 | Gramicidin | ||||
| R02AD | Anesthetics, local | ||||
| R02AD01 | Benzocaine | ||||
| R02AD02 | Lidocaine | ||||
| R02AD03 | Cocaine | ||||
| R02AD04 | Dyclonine | ||||
| R02AX | Other throat preparations | ||||
| R02AX01 | Flurbiprofen | ||||
| R02AX02 | ibuprofen | ||||
| R02AX03 | benzydamine | ||||
| R03 | Drugs for obstructive airway diseases | ||||
| R03A | Adrenergics, inhalants | ||||
| R03AA | Alpha- and beta-adrenoreceptor agonists | ||||
| R03AA01 | Epinephrine | ||||
| R03AB | Non-selective beta-adrenoreceptor agonists | ||||
| R03AB02 | Isoprenaline | ||||
| R03AB03 | Orciprenaline | ||||
| R03AC | Selective beta-2-adrenoreceptor agonists | ||||
| R03AC02 | Salbutamol | ||||
| R03AC03 | Terbutaline | ||||
| R03AC04 | Fenoterol | ||||
| R03AC05 | Rimiterol | ||||
| R03AC06 | Hexoprenaline | ||||
| R03AC07 | Isoetarine | ||||
| R03AC08 | Pirbuterol | ||||
| R03AC09 | Tretoquinol | ||||
| R03AC10 | Carbuterol | ||||
| R03AC11 | Tulobuterol | ||||
| R03AC12 | Salmeterol | ||||
| R03AC13 | Formoterol | ||||
| R03AC14 | Clenbuterol | ||||
| R03AC15 | Reproterol | ||||
| R03AC16 | Procaterol | ||||
| R03AC17 | Bitolterol | ||||
| R03AC18 | Indacaterol | ||||
| R03AH | Combinations of adrenergics | ||||
| empty | |||||
| R03AK | Adrenergics and other drugs for obstructive airway diseases | ||||
| R03AK01 | Epinephrine and other drugs for obstructive airway diseases | ||||
| R03AK02 | Isoprenaline and other drugs for obstructive airway diseases | ||||
| R03AK03 | Fenoterol and other drugs for obstructive airway diseases (בוטל, קוד חדש R03AL01) | ||||
| R03AK04 | Salbutamol and other drugs for obstructive airway diseases (בוטל, קוד חדש R03AL02) | ||||
| R03AK05 | reproterol and sodium cromoglicate | ||||
| R03AK06 | salmeterol and fluticasone | ||||
| R03AK07 | formoterol and budesonide (חלק מהסיווג הישן עבר לקוד חדש R03AK08, R03AK09) | ||||
| R03AK08 | formoterol and beclometasone | ||||
| R03AK09 | formoterol and mometasone | ||||
| R03AK10 | vilanterol and fluticasone furoate | ||||
| R03AK11 | formoterol and fluticasone | ||||
| R03AK12 | salmeterol and budesonide | ||||
| R03AK13 | salbutamol and beclometasone | ||||
| R03AK14 | indacaterol and mometasone | ||||
| R03AL | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids | ||||
| R03AL01 | fenoterol and ipratropium bromide | ||||
| R03AL02 | salbutamol and ipratropium bromide | ||||
| R03AL03 | vilanterol and umeclidinium bromide | ||||
| R03AL04 | indacaterol and glycopyrronium bromide | ||||
| R03AL05 | formoterol and aclidinium bromide | ||||
| R03AL06 | olodaterol and tiotropium bromide | ||||
| R03AL07 | formoterol and glycopyrronium bromide | ||||
| R03AL08 | vilanterol, umeclidinium bromide and fluticasone furoate | ||||
| R03AL09 | formoterol, glycopyrronium bromide and beclometasone | ||||
| R03AL10 | formoterol and tiotropium bromide | ||||
| R03AL11 | formoterol, glycopyrronium bromide and budesonide | ||||
| R03AL12 | indacaterol, glycopyrronium bromide and mometasone | ||||
| R03B | Other drugs for obstructive airway diseases, inhalants | ||||
| R03BA | Glucocorticoids | ||||
| R03BA01 | Beclometasone | ||||
| R03BA02 | Budesonide | ||||
| R03BA03 | Flunisolide | ||||
| R03BA04 | Betamethasone | ||||
| R03BA05 | Fluticasone | ||||
| R03BA06 | Triamcinolone | ||||
| R03BA07 | Mometasone | ||||
| R03BA08 | Ciclesonide | ||||
| R03BB | Anticholinergics | ||||
| R03BB01 | Ipratropium bromide | ||||
| R03BB02 | Oxitropium bromide | ||||
| R03BB03 | Stramoni preparations | ||||
| R03BB04 | Tiotropium bromide | ||||
| R03BB05 | Aclidinium bromide | ||||
| R03BB06 | Glycopyrronium bromide | ||||
| R03BC | Antiallergic agents, excluding corticosteroids | ||||
| R03BC01 | Cromoglicic acid | ||||
| R03BC03 | Nedocromil | ||||
| R03BX | Other drugs for obstructive airway diseases, inhalants | ||||
| R03BX01 | Fenspiride | ||||
| R03C | Adrenergics for systemic use | ||||
| R03CA | Alpha- and beta-adrenoreceptor agonists | ||||
| R03CA02 | Ephedrine (בוטל, קוד חדש C01CA26) | ||||
| R03CB | Non-selective beta-adrenoreceptor agonists | ||||
| R03CB01 | Isoprenaline | ||||
| R03CB02 | Methoxyphenamine | ||||
| R03CB03 | Orciprenaline | ||||
| R03CB51 | Isoprenaline, combinations | ||||
| R03CB53 | Orciprenaline, combinations | ||||
| R03CC | Selective beta-2-adrenoreceptor agonists | ||||
| R03CC02 | Salbutamol | ||||
| R03CC03 | Terbutaline | ||||
| R03CC04 | Fenoterol | ||||
| R03CC05 | Hexoprenaline | ||||
| R03CC06 | Isoetarine | ||||
| R03CC07 | Pirbuterol | ||||
| R03CC08 | Procaterol | ||||
| R03CC09 | Tretoquinol | ||||
| R03CC10 | Carbuterol | ||||
| R03CC11 | Tulobuterol | ||||
| R03CC12 | Bambuterol | ||||
| R03CC13 | Clenbuterol | ||||
| R03CC14 | Reproterol | ||||
| R03CC53 | Terbutaline, combinations | ||||
| R03CK | Adrenergics and other drugs for obstructive airway diseases | ||||
| empty | |||||
| R03D | Other systemic drugs for obstructive airway diseases | ||||
| R03DA | Xanthines | ||||
| R03DA01 | Diprophylline | ||||
| R03DA02 | Choline theophyllinate | ||||
| R03DA03 | Proxyphylline | ||||
| R03DA04 | Theophylline | ||||
| R03DA05 | Aminophylline | ||||
| R03DA06 | Etamiphylline | ||||
| R03DA07 | Theobromine | ||||
| R03DA08 | Bamifylline | ||||
| R03DA09 | Acefylline piperazine | ||||
| R03DA10 | Bufylline | ||||
| R03DA11 | Doxofylline | ||||
| R03DA20 | Combinations of xanthines | ||||
| R03DA51 | Diprophylline, combinations | ||||
| R03DA54 | Theophylline, combinations excluding psycholeptics | ||||
| R03DA55 | Aminophylline, combinations | ||||
| R03DA57 | Theobromine, combinations | ||||
| R03DA74 | Theophylline, combinations with psycholeptics | ||||
| R03DB | Xanthines and adrenergics | ||||
| R03DB01 | Diprophylline and adrenergics | ||||
| R03DB02 | Choline theophyllinate and adrenergics | ||||
| R03DB03 | Proxyphylline and adrenergics | ||||
| R03DB04 | Theophylline and adrenergics | ||||
| R03DB05 | Aminophylline and adrenergics | ||||
| R03DB06 | Etamiphylline and adrenergics | ||||
| R03DC | Leukotriene receptor antagonists | ||||
| R03DC01 | Zafirlukast | ||||
| R03DC02 | Pranlukast | ||||
| R03DC03 | Montelukast | ||||
| R03DC04 | Ibudilast | ||||
| R03DX | Other systemic drugs for obstructive airway diseases | ||||
| R03DX01 | Amlexanox | ||||
| R03DX02 | Eprozinol | ||||
| R03DX03 | Fenspiride | ||||
| R03DX05 | Omalizumab | ||||
| R03DX06 | Seratrodast | ||||
| R03DX07 | Roflumilast | ||||
| R03DX08 | Reslizumab | ||||
| R03DX09 | Mepolizumab | ||||
| R03DX10 | Benralizumab | ||||
| R03DX11 | tezepelumab | ||||
| R05 | Cough and cold preparations | ||||
| R05C | Expectorants, excluding combinations with cough suppressants | ||||
| R05CA | Expectorants | ||||
| R05CA01 | Tyloxapol | ||||
| R05CA02 | Potassium iodide | ||||
| R05CA03 | Guaifenesin | ||||
| R05CA04 | Ipecacuanha | ||||
| R05CA05 | Althea root | ||||
| R05CA06 | Senega | ||||
| R05CA07 | Antimony pentasulfide | ||||
| R05CA08 | Creosote | ||||
| R05CA09 | Guaiacolsulfonate | ||||
| R05CA10 | Combinations | ||||
| R05CA11 | Levoverbenone | ||||
| R05CA12 | Hederae helicis folium | ||||
| R05CB | Mucolytics | ||||
| R05CB01 | Acetylcysteine | ||||
| R05CB02 | Bromhexine | ||||
| R05CB03 | Carbocisteine | ||||
| R05CB04 | Eprazinone | ||||
| R05CB05 | Mesna | ||||
| R05CB06 | Ambroxol | ||||
| R05CB07 | Sobrerol | ||||
| R05CB08 | Domiodol | ||||
| R05CB09 | Letosteine | ||||
| R05CB10 | Combinations | ||||
| R05CB11 | Stepronin | ||||
| R05CB12 | Tiopronin (בוטל, קוד חדש G04BX16) | ||||
| R05CB13 | Dornase alfa (desoxyribonuclease) | ||||
| R05CB14 | Neltenexine | ||||
| R05CB15 | Erdosteine | ||||
| R05CB16 | Mannitol | ||||
| R05D | Cough suppressants, excluding combinations with expectorants | ||||
| R05DA | Opium alkaloids and derivatives | ||||
| R05DA01 | Ethylmorphine | ||||
| R05DA03 | Hydrocodone | ||||
| R05DA04 | Codeine | ||||
| R05DA05 | Opium alkaloids with morphine | ||||
| R05DA06 | Normethadone | ||||
| R05DA07 | Noscapine | ||||
| R05DA08 | Pholcodine | ||||
| R05DA09 | Dextromethorphan | ||||
| R05DA10 | Thebacon | ||||
| R05DA11 | Dimemorfan | ||||
| R05DA12 | Acetyldihydrocodeine | ||||
| R05DA20 | Combinations | ||||
| R05DB | Other cough suppressants | ||||
| R05DB01 | Benzonatate | ||||
| R05DB02 | Benproperine | ||||
| R05DB03 | Clobutinol | ||||
| R05DB04 | Isoaminile | ||||
| R05DB05 | Pentoxyverine | ||||
| R05DB07 | Oxolamine | ||||
| R05DB09 | Oxeladin | ||||
| R05DB10 | Clofedanol | ||||
| R05DB11 | Pipazetate | ||||
| R05DB12 | Bibenzonium bromide | ||||
| R05DB13 | Butamirate | ||||
| R05DB14 | Fedrilate | ||||
| R05DB15 | Zipeprol | ||||
| R05DB16 | Dibunate | ||||
| R05DB17 | Droxypropine | ||||
| R05DB18 | Prenoxdiazine | ||||
| R05DB19 | Dropropizine | ||||
| R05DB20 | Combinations | ||||
| R05DB21 | Cloperastine | ||||
| R05DB22 | Meprotixol | ||||
| R05DB23 | Piperidione | ||||
| R05DB24 | Tipepidine | ||||
| R05DB25 | Morclofone | ||||
| R05DB26 | Nepinalone | ||||
| R05DB27 | Levodropropizine | ||||
| R05DB28 | Dimethoxanate | ||||
| R05F | Cough suppressants and expectorants, combinations | ||||
| R05FA | Opium derivatives and expectorants | ||||
| R05FA01 | Opium derivatives and mucolytics | ||||
| R05FA02 | Opium derivatives and expectorants | ||||
| R05FB | Other cough suppressants and expectorants | ||||
| R05FB01 | Cough suppressants and mucolytics | ||||
| R05FB02 | Cough suppressants and expectorants | ||||
| R05X | Other cold preparations | ||||
| Empty group | |||||
| R06 | Antihistamines for systemic use | ||||
| R06A | Antihistamines for systemic use | ||||
| R06AA | Aminoalkyl ethers | ||||
| R06AA01 | Bromazine | ||||
| R06AA02 | Diphenhydramine | ||||
| R06AA04 | Clemastine | ||||
| R06AA06 | Chlorphenoxamine | ||||
| R06AA07 | Diphenylpyraline | ||||
| R06AA08 | Carbinoxamine | ||||
| R06AA09 | Doxylamine | ||||
| R06AA10 | trimethobenzamide | ||||
| R06AA11 | dimenhydrinate | ||||
| R06AA52 | Diphenhydramine, combinations | ||||
| R06AA54 | Clemastine, combinations | ||||
| R06AA56 | Chlorphenoxamine, combinations | ||||
| R06AA57 | Diphenylpyraline, combinations | ||||
| R06AA59 | Doxylamine, combinations | ||||
| R06AA61 | dimenhydrinate, combinations | ||||
| R06AB | Substituted alkylamines | ||||
| R06AB01 | Brompheniramine | ||||
| R06AB02 | Dexchlorpheniramine | ||||
| R06AB03 | Dimetindene | ||||
| R06AB04 | Chlorphenamine | ||||
| R06AB05 | Pheniramine | ||||
| R06AB06 | Dexbrompheniramine | ||||
| R06AB07 | Talastine | ||||
| R06AB51 | Brompheniramine, combinations | ||||
| R06AB52 | Dexchlorpheniramine, combinations | ||||
| R06AB54 | Chlorphenamine, combinations | ||||
| R06AB56 | Dexbrompheniramine, combinations | ||||
| R06AC | Substituted ethylene diamines | ||||
| R06AC01 | Mepyramine | ||||
| R06AC02 | Histapyrrodine | ||||
| R06AC03 | Chloropyramine | ||||
| R06AC04 | Tripelennamine | ||||
| R06AC05 | Methapyrilene | ||||
| R06AC06 | Thonzylamine | ||||
| R06AC52 | Histapyrrodine, combinations | ||||
| R06AC53 | Chloropyramine, combinations | ||||
| R06AD | Phenothiazine derivatives | ||||
| R06AD01 | Alimemazine | ||||
| R06AD02 | Promethazine | ||||
| R06AD03 | Thiethylperazine | ||||
| R06AD04 | Methdilazine | ||||
| R06AD05 | Hydroxyethylpromethazine | ||||
| R06AD06 | Thiazinam | ||||
| R06AD07 | Mequitazine | ||||
| R06AD08 | Oxomemazine | ||||
| R06AD09 | Isothipendyl | ||||
| R06AD52 | Promethazine, combinations | ||||
| R06AD55 | Hydroxyethylpromethazine, combinations | ||||
| R06AE | Piperazine derivatives | ||||
| R06AE01 | Buclizine | ||||
| R06AE03 | Cyclizine | ||||
| R06AE04 | Chlorcyclizine | ||||
| R06AE05 | Meclozine | ||||
| R06AE06 | Oxatomide | ||||
| R06AE07 | Cetirizine | ||||
| R06AE09 | Levocetirizine | ||||
| R06AE51 | Buclizine, combinations | ||||
| R06AE53 | Cyclizine, combinations | ||||
| R06AE55 | Meclozine, combinations | ||||
| R06AK | Combinations of antihistamines | ||||
| Empty group | |||||
| R06AX | Other antihistamines for systemic use | ||||
| R06AX01 | Bamipine | ||||
| R06AX02 | Cyproheptadine | ||||
| R06AX03 | Thenalidine | ||||
| R06AX04 | Phenindamine | ||||
| R06AX05 | Antazoline | ||||
| R06AX07 | Triprolidine | ||||
| R06AX08 | Pyrrobutamine | ||||
| R06AX09 | Azatadine | ||||
| R06AX11 | Astemizole | ||||
| R06AX12 | Terfenadine | ||||
| R06AX13 | Loratadine | ||||
| R06AX15 | Mebhydrolin | ||||
| R06AX16 | Deptropine | ||||
| R06AX17 | Ketotifen | ||||
| R06AX18 | Acrivastine | ||||
| R06AX19 | Azelastine | ||||
| R06AX21 | Tritoqualine | ||||
| R06AX22 | Ebastine | ||||
| R06AX23 | Pimethixene | ||||
| R06AX24 | Epinastine | ||||
| R06AX25 | Mizolastine | ||||
| R06AX26 | Fexofenadine | ||||
| R06AX27 | Desloratadine | ||||
| R06AX28 | Rupatadine | ||||
| R06AX29 | Bilastine | ||||
| R06AX31 | Quifenadine | ||||
| R06AX53 | Thenalidine, combinations | ||||
| R06AX58 | Pyrrobutamine, combinations | ||||
| R07 | Other respiratory system products | ||||
| R07A | Other respiratory system products | ||||
| R07AA | Lung surfactants | ||||
| R07AA01 | Colfosceril palmitate | ||||
| R07AA02 | Natural phospholipids | ||||
| R07AA30 | Combinations | ||||
| R07AB | Respiratory stimulants | ||||
| R07AB01 | Doxapram | ||||
| R07AB02 | Nikethamide | ||||
| R07AB03 | Pentetrazol | ||||
| R07AB04 | Etamivan | ||||
| R07AB05 | Bemegride | ||||
| R07AB06 | Prethcamide | ||||
| R07AB07 | Almitrine | ||||
| R07AB08 | Dimefline | ||||
| R07AB09 | Mepixanox | ||||
| R07AB52 | Nikethamide, combinations | ||||
| R07AB53 | Pentetrazol, combinations | ||||
| R07AX | Other respiratory system products | ||||
| R07AX01 | Nitric oxide | ||||
| R07AX02 | Ivacaftor | ||||
| R07AX30 | ivacaftor and lumacaftor | ||||
| R07AX31 | ivacaftor and tezacaftor | ||||
| R07AX32 | ivacaftor, tezacaftor and elexacaftor | ||||
| S | Sensory organs | ||||
| S01 | Ophthalmologicals | ||||
| S01A | Anti-infectives | ||||
| S01AA | Antibiotics | ||||
| S01AA01 | Chloramphenicol | ||||
| S01AA02 | Chlortetracycline | ||||
| S01AA03 | Neomycin | ||||
| S01AA04 | Oxytetracycline | ||||
| S01AA05 | Tyrothricin | ||||
| S01AA07 | Framycetin | ||||
| S01AA09 | Tetracycline | ||||
| S01AA10 | Natamycin | ||||
| S01AA11 | Gentamicin | ||||
| S01AA12 | Tobramycin | ||||
| S01AA13 | Fusidic acid | ||||
| S01AA14 | Benzylpenicillin | ||||
| S01AA15 | Dihydrostreptomycin | ||||
| S01AA16 | Rifamycin | ||||
| S01AA17 | Erythromycin | ||||
| S01AA18 | Polymyxin B | ||||
| S01AA19 | Ampicillin | ||||
| S01AA20 | Antibiotics in combination with other drugs | ||||
| S01AA21 | Amikacin | ||||
| S01AA22 | Micronomicin | ||||
| S01AA23 | Netilmicin | ||||
| S01AA24 | Kanamycin | ||||
| S01AA25 | Azidamfenicol | ||||
| S01AA26 | Azithromycin | ||||
| S01AA27 | Cefuroxime | ||||
| S01AA30 | Combinations of different antibiotics | ||||
| S01AB | Sulfonamides | ||||
| S01AB01 | Sulfamethizole | ||||
| S01AB02 | Sulfafurazole | ||||
| S01AB03 | Sulfadicramide | ||||
| S01AB04 | Sulfacetamide | ||||
| S01AB05 | Sulfafenazol | ||||
| S01AD | Antivirals | ||||
| S01AD01 | Idoxuridine | ||||
| S01AD02 | Trifluridine | ||||
| S01AD03 | Aciclovir | ||||
| S01AD05 | Interferon | ||||
| S01AD06 | Vidarabine | ||||
| S01AD07 | Famciclovir | ||||
| S01AD08 | Fomivirsen | ||||
| S01AD09 | Ganciclovir | ||||
| S01AE | Fluoroquinolones | ||||
| S01AE01 | Ofloxacin | ||||
| S01AE02 | Norfloxacin | ||||
| S01AE03 | Ciprofloxacin | ||||
| S01AE04 | Lomefloxacin | ||||
| S01AE05 | Levofloxacin | ||||
| S01AE06 | Gatifloxacin | ||||
| S01AE07 | Moxifloxacin | ||||
| S01AE08 | Besifloxacin | ||||
| S01AX | Other anti-infectives | ||||
| S01AX01 | Mercury compounds | ||||
| S01AX02 | Silver compounds | ||||
| S01AX03 | Zinc compounds | ||||
| S01AX04 | Nitrofural | ||||
| S01AX05 | Bibrocathol | ||||
| S01AX06 | Resorcinol | ||||
| S01AX07 | Sodium borate | ||||
| S01AX08 | Hexamidine | ||||
| S01AX09 | Chlorhexidine | ||||
| S01AX10 | Sodium propionate | ||||
| S01AX11 | ofloxacin (בוטל, קוד חדש S01AE01) | ||||
| S01AX12 | norfloxacin (בוטל, קוד חדש S01AE02) | ||||
| S01AX13 | ciprofloxacin (בוטל, קוד חדש S01AE03) | ||||
| S01AX14 | Dibrompropamidine | ||||
| S01AX15 | Propamidine | ||||
| S01AX16 | Picloxydine | ||||
| S01AX17 | lomefloxacin (בוטל, קוד חדש S01AE04) | ||||
| S01AX18 | Povidone-iodine | ||||
| S01AX19 | levofloxacin (בוטל, קוד חדש S01AE05) | ||||
| S01AX21 | levofloxacin (בוטל, קוד חדש S01AE06) | ||||
| S01AX22 | moxifloxacin (בוטל, קוד חדש S01AE07) | ||||
| S01AX23 | besifloxacin (בוטל, קוד חדש S01AE08) | ||||
| S01B | Anti-inflammatory agents | ||||
| S01BA | Corticosteroids, plain | ||||
| S01BA01 | Dexamethasone | ||||
| S01BA02 | Hydrocortisone | ||||
| S01BA03 | Cortisone | ||||
| S01BA04 | Prednisolone | ||||
| S01BA05 | Triamcinolone | ||||
| S01BA06 | Betamethasone | ||||
| S01BA07 | Fluorometholone | ||||
| S01BA08 | Medrysone | ||||
| S01BA09 | Clobetasone | ||||
| S01BA10 | Alclometasone | ||||
| S01BA11 | Desonide | ||||
| S01BA12 | Formocortal | ||||
| S01BA13 | Rimexolone | ||||
| S01BA14 | Loteprednol | ||||
| S01BA15 | Fluocinolone acetonide | ||||
| S01BB | Corticosteroids and mydriatics in combination | ||||
| S01BB01 | Hydrocortisone and mydriatics | ||||
| S01BB02 | Prednisolone and mydriatics | ||||
| S01BB03 | Fluorometholone and mydriatics | ||||
| S01BB04 | Betamethasone and mydriatics | ||||
| S01BC | Anti-inflammatory agents, non-steroids | ||||
| S01BC01 | Indometacin | ||||
| S01BC02 | Oxyphenbutazone | ||||
| S01BC03 | Diclofenac | ||||
| S01BC04 | Flurbiprofen | ||||
| S01BC05 | Ketorolac | ||||
| S01BC06 | Piroxicam | ||||
| S01BC07 | Bendazac | ||||
| S01BC08 | Salicylic acid | ||||
| S01BC09 | Pranoprofen | ||||
| S01BC10 | Nepafenac | ||||
| S01BC11 | Bromfenac | ||||
| S01C | Anti-inflammatory agents and anti-infectives in combination | ||||
| S01CA | Corticosteroids and anti-infectives in combination | ||||
| S01CA01 | Dexamethasone and antiinfectives | ||||
| S01CA02 | Prednisolone and antiinfectives | ||||
| S01CA03 | Hydrocortisone and antiinfectives | ||||
| S01CA04 | Fluocortolone and antiinfectives | ||||
| S01CA05 | Betamethasone and antiinfectives | ||||
| S01CA06 | Fludrocortisone and antiinfectives | ||||
| S01CA07 | Fluorometholone and antiinfectives | ||||
| S01CA08 | Methylprednisolone and antiinfectives | ||||
| S01CA09 | Chloroprednisone and antiinfectives | ||||
| S01CA10 | Fluocinolone acetonide and antiinfectives | ||||
| S01CA11 | Clobetasone and antiinfectives | ||||
| S01CB | Corticosteroids/anti-infectives/mydriatics in combination | ||||
| S01CB01 | Dexamethasone | ||||
| S01CB02 | Prednisolone | ||||
| S01CB03 | Hydrocortisone | ||||
| S01CB04 | Betamethasone | ||||
| S01CB05 | Fluorometholone | ||||
| S01CC | Anti-inflammatory agents, non-steroids and anti-infectives in combination | ||||
| S01CC01 | Diclofenac and antiinfectives | ||||
| S01E | Antiglaucoma preparations and miotics | ||||
| S01EA | Sympathomimetics in glaucoma therapy | ||||
| S01EA01 | Epinephrine | ||||
| S01EA02 | Dipivefrine | ||||
| S01EA03 | Apraclonidine | ||||
| S01EA04 | Clonidine | ||||
| S01EA05 | Brimonidine | ||||
| S01EA51 | Epinephrine, combinations | ||||
| S01EB | Parasympathomimetics | ||||
| S01EB01 | Pilocarpine | ||||
| S01EB02 | Carbachol | ||||
| S01EB03 | Ecothiopate | ||||
| S01EB04 | Demecarium | ||||
| S01EB05 | Physostigmine | ||||
| S01EB06 | Neostigmine | ||||
| S01EB07 | Fluostigmine | ||||
| S01EB08 | Aceclidine | ||||
| S01EB09 | Acetylcholine | ||||
| S01EB10 | Paraoxon | ||||
| S01EB51 | Pilocarpine, combinations | ||||
| S01EB58 | Aceclidine, combinations | ||||
| S01EC | Carbonic anhydrase inhibitors | ||||
| S01EC01 | Acetazolamide | ||||
| S01EC02 | Diclofenamide | ||||
| S01EC03 | Dorzolamide | ||||
| S01EC04 | Brinzolamide | ||||
| S01EC05 | Methazolamide | ||||
| S01ED | Beta blocking agents | ||||
| S01ED01 | Timolol | ||||
| S01ED02 | Betaxolol | ||||
| S01ED03 | Levobunolol | ||||
| S01ED04 | Metipranolol | ||||
| S01ED05 | Carteolol | ||||
| S01ED06 | Befunolol | ||||
| S01ED51 | Timolol, combinations | ||||
| S01ED52 | Betaxolol, combinations | ||||
| S01ED54 | Metipranolol, combinations | ||||
| S01ED55 | Carteolol, combinations | ||||
| S01EE | Prostaglandin analogues | ||||
| S01EE01 | Latanoprost | ||||
| S01EE02 | Unoprostone | ||||
| S01EE03 | Bimatoprost | ||||
| S01EE04 | Travoprost | ||||
| S01EE05 | Tafluprost | ||||
| S01EE06 | latanoprostene bunod | ||||
| S01EE51 | latanoprost and netarsudil | ||||
| S01EX | Other antiglaucoma preparations | ||||
| S01EX01 | Guanethidine | ||||
| S01EX02 | Dapiprazole | ||||
| S01F | Mydriatics and cycloplegics | ||||
| S01FA | Anticholinergics | ||||
| S01FA01 | Atropine | ||||
| S01FA02 | Scopolamine | ||||
| S01FA03 | Methylscopolamine | ||||
| S01FA04 | Cyclopentolate | ||||
| S01FA05 | Homatropine | ||||
| S01FA06 | Tropicamide | ||||
| S01FA56 | Tropicamide, combinations | ||||
| S01FB | Sympathomimetics excluding antiglaucoma preparations | ||||
| S01FB01 | Phenylephrine | ||||
| S01FB02 | Ephedrine | ||||
| S01FB03 | Ibopamine | ||||
| S01G | Decongestants and antiallergics | ||||
| S01GA | Sympathomimetics used as decongestants | ||||
| S01GA01 | Naphazoline | ||||
| S01GA02 | Tetryzoline | ||||
| S01GA03 | Xylometazoline | ||||
| S01GA04 | Oxymetazoline | ||||
| S01GA05 | Phenylephrine | ||||
| S01GA06 | Oxedrine | ||||
| S01GA51 | Naphazoline, combinations | ||||
| S01GA52 | Tetryzoline, combinations | ||||
| S01GA53 | Xylometazoline, combinations | ||||
| S01GA55 | Phenylephrine, combinations | ||||
| S01GA56 | Oxedrine, combinations | ||||
| S01GX | Other antiallergics | ||||
| S01GX01 | Cromoglicic acid | ||||
| S01GX02 | Levocabastine | ||||
| S01GX03 | Spaglumic acid | ||||
| S01GX04 | Nedocromil | ||||
| S01GX05 | Lodoxamide | ||||
| S01GX06 | Emedastine | ||||
| S01GX07 | Azelastine | ||||
| S01GX08 | Ketotifen | ||||
| S01GX09 | Olopatadine | ||||
| S01GX10 | Epinastine | ||||
| S01GX11 | Alcaftadine | ||||
| S01GX51 | Cromoglicic acid, combinations | ||||
| S01H | Local anesthetics | ||||
| S01HA | Local anesthetics | ||||
| S01HA01 | Cocaine | ||||
| S01HA02 | Oxybuprocaine | ||||
| S01HA03 | Tetracaine | ||||
| S01HA04 | Proxymetacaine | ||||
| S01HA05 | Procaine | ||||
| S01HA06 | Cinchocaine | ||||
| S01HA07 | Lidocaine | ||||
| S01HA30 | Combinations | ||||
| S01J | Diagnostic agents | ||||
| S01JA | Colouring agents | ||||
| S01JA01 | Fluorescein | ||||
| S01JA02 | Rose bengal sodium | ||||
| S01JA51 | Fluorescein, combinations | ||||
| S01JX | Other ophthalmological diagnostic agents | ||||
| empty | |||||
| S01K | Surgical aids | ||||
| S01KA | Viscoelastic substances | ||||
| S01KA01 | Hyaluronic acid | ||||
| S01KA02 | Hypromellose | ||||
| S01KA51 | Hyaluronic acid, combinations | ||||
| S01KX | Other surgical aids | ||||
| S01KX01 | Chymotrypsin | ||||
| S01L | Ocular vascular disorder agents | ||||
| S01LA | Antineovascularisation agents | ||||
| S01LA01 | Verteporfin | ||||
| S01LA02 | Anecortave | ||||
| S01LA03 | Pegaptanib | ||||
| S01LA04 | Ranibizumab | ||||
| S01LA05 | Aflibercept | ||||
| S01LA06 | brolucizumab | ||||
| S01LA07 | abicipar pegol | ||||
| S01LA08 | bevacizumab | ||||
| S01LA09 | faricimab | ||||
| S01X | Other ophthalmologicals | ||||
| S01XA | Other ophthalmologicals | ||||
| S01XA01 | Guaiazulene | ||||
| S01XA02 | Retinol | ||||
| S01XA03 | Sodium chloride, hypertonic | ||||
| S01XA04 | Potassium iodide | ||||
| S01XA05 | Sodium edetate | ||||
| S01XA06 | Ethylmorphine | ||||
| S01XA07 | Alum | ||||
| S01XA08 | Acetylcysteine | ||||
| S01XA09 | Iodoheparinate | ||||
| S01XA10 | Inosine | ||||
| S01XA11 | Nandrolone | ||||
| S01XA12 | Dexpanthenol | ||||
| S01XA13 | Alteplase | ||||
| S01XA14 | Heparin | ||||
| S01XA15 | Ascorbic acid | ||||
| S01XA16 | anecortave (New ATC code S01LA02) | ||||
| S01XA17 | pegaptanib (New ATC code S01LA03) | ||||
| S01XA18 | Ciclosporin | ||||
| S01XA19 | Limbal stem cells, autologous | ||||
| S01XA20 | Artificial tears and other indifferent preparations | ||||
| S01XA21 | mercaptamine | ||||
| S01XA22 | ocriplasmin | ||||
| S01XA23 | sirolimus | ||||
| S01XA24 | cenegermin | ||||
| S01XA25 | lifitegrast | ||||
| S01XA26 | riboflavin | ||||
| S01XA27 | voretigene neparvovec | ||||
| S01XA28 | varenicline | ||||
| S01XA29 | sepofarsen | ||||
| S01XA31 | pegcetacoplan | ||||
| S01XA32 | avacincaptad pegol | ||||
| S02 | Otologicals | ||||
| S02A | Anti-infectives | ||||
| S02AA | Anti-infectives | ||||
| S02AA01 | Chloramphenicol | ||||
| S02AA02 | Nitrofural | ||||
| S02AA03 | Boric acid | ||||
| S02AA04 | Aluminium acetotartrate | ||||
| S02AA05 | Clioquinol | ||||
| S02AA06 | Hydrogen peroxide | ||||
| S02AA07 | Neomycin | ||||
| S02AA08 | Tetracycline | ||||
| S02AA09 | Chlorhexidine | ||||
| S02AA10 | Acetic acid | ||||
| S02AA11 | Polymyxin B | ||||
| S02AA12 | Rifamycin | ||||
| S02AA13 | Miconazole | ||||
| S02AA14 | Gentamicin | ||||
| S02AA15 | Ciprofloxacin | ||||
| S02AA16 | Ofloxacin | ||||
| S02AA30 | Antiinfectives, combinations | ||||
| S02B | Corticosteroids | ||||
| S02BA | Corticosteroids | ||||
| S02BA01 | Hydrocortisone | ||||
| S02BA03 | Prednisolone | ||||
| S02BA06 | Dexamethasone | ||||
| S02BA07 | Betamethasone | ||||
| S02BA08 | Fluocinolone acetonide | ||||
| S02C | Corticosteroids and anti-infectives in combination | ||||
| S02CA | Corticosteroids and anti-infectives in combination | ||||
| S02CA01 | Prednisolone and antiinfectives | ||||
| S02CA02 | Flumetasone and antiinfectives | ||||
| S02CA03 | Hydrocortisone and antiinfectives | ||||
| S02CA04 | Triamcinolone and antiinfectives | ||||
| S02CA05 | Fluocinolone acetonide and antiinfectives | ||||
| S02CA06 | Dexamethasone and antiinfectives | ||||
| S02CA07 | Fludrocortisone and antiinfectives | ||||
| S02D | Other otologicals | ||||
| S02DA | Analgesics and anesthetics | ||||
| S02DA01 | Lidocaine | ||||
| S02DA02 | Cocaine | ||||
| S02DA03 | Phenazone | ||||
| S02DA04 | Cinchocaine | ||||
| S02DA30 | Combinations | ||||
| S02DC | Indifferent preparations | ||||
| Empty group | |||||
| S03 | Ophthalmological and otological preparations | ||||
| S03A | Anti-infectives | ||||
| S03AA | Anti-infectives | ||||
| S03AA01 | Neomycin | ||||
| S03AA02 | Tetracycline | ||||
| S03AA03 | Polymyxin B | ||||
| S03AA04 | Chlorhexidine | ||||
| S03AA05 | Hexamidine | ||||
| S03AA06 | Gentamicin | ||||
| S03AA07 | Ciprofloxacin | ||||
| S03AA08 | Chloramphenicol | ||||
| S03AA30 | Antiinfectives, combinations | ||||
| S03B | Corticosteroids | ||||
| S03BA | Corticosteroids | ||||
| S03BA01 | Dexamethasone | ||||
| S03BA02 | Prednisolone | ||||
| S03BA03 | Betamethasone | ||||
| S03C | Corticosteroids and anti-infectives in combination | ||||
| S03CA | Corticosteroids and anti-infectives in combination | ||||
| S03CA01 | Dexamethasone and antiinfectives | ||||
| S03CA02 | Prednisolone and antiinfectives | ||||
| S03CA04 | Hydrocortisone and antiinfectives | ||||
| S03CA05 | Fludrocortisone and antiinfectives | ||||
| S03CA06 | Betamethasone and antiinfectives | ||||
| S03D | Other ophthalmological and otological preparations | ||||
| Empty group | |||||
| V | Various | ||||
| V01 | Allergens | ||||
| V01A | Allergens | ||||
| V01AA | Allergen extracts | ||||
| V01AA01 | Feather | ||||
| V01AA02 | Grass pollen | ||||
| V01AA03 | House dust mites | ||||
| V01AA04 | Mould fungus and yeast fungus | ||||
| V01AA05 | Tree pollen | ||||
| V01AA07 | Insects | ||||
| V01AA08 | Food | ||||
| V01AA09 | Textiles | ||||
| V01AA10 | Flowers | ||||
| V01AA11 | Animals | ||||
| V01AA20 | Various | ||||
| V03 | All other therapeutic products | ||||
| V03A | All other therapeutic products | ||||
| V03AB | Antidotes | ||||
| V03AB01 | Ipecacuanha | ||||
| V03AB02 | Nalorphine | ||||
| V03AB03 | Edetates | ||||
| V03AB04 | Pralidoxime | ||||
| V03AB05 | Prednisolone and promethazine | ||||
| V03AB06 | Thiosulfate | ||||
| V03AB08 | Sodium nitrite | ||||
| V03AB09 | Dimercaprol | ||||
| V03AB13 | Obidoxime | ||||
| V03AB14 | Protamine | ||||
| V03AB15 | Naloxone | ||||
| V03AB16 | Ethanol | ||||
| V03AB17 | Methylthioninium chloride | ||||
| V03AB18 | Potassium permanganate | ||||
| V03AB19 | Physostigmine | ||||
| V03AB20 | Copper sulfate | ||||
| V03AB21 | Potassium iodide | ||||
| V03AB22 | Amyl nitrite | ||||
| V03AB23 | Acetylcysteine | ||||
| V03AB24 | Digitalis antitoxin | ||||
| V03AB25 | Flumazenil | ||||
| V03AB26 | Methionine | ||||
| V03AB27 | 4-dimethylaminophenol | ||||
| V03AB29 | Cholinesterase | ||||
| V03AB31 | Prussian blue | ||||
| V03AB32 | Glutathione | ||||
| V03AB33 | Hydroxocobalamin | ||||
| V03AB34 | Fomepizole | ||||
| V03AB35 | Sugammadex | ||||
| V03AB36 | Phentolamine | ||||
| V03AB37 | idarucizumab | ||||
| V03AB38 | andexanet alfa | ||||
| V03AC | Iron chelating agents | ||||
| V03AC01 | Deferoxamine | ||||
| V03AC02 | Deferiprone | ||||
| V03AC03 | Deferasirox | ||||
| V03AE | Drugs for treatment of hyperkalemia and hyperphosphatemia | ||||
| V03AE01 | Polystyrene sulfonate | ||||
| V03AE02 | Sevelamer | ||||
| V03AE03 | Lanthanum carbonate | ||||
| V03AE04 | Calcium acetate and magnesium carbonate | ||||
| V03AE05 | sucroferric oxyhydroxide | ||||
| V03AE06 | colestilan | ||||
| V03AE07 | calcium acetate | ||||
| V03AE08 | ferric citrate | ||||
| V03AE09 | patiromer calcium | ||||
| V03AE10 | patiromer calcium | ||||
| V03AF | Detoxifying agents for antineoplastic treatment | ||||
| V03AF01 | Mesna | ||||
| V03AF02 | Dexrazoxane | ||||
| V03AF03 | Calcium folinate | ||||
| V03AF04 | Calcium levofolinate | ||||
| V03AF05 | Amifostine | ||||
| V03AF06 | Sodium folinate | ||||
| V03AF07 | Rasburicase | ||||
| V03AF08 | Palifermin | ||||
| V03AF09 | Glucarpidase | ||||
| V03AF10 | Sodium levofolinate | ||||
| V03AF11 | arginine and lysine | ||||
| V03AG | Drugs for treatment of hypercalcemia | ||||
| V03AG01 | Sodium cellulose phosphate | ||||
| V03AH | Drugs for treatment of hypoglycaemia | ||||
| V03AH01 | Diazoxide | ||||
| V03AK | Tissue adhesives | ||||
| empty | |||||
| V03AM | Drugs for embolisation | ||||
| empty | |||||
| V03AN | Medical gases | ||||
| V03AN01 | Oxygen | ||||
| V03AN02 | Carbon dioxide | ||||
| V03AN03 | Helium | ||||
| V03AN04 | Nitrogen | ||||
| V03AN05 | Medical air | ||||
| V03AX | Other therapeutic products | ||||
| V03AX02 | Nalfurafine | ||||
| V03AX03 | Cobicistat | ||||
| V03AX04 | difelikefalin | ||||
| V03AZ | Nerve depressants | ||||
| V03AZ01 | Ethanol | ||||
| V04 | Diagnostic agents | ||||
| V04B | Urine tests | ||||
| Empty group | |||||
| V04C | Other diagnostic agents | ||||
| V04CA | Tests for diabetes | ||||
| V04CA01 | Tolbutamide | ||||
| V04CA02 | Glucose | ||||
| V04CB | Tests for fat absorption | ||||
| V04CB01 | Vitamin A concentrates | ||||
| V04CC | Tests for bile duct patency | ||||
| V04CC01 | Sorbitol | ||||
| V04CC02 | Magnesium sulfate | ||||
| V04CC03 | Sincalide | ||||
| V04CC04 | Ceruletide | ||||
| V04CD | Tests for pituitary function | ||||
| V04CD01 | Metyrapone | ||||
| V04CD03 | Sermorelin | ||||
| V04CD04 | Corticorelin | ||||
| V04CD05 | Somatorelin | ||||
| V04CE | Tests for liver functional capacity | ||||
| V04CE01 | Galactose | ||||
| V04CE02 | Sulfobromophthalein | ||||
| V04CF | Tuberculosis diagnostics | ||||
| V04CF01 | Tuberculin | ||||
| V04CG | Tests for gastric secretion | ||||
| V04CG01 | Cation exchange resins | ||||
| V04CG02 | Betazole | ||||
| V04CG03 | Histamine phosphate | ||||
| V04CG04 | Pentagastrin | ||||
| V04CG05 | Methylthioninium chloride | ||||
| V04CG30 | Caffeine and sodium benzoate | ||||
| V04CH | Tests for renal function and ureteral injuries | ||||
| V04CH01 | Inulin and other polyfructosans | ||||
| V04CH02 | Indigo carmine | ||||
| V04CH03 | Phenolsulfonphthalein | ||||
| V04CH04 | Alsactide | ||||
| V04CH30 | Aminohippuric acid | ||||
| V04CJ | Tests for thyreoidea function | ||||
| V04CJ01 | Thyrotropin | ||||
| V04CJ02 | Protirelin | ||||
| V04CK | Tests for pancreatic function | ||||
| V04CK01 | Secretin | ||||
| V04CK02 | Pancreozymin (cholecystokinin) | ||||
| V04CK03 | Bentiromide | ||||
| V04CL | Tests for allergic diseases | ||||
| Empty group | |||||
| V04CM | Tests for fertility disturbances | ||||
| V04CM01 | Gonadorelin | ||||
| V04CX | Other diagnostic agents | ||||
| V04CX01 | indocyanine green | ||||
| V04CX02 | folic acid | ||||
| V04CX03 | methacholine | ||||
| V04CX04 | mannitol | ||||
| V04CX05 | 13C-urea | ||||
| V04CX06 | hexaminolevulinate | ||||
| V04CX07 | edrophonium | ||||
| V04CX08 | carbon monoxide | ||||
| V04CX09 | patent blue | ||||
| V04CX10 | pafolacianine | ||||
| V04CX11 | lithium chloride | ||||
| V06 | General nutrients | ||||
| V06A | Diet formulations for treatment of obesity | ||||
| V06AA | Low-energy diets | ||||
| Empty group | |||||
| V06B | Protein supplements | ||||
| Empty group | |||||
| V06C | Infant formulas | ||||
| V06CA | Nutrients without phenylalanine | ||||
| Empty group | |||||
| V06D | Other nutrients | ||||
| V06DA | Carbohydrates/proteins/minerals/vitamins, combinations | ||||
| Empty group | |||||
| V06DB | Fat/carbohydrates/proteins/minerals/vitamins, combinations | ||||
| Empty group | |||||
| V06DC | Carbohydrates | ||||
| V06DC01 | Glucose | ||||
| V06DC02 | Fructose | ||||
| V06DD | Amino acids, including combinations with polypeptides | ||||
| Empty group | |||||
| V06DE | Amino acids/carbohydrates/minerals/vitamins, combinations | ||||
| Empty group | |||||
| V06DF | Milk substitutes | ||||
| Empty group | |||||
| V06DX | Other combinations of nutrients | ||||
| Empty group | |||||
| V07 | All other non-therapeutic products | ||||
| V07A | All other non-therapeutic products | ||||
| V07AA | Plasters | ||||
| Empty group | |||||
| V07AB | Solvents and diluting agents, including irrigating solutions | ||||
| Empty group | |||||
| V07AC | Blood transfusion, auxiliary products | ||||
| Empty group | |||||
| V07AD | Blood tests, auxiliary products | ||||
| Empty group | |||||
| V07AN | Incontinence equipment | ||||
| Empty group | |||||
| V07AR | Sensitivity tests, discs and tablets | ||||
| Empty group | |||||
| V07AS | Stoma equipment | ||||
| Empty group | |||||
| V07AT | Cosmetics | ||||
| Empty group | |||||
| V07AV | Technical disinfectants | ||||
| Empty group | |||||
| V07AX | Washing agents etc. | ||||
| Empty group | |||||
| V07AY | Other non-therapeutic auxiliary products | ||||
| Empty group | |||||
| V07AZ | Chemicals and reagents for analysis | ||||
| V08 | Contrast media | ||||
| V08A | X-ray contrast media, iodinated | ||||
| V08AA | Water-soluble, nephrotropic, high osmolar X-ray contrast media | ||||
| V08AA01 | Diatrizoic acid | ||||
| V08AA02 | Metrizoic acid | ||||
| V08AA03 | Iodamide | ||||
| V08AA04 | Iotalamic acid | ||||
| V08AA05 | Ioxitalamic acid | ||||
| V08AA06 | Ioglicic acid | ||||
| V08AA07 | Acetrizoic acid | ||||
| V08AA08 | Iocarmic acid | ||||
| V08AA09 | Methiodal | ||||
| V08AA10 | Diodone | ||||
| V08AB | Water-soluble, nephrotropic, low osmolar X-ray contrast media | ||||
| V08AB01 | Metrizamide | ||||
| V08AB02 | Iohexol | ||||
| V08AB03 | Ioxaglic acid | ||||
| V08AB04 | Iopamidol | ||||
| V08AB05 | Iopromide | ||||
| V08AB06 | Iotrolan | ||||
| V08AB07 | Ioversol | ||||
| V08AB08 | Iopentol | ||||
| V08AB09 | Iodixanol | ||||
| V08AB10 | Iomeprol | ||||
| V08AB11 | Iobitridol | ||||
| V08AB12 | Ioxilan | ||||
| V08AC | Water-soluble, hepatotropic X-ray contrast media | ||||
| V08AC01 | Iodoxamic acid | ||||
| V08AC02 | Iotroxic acid | ||||
| V08AC03 | Ioglycamic acid | ||||
| V08AC04 | Adipiodone | ||||
| V08AC05 | Iobenzamic acid | ||||
| V08AC06 | Iopanoic acid | ||||
| V08AC07 | Iocetamic acid | ||||
| V08AC08 | Sodium iopodate | ||||
| V08AC09 | Tyropanoic acid | ||||
| V08AC10 | Calcium iopodate | ||||
| V08AD | Non-watersoluble X-ray contrast media | ||||
| V08AD01 | Ethyl esters of iodised fatty acids | ||||
| V08AD02 | Iopydol | ||||
| V08AD03 | Propyliodone | ||||
| V08AD04 | Iofendylate | ||||
| V08B | X-ray contrast media, non-iodinated | ||||
| V08BA | Barium sulfate containing X-ray contrast media | ||||
| V08BA01 | Barium sulfate with suspending agents | ||||
| V08BA02 | Barium sulfate without suspending agents | ||||
| V08C | Magnetic resonance imaging contrast media | ||||
| V08CA | Paramagnetic contrast media | ||||
| V08CA01 | Gadopentetic acid | ||||
| V08CA02 | Gadoteric acid | ||||
| V08CA03 | Gadodiamide | ||||
| V08CA04 | Gadoteridol | ||||
| V08CA05 | Mangafodipir | ||||
| V08CA06 | Gadoversetamide | ||||
| V08CA07 | Ferric ammonium citrate | ||||
| V08CA08 | Gadobenic acid | ||||
| V08CA09 | Gadobutrol | ||||
| V08CA10 | Gadoxetic acid | ||||
| V08CA11 | Gadofosveset | ||||
| V08CB | Superparamagnetic contrast media | ||||
| V08CB01 | Ferumoxsil | ||||
| V08CB02 | Ferristene | ||||
| V08CB03 | Iron oxide, nanoparticles | ||||
| V08CX | Other magnetic resonance imaging contrast media | ||||
| V08CX01 | Perflubron | ||||
| V08D | Ultrasound contrast media | ||||
| V08DA | Ultrasound contrast media | ||||
| V08DA01 | perflutren, human albumin microspheres | ||||
| V08DA02 | microparticles of galactose | ||||
| V08DA03 | Perflenapent | ||||
| V08DA04 | perflutren, phospholipid microspheres | ||||
| V08DA05 | sulfur hexafluoride, phospholipid microspheres | ||||
| V08DA06 | perflubutane, phospholipid microspheres | ||||
| V09 | Diagnostic radiopharmaceuticals | ||||
| V09A | Central nervous system | ||||
| V09AA | Technetium (99mTc) compounds | ||||
| V09AA01 | Technetium (99mTc) exametazime | ||||
| V09AA02 | Technetium (99mTc) bicisate | ||||
| V09AB | Iodine (123I) compounds | ||||
| V09AB01 | Iodine iofetamine (123I) | ||||
| V09AB02 | Iodine iolopride (123I) | ||||
| V09AB03 | Iodine ioflupane (123I) | ||||
| V09AX | Other central nervous system diagnostic radiopharmaceuticals | ||||
| V09AX01 | Indium (111In) pentetic acid | ||||
| V09AX02 | fludeoxyglucose (בוטל, קוד חדש V09IX04) | ||||
| V09AX03 | Iodine (124I) 2β-carbomethoxy-3β-(4-iodophenyl)-tropane | ||||
| V09AX04 | Flutemetamol (18F) | ||||
| V09AX05 | Florbetapir (18F) | ||||
| V09B | Skeleton | ||||
| V09BA | Technetium (99mTc) compounds | ||||
| V09BA01 | Technetium (99mTc) oxidronic acid | ||||
| V09BA02 | Technetium (99mTc) medronic acid | ||||
| V09BA03 | Technetium (99mTc) pyrophosphate | ||||
| V09BA04 | Technetium (99mTc) butedronic acid | ||||
| V09C | Renal system | ||||
| V09CA | Technetium (99mTc) compounds | ||||
| V09CA01 | Technetium (99mTc) pentetic acid | ||||
| V09CA02 | Technetium (99mTc) succimer | ||||
| V09CA03 | Technetium (99mTc) mertiatide | ||||
| V09CA04 | Technetium (99mTc) gluceptate | ||||
| V09CA05 | Technetium (99mTc) gluconate | ||||
| V09CA06 | Technetium (99mTc) ethylenedicysteine | ||||
| V09CX | Other renal system diagnostic radiopharmaceuticals | ||||
| V09CX01 | Sodium iodohippurate (123I) | ||||
| V09CX02 | Sodium iodohippurate (131I) | ||||
| V09CX03 | Sodium iothalamate (125I) | ||||
| V09CX04 | Chromium (51Cr) edetate | ||||
| V09D | Hepatic and reticulo endothelial system | ||||
| V09DA | Technetium (99mTc) compounds | ||||
| V09DA01 | Technetium (99mTc) disofenin | ||||
| V09DA02 | Technetium (99mTc) etifenin | ||||
| V09DA03 | Technetium (99mTc) lidofenin | ||||
| V09DA04 | Technetium (99mTc) mebrofenin | ||||
| V09DA05 | Technetium (99mTc) galtifenin | ||||
| V09DB | Technetium (99mTc), particles and colloids | ||||
| V09DB01 | Technetium (99mTc) nanocolloid | ||||
| V09DB02 | Technetium (99mTc) microcolloid | ||||
| V09DB03 | Technetium (99mTc) millimicrospheres | ||||
| V09DB04 | Technetium (99mTc) tin colloid | ||||
| V09DB05 | Technetium (99mTc) sulfur colloid | ||||
| V09DB06 | Technetium (99mTc) rheniumsulfide colloid | ||||
| V09DB07 | Technetium (99mTc) phytate | ||||
| V09DX | Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals | ||||
| V09DX01 | Selenium (75Se) tauroselcholic acid | ||||
| V09E | Respiratory system | ||||
| V09EA | Technetium (99mTc) inhalants | ||||
| V09EA01 | Technetium (99mTc) pentetic acid | ||||
| V09EA02 | Technetium (99mTc) technegas | ||||
| V09EA03 | Technetium (99mTc) nanocolloid | ||||
| V09EB | Technetium (99mTc) particles for injection | ||||
| V09EB01 | Technetium (99mTc) macrosalb | ||||
| V09EB02 | Technetium (99mTc) microspheres | ||||
| V09EX | Other respiratory system diagnostic radiopharmaceuticals | ||||
| V09EX01 | Krypton (81mKr) gas | ||||
| V09EX02 | Xenon (127Xe) gas | ||||
| V09EX03 | Xenon (133Xe) gas | ||||
| V09F | Thyroid | ||||
|
V09FX |
Various thyroid diagnostic radiopharmaceuticals | ||||
| V09FX01 | Technetium (99mTc) pertechnetate | ||||
| V09FX02 | Sodium iodide (123I) | ||||
| V09FX03 | Sodium iodide (131I) | ||||
| V09FX04 | Sodium iodide (124I) | ||||
| V09G | Cardiovascular system | ||||
| V09GA | Technetium (99mTc) compounds | ||||
| V09GA01 | Technetium (99mTc) sestamibi | ||||
| V09GA02 | Technetium (99mTc) tetrofosmin | ||||
| V09GA03 | Technetium (99mTc) teboroxime | ||||
| V09GA04 | Technetium (99mTc) human albumin | ||||
| V09GA05 | Technetium (99mTc) furifosmin | ||||
| V09GA06 | Technetium (99mTc) stannous agent labelled cells | ||||
| V09GA07 | Technetium (99mTc) apcitide | ||||
| V09GB | Iodine (125I) compounds | ||||
| V09GB01 | Fibrinogen (125I) | ||||
| V09GB02 | Iodine (125I) human albumin | ||||
| V09GX | Other cardiovascular system diagnostic radiopharmaceuticals | ||||
| V09GX01 | Thallium (201Tl) chloride | ||||
| V09GX02 | Indium (111In) imciromab | ||||
| V09GX03 | Chromium (51Cr) chromate labelled cells | ||||
| V09GX04 | Rubidium (82Rb) chloride | ||||
| V09H | Inflammation and infection detection | ||||
| V09HA | Technetium (99mTc) compounds | ||||
| V09HA01 | Technetium (99mTc) human immunoglobulin | ||||
| V09HA02 | Technetium (99mTc) exametazime labelled cells | ||||
| V09HA03 | Technetium (99mTc) antigranulocyte antibody | ||||
| V09HA04 | Technetium (99mTc) sulesomab | ||||
| V09HB | Indium (111In) compounds | ||||
| V09HB01 | Indium (111In) oxinate labelled cells | ||||
| V09HB02 | Indium (111In) tropolonate labelled cells | ||||
| V09HX | Other diagnostic radiopharmaceuticals for inflammation and infection detection | ||||
| V09HX01 | Gallium (67Ga) citrate | ||||
| V09I | Tumour detection | ||||
| V09IA | Technetium (99mTc) compounds | ||||
| V09IA01 | Technetium (99mTc) antiCarcinoEmbryonicAntigen antibody | ||||
| V09IA02 | Technetium (99mTc) antimelanoma antibody | ||||
| V09IA03 | Technetium (99mTc) pentavalent succimer | ||||
| V09IA04 | Technetium (99mTc) votumumab | ||||
| V09IA05 | Technetium (99mTc) depreotide | ||||
| V09IA06 | Technetium (99mTc) arcitumomab | ||||
| V09IA07 | Technetium (99mTc) hynic-octreotide | ||||
| V09IB | Indium (111In) compounds | ||||
| V09IB01 | Indium (111In) pentetreotide | ||||
| V09IB02 | Indium (111In) satumomab pendetide | ||||
| V09IB03 | Indium (111In) antiovariumcarcinoma antibody | ||||
| V09IB04 | Indium (111In) capromab pendetide | ||||
| V09IX | Other diagnostic radiopharmaceuticals for tumour detection | ||||
| V09IX01 | Iobenguane (123I) | ||||
| V09IX02 | Iobenguane (131I) | ||||
| V09IX03 | Iodine (125I) CC49-monoclonal antibody | ||||
| V09IX04 | Fludeoxyglucose (18F) | ||||
| V09IX05 | Fluorodopa (18F) | ||||
| V09IX06 | Sodium fluoride (18F) | ||||
| V09IX07 | Fluoromethylcholine (18F) | ||||
| V09IX08 | Fluoroethylcholine (18F) | ||||
| V09X | Other diagnostic radiopharmaceuticals | ||||
| V09XA | Iodine (131I) compounds | ||||
| V09XA01 | Iodine (131I) norcholesterol | ||||
| V09XA02 | Iodocholesterol (131I) | ||||
| V09XA03 | Iodine (131I) human albumin | ||||
| V09XX | Various diagnostic radiopharmaceuticals | ||||
| V09XX01 | Cobalt (57Co) cyanocobalamine | ||||
| V09XX02 | Cobalt (58Co) cyanocobalamine | ||||
| V09XX03 | Selenium (75Se) norcholesterol | ||||
| V09XX04 | Ferric (59Fe) citrate | ||||
| V10 | Therapeutic radiopharmaceuticals | ||||
| V10A | Anti-inflammatory agents | ||||
| V10AA | Yttrium (90Y) compounds | ||||
| V10AA01 | Yttrium (90Y) citrate colloid | ||||
| V10AA02 | Yttrium (90Y) ferrihydroxide colloid | ||||
| V10AA03 | Yttrium (90Y) silicate colloid | ||||
| V10AX | Other anti-inflammatory therapeutic radiopharmaceuticals | ||||
| V10AX01 | Phosphorus (32P) chromicphosphate colloid | ||||
| V10AX02 | Samarium (153Sm) hydroxyapatite colloid | ||||
| V10AX03 | Dysprosium (165Dy) colloid | ||||
| V10AX04 | Erbium (169Er) citrate colloid | ||||
| V10AX05 | Rhenium (186Re) sulfide colloid | ||||
| V10AX06 | Gold (198Au) colloidal | ||||
| V10B | Pain palliation (bone seeking agents) | ||||
| V10BX | Various pain palliation radiopharmaceuticals | ||||
| V10BX01 | Strontium (89Sr) chloride | ||||
| V10BX02 | Samarium (153Sm) lexidronam | ||||
| V10BX03 | Rhenium (186Re) etidronic acid | ||||
| V10X | Other therapeutic radiopharmaceuticals | ||||
| V10XA | Iodine (131I) compounds | ||||
| V10XA01 | Sodium iodide (131I) | ||||
| V10XA02 | Iobenguane (131I) | ||||
| V10XA53 | Tositumomab/iodine (131I) tositumomab | ||||
| V10XX | Various therapeutic radiopharmaceuticals | ||||
| V10XX01 | Sodium phosphate (32P) | ||||
| V10XX02 | Ibritumomab tiuxetan (90Y) | ||||
| V10XX03 | radium (223Ra) dichloride | ||||
| V10XX04 | lutetium (177Lu) oxodotreotide | ||||
| V10XX05 | lutetium (177Lu) vipivotide tetraxetan | ||||
| V20 | Surgical dressings | ||||
| empty |
השינוי האחרון נעשה בֹ־17 באוקטובר 2024 ב־07:51